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1 Introduction 
The Diels-Alder (DA) reaction, first described in 1928 by Otto Diels and Kurt Alder
1
 and 
acknowledged with the Nobel Prize in 1950, involves the reaction of a diene A with a 
dienophile B to form a six-membered ring C (Scheme 1). By the exchange of any of the 
carbon atoms a-f with a hetero atom it becomes a hetero Diels-Alder reaction.
2
 And therefore 
what one often meets is the main classification into a DA and hetero DA reaction. In concern 
of my work it is more illustrative to categorize into a (normal) DA and an inverse electron 
demand Diels-Alder (IEDDA) reaction on the basis of the FMO theory (Figure 1). 
Scheme 1. Diels-Alder reaction. 
 
Today, the Diels-Alder reaction is one of the most powerful synthetic method both intensively 
applied in academia as well as in industry.
3
 Despite the age of the Diels-Alder reaction, by the 
simultaneous formation of two single bonds in a very controlled manner with high atomic 
economy, it meets more than ever the definition of a modern synthetic transformation. Also 
nature uses the Diels-Alder reaction, for example first postulated in 1980 by Black et al.
4
 for 
the biosynthesis of endiandric acids and 1982 confirmed by Nicolaou et al.
5
 by biomimetic 
synthesis (Scheme 2). 
Scheme 2. Biomimetic Diels-Alder key-step in the total synthesis of endiandric acid by Nicolaou. 
 
Recently, the question arose if nature also makes use of so called Diels-Alderases as a catalyst 
to overcome non-spontaneous cycloaddition reactions.
6
 Different reports appeared on the 
catalysis of Diels-Alder reactions by artificial antibodies or ribonucleic acid (RNA).
7
 
Eventually the long sought Diels-Alderase was found in the biosynthesis of spinosyn A 
(Scheme 3).
8
 However, it is stated that a stepwise [4+2]-cycloaddition cannot be ruled out at 
present. 
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Scheme 3. Diels-Alder reaction catalyzed by cyclase SpnF in the biosynthesis of spinosyn A. 
 
In spite of nature’s supremacy also in this field, chemists intensively studied the catalysis and 
stereoselective catalysis of the Diels-Alder reaction.
9–12
 
1.1 Mechanism of the Diels-Alder reaction 
As defined by the Woodward-Hoffmann rules the Diels-Alder reaction is a symmetry allowed 
suprafacial-suprafacial [4+2]-cycloaddition.
13
 One of the simplest and most successful 
methods to describe the mechanistics of the Diels-Alder reaction in more detail was found in 
the frontier molecular orbital (FMO) theory.
14
 The interaction of reactants was 
mathematically described by Klopman
15
 and Salem
16
 derived from the perturbation theory. 
The third term of the Klopman-Salem (KS) equation describes the interaction of occupied 
with unoccupied molecular orbitals (MO) of reactants, whereas the most important orbitals 
are the frontier molecular orbitals (FMO) as recognized by Fukui.
17
 The simplified third term 
of the KS equation (Eq. 1) can also be used to describe Diels-Alder reactions.
18–21
 
     
 
                                
 
 
                                
  (Eq. 1) 
This equation can be even further simplified by focusing on the dominant FMO interactions 
(Eq. 2). 
   
 
           
 (Eq. 2) 
According to this description (Eq. 2), the [4+2]-cycloaddition is generally divided into three 
modes by considering substituent effects on diene and dienophile.
19–21
 The DA reaction can 
be classified by the strongest interacting FMO’s into a normal and an inverse electron demand 
DA reaction (Figure 1). If both energy terms in Equation 1 are equal the reaction is called a 
neutral DA reaction. 
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Figure 1. Different classes of DA reactions by their electron demand. Red arrow denominates main 
interactions 
As described above, the best interaction arises from the overlap of the FMO’s, which are 
closest in energy. Thus, in the most common, the normal DA reaction the major energy 
contribution stems from the overlap of the diene’s HOMO with the dienophile’s LUMO and 
vice versa in case of the inverse electron demand DA reaction. The influence of substituents 
on the dienophile was described by Houk
19,20
 as following: 
-Electron releasing groups (ERG), increase both the HOMO and the LUMO energies, 
the former more than the later and the unsubstituted HOMO coefficient is larger than 
the substituted one. 
-Electron withdrawing groups (EWG), decrease HOMO and LUMO energies, the later 
more than the former and the unsubstituted coefficient is larger than the substituted one 
in both the LUMO and the HOMO but the difference of coefficients is greater in the 
LUMO. 
The substituent effects can be reasoned in the same manner for dienes as calculated by Houk 
(Figure 2).
19
 
 
Figure 2. MO coefficients of dienophiles and dienes substituted with ERG or EWG, by Houk.
19
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An essential prerequisite in the DA reaction is the s-cis conformation of the diene which, if 
congested or not possible by constrains, slows down or does not allow a DA reaction to 
proceed (Scheme 4).
22,23
 
Scheme 4. Steric or structural constrains in the s-cis/s-trans isomerisation of dienes. 
 
The ortho, meta and trans regiospecificity of a DA reaction was as well described using the 
perturbation theory.
19,20
 For this reason the frontier molecular orbital coefficients have been 
taken into account. The preferred sites of interaction of HOMO-LUMO are those of similar 
orbital coefficients. A high orbital coefficient of the HOMO reacts with the high orbital 
coefficient of the LUMO and the same is valid for small MO coefficients (Scheme 5). 
Scheme 5. Ortho, meta, para regioselectivity of the DA reaction. 
 
The diastereoselectivity of the DA reaction is determined via the endo or the exo transition 
state and products thereof, also known as Alder’s endo rule. The rule formulated by Alder and 
Stein
24
 points out based on empirical data that an endo transition state is preferred over an exo 
transition state although it is often the more sterically crowded one (Scheme 6). 
Scheme 6. The endo-product is preferred according to the Alder rule. 
 
The origin of the endo-rule is still under discussion. An old and still prominent rationalization 
is the secondary orbital interaction (SOI) of the not directly in the bond forming process 
involved parts of the π-system. This effect, first coined by Woodward and Hoffmann13 can 
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only act if this part can overlap as it is the case in the endo-TS (Scheme 6). Although SOIs 
have been confirmed by Houk and Schleyer et al.
25
 as the cause of endo-selectivity, they 
remain controversial.
26
 The endo selectivity as well as the DA reaction itself is very sensitive 
to sterical interactions, being able to reverse endo/exo-selectivity as well as slowing down the 
reaction.
27
 
The synchronicity of the formation of the two bonds determines the stereochemical outcome, 
conserving E/Z-stereoinformations in the product, which is known as the cis principle also 
first illustrated by Alder and Stein (Scheme 7). 
Scheme 7. Cis-principle, the preservation of E/Z-stereoinformation in the product. 
 
1.2 Hetero Diels-Alder reaction 
The hetero (normal) DA reaction is also a very broad applied method to obtain six membered 
heterocyclic systems.
2,28–30
 By incorporation of an electronegative heteroatom mostly oxygen 
or nitrogen in the dienophile, its LUMO decreases to obtain a better interaction between the 
HOMO of the diene. The most common hetero dienophiles are oxa, aza and nitroso 
compounds (Figure 3). 
 
Figure 3. Most common heterodienes and dienophiles in the hetero (normal) DA reaction. 
The aza dienes in turn react mainly by HOMO control in a normal DA reactions and the oxa 
dienes by LUMO control in an IEDDA reaction as discussed later in Chap. 0.  
The oxa DA is utilized to form a dihydropyran by reaction of aldehyde or ketone with an 
electron rich diene.
30–33
 The reaction was first discovered by Gresham and Steadman in 1949 
by reacting 1,3-butadiene 14 and formaldehyde 15 to give dihydropyran 16 (Scheme 8). 
Introduction 
6 
Scheme 8. First reported oxa DA reaction. 
 
The oxa DA reaction is usually only feasible in connection with a Lewis acid catalyst and as 
such has been applied to the total synthesis of a broad range of natural products. It has for 
example been used as a key step in the total synthesis of phorboxazole B (20), where 
Brassard’s diene 17 was reacted with aldehyde 18 in a diastereoselective manner, catalyzed 
by Eu(fod)3 (Scheme 9).
34
 
Scheme 9. Eu-catalyzed oxa DA step in the total synthesis of phorboxazole B. 
 
As well as the oxa DA, the aza DA reaction is used to produce piperidine by employing 
imines or iminium ions and electron rich dienes.
30,35
 The applicability of this cycloaddition 
has been demonstrated in the brief total synthesis of dihydro lupinine (24) and dihydro epi-
lupinine (23) via in situ formation of iminium ion 22, which undergoes the intramolecular DA 
(Scheme 10).
36
 
Scheme 10. In situ generation of an iminium ion that undergoes an aza DA reaction to form lupinines. 
 
Also azadienes are regularly used in the total synthesis of natural products like Moody and co-
workers showed in the key step of the synthesis of amythiamicin D (28) by their “biomimetic” 
DA reaction of 2-azabutadiene 25 (Scheme 11).
37
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Scheme 11. The DA reaction of 2-azabutadiene as key step in the synthesis of amythiamicin D. 
 
The 1-azabutadiens are less often encountered since they are less reactive than 2-
azabutadienes
38
 but in a recent total synthesis of (–)-methyl palustramate (33) a 1-
azabutadiene 29 was applied (Scheme 12). 
Scheme 12. Usage of a 1-azabutadiene in the total synthesis of (–)-methyl palustramate. 
 
Nitroso-dienophiles are often used to either form pyrrolidines or piperidines as it is nicely 
presented in the total synthesis of the marine alkaloids fasicularin (36) and lepadiformine (37) 
(Scheme 13).
39
 
Scheme 13. Total synthesis of fasicularin and lepadiformine via intramolecular DA reaction of a 
nitroso-dienophile. 
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1.3 Retro Diels-Alder reaction 
The DA reaction is a reversible process. Since the entropy of the product compared to the 
starting materials decreases, the entropy term is negative, so that in principle a DA reaction 
can be thermally reversible (Scheme 14). The so called retro DA or [4+2]-cycloreversion 
allows the stereospecific formation or restoration of unsaturated bonds. The retro DA reaction 
is most useful where thermally very stable compounds occur such as aromatics, nitrogen, 
carbon dioxide or where one product can be degassed or scavenged during the reaction. 
Scheme 14. Reversibility leading to the Retro DA at elevated temperatures. 
 
This strategy has intensively been used in total synthesis for the protection of one or two 
double bonds. Because most of the retro DA reactions make use of extensive heating the 
procedures are not always convenient and often involve elaborate equipment such as flash 
vacuum pyrolysis (FVP). In turn, some of the methods are very elegant and will be mentioned 
in the following. Such a practical example is the reversible protection of dienes by 4-phenyl-
1,2,4-triazoline-3,5-dione (PTAD) that can be cleaved under basic treatment at mediocre 
temperatures (Scheme 15).
40,41
 
Scheme 15. Protection of sterol 38 by PTAD and release by cycloreversion in the synthesis of a 
vitamin D3 derivative 40. 
A common way to protect double bonds is via norbornene as in 41 which under thermolysis 
fragments into cyclopentadiene and the desired dienophile as displayed in the final step of the 
total synthesis of (±)-diepoxin σ (42) (Scheme 16).42 
Scheme 16. Restoration of a double bond by a retro DA reaction. 
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Recently, tetramethylnorbornadiene has been used as an acetylene equivalent in the synthesis 
of substituted malonic cyclopentenones 44, where the diene is consumed by the more reactive 
acid anhydride (Scheme 17). 
Scheme 17. Retro DA reaction of tetramethylnorbornene giving rise to cyclopentanones. 
 
Another application of the [4+2]-cycloreversion is the addition of one dienophile B and the 
release of another E by cycloreversion, creating new functionalities (Scheme 18).
43–46
 
Scheme 18. DA/retro DA reaction transforming compound A into D. 
 
A common method in this sense is the synthesis of furans via DA of an alkyne and an oxazole 
and subsequent retro Diels-Alder of the oxa-azabicycle under evolution of hydrogen cyanide. 
This strategy has very recently been used in the synthesis of furanosteroid (47) via 
intramolecular DA/retro DA reaction of oxazole 45 (Scheme 19).
47
 
Scheme 19. Studies of the use of DA/retro DA reaction for the formation of furans in the synthesis of 
furanosteroids. 
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1.4 Inverse electron demand Diels-Alder reaction 
In the inverse electron demand Diels-Alder (IEDDA) reaction, electron rich dienophiles react 
with electron deficient dienes, i.e. the interaction of the HOMO of the dienophile with the 
LUMO of the diene gives the major contribution to the reaction energy (Figure 1). For this 
reason the diene is either consisting of very electronegative heteroatoms or substituted by 
EWGs. 
The existence of the IEDDA reaction was first demonstrated through a kinetic study in the 
early 60’s by Sauer and Wiest.48 One of the first IEDDA reactions was the synthesis of 
pyridazines 51 from 1,2,4,5-tetrazines 48 (Scheme 20) in the late 50’s49 by Carboni and 
Lindsey. Since its discovery, the IEDDA reaction of tetrazines has gradually gained in interest 
over the past fifty years and nowadays offers a broad application spectrum.
50,51
 
Scheme 20. First IEDDA reaction by Carboni and Lindsey to synthesize substituted pyridazines. 
 
Often, the IEDDA reaction involves hetero dienes, so that one can meet certain ambiguity 
concerning the equal semantic usage of “hetero” and “inverse electron demand” that is 
especially not possible since hetero DA reactions of heterodienophiles are generally normal 
DA reactions as we have seen in Chap. 1.2. 
Frequently, also non-hetero dienes can be found in the IEDDA reaction. A very common 
diene in this perspective is the α-pyranone 52, which for example has been used in the total 
synthesis of (±)-occidentalol 56 within a DA/cycloreversion cascade (Scheme 21).
52
 
Scheme 21. IEDDA reaction involving pyranone in the total synthesis of (±)-occidentalol. 
 
Or recently the total synthesis of (±)-galanthamine (61) was presented, where an 
intramolecular cycloaddition of pyranone 59 at lower temperatures did not further proceed to 
eliminate carbon dioxide (Scheme 22).
53
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Scheme 22. Pyranone in an intramolecular IEDDA reaction employed in the total synthesis of (±)-
galanthamine. 
 
Also o-Quinones have been engaged in cycloaddition as an electron deficient dienophile. This 
is shown by a late example where the reactivity of o-fluoranil (62), a perfluorinated o-quinone 
was studied (Scheme 23). 
Scheme 23. O-fluoranil as a very electron deficient homo dienophile in the IEDDA reaction. 
 
As discussed above much often encountered in the IEDDA reaction is the use of a hetero 
dienophile where one or more atoms are exchanged by more electronegative atoms (Figure 3). 
In this perspective the 1-azadiens are rather part of the normal DA reactions. But none the 
less, they can be activated with an EWG as in N-sulfonyl-1-azadienes developed by Boger et 
al. and applied to the total synthesis of nothapodytine B (69),
54
 by reacting sulfonyl-1-
azadiene 66 with the electron rich ketene acetal 67 and other natural products (Scheme 24).
55
 
Scheme 24. Activated N-sulfonyl-1-azadiene in the total synthesis of nothapodytine B. 
 
1.4.1 Inverse electron demand Diels-Alder reaction of aza-heteroaromatics 
The “azine” DA reactions involve the reaction of nitrogen heteroaromatics as electron 
deficient dienes. The DA reaction of such compounds is also sometimes called hetero DA 
reaction and is further strictly termed an inverse electron demand hetero DA reaction. 
The IEDDA reaction of heteroaromatics A generally follows a DA/retro DA reaction scheme 
as described in Chap. 0, where often molecular nitrogen is formed. The diene intermediate D 
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can rearomatize by oxidation or by elimination of a leaving group, which can be introduced 
with both the diene and the dienophile B as we will see later (Scheme 25). 
Scheme 25. DA/retro DA reaction of heteroaromatics. 
 
1.4.2 Inverse electron demand Diels-Alder reaction of tetrazines 
The 1,2,4,5-tetrazine
56
 is the only really described diene in the IEDDA reaction, where the 
DA chemistry of 1,2,3,4-tetrazines
57
 and 1,2,3,5-tetrazines is rather unknown (Figure 4). 
 
Figure 4. All possible tetrazines. 
Tetrazines are often substituted with EWG to further lower the LUMO energies to facilitate 
the reaction with an electron rich dienophile. In turn, the dienophiles posses ERGs to obtain 
an electron rich double bond concomitantly increasing the HOMO energy. Sauer et al. have 
intensively studied the kinetics of the IEDDA reaction of 1,2,4,5-tetrazine with a variety of 
different dienophiles, giving an excellent assumption about the general reactivity of 
dienophiles (Figure 5).
58
 
 
Figure 5. A selection of the most important dienophiles in the reaction with 1,2,4,5-tetrazine with the 
relative kinetic rate constants in M
-1
s
-1
 at 20°C in 1,4-dioxane. 
Thereby, nitrogen is a much better ERG than oxygen. The linear dienophiles are more 
reactive than their cyclic analogues and the reactivity of the linear dienophiles is very much 
depending on the bulk of the second ERG, more than on its electronic effect.
59
 
The IEDDA reaction of tetrazines, as Carboni and Lindsey realized in their pioneering work, 
has been used to synthesize diazines (Scheme 20) and has been very much put forward by the 
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work of Boger and co-workers. A neat way they made use of the pyridazine synthesis, is the 
divergent method to react tetrazine 70 to indoline 73 or pyrrole 72 via 1,2-diazine 71, which 
has been intensively used in the natural product synthesis (Scheme 26).
60
 
Scheme 26. Divergent method via IEDDA reaction to access highly substituted indoles and pyrroles. 
 
Compared to conventional synthetic methods, this method gives direct access to highly 
substituted heteroaromatics, such as lately displayed in the total synthesis of lycogarubin C 
(77) (Scheme 27). 
Scheme 27. Total synthesis of lycogarubin C utilizing the tetrazine → diazine → pyrrole DA strategy. 
 
The IEEDA reaction strategy to access indoles from tetrazine via diazine was put into context 
in the total synthesis of trikentrin A (83) (Scheme 28).
61
 
Scheme 28. The divergent tetrazine → diazine → indoline DA strategy applied in the total synthesis of 
cis-trikentrin A. 
 
Lately the IEDDA reaction of 1,2,4,5-tetrazine 85 was extensively used as a ligation reaction 
with the very strained trans-cyclooctenes 84 (Scheme 29).
62–65
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Scheme 29. IEDDA reaction of strained trans-cyclooctenes for the ligation of thioredoxin (Trx). 
 
1.4.3 Inverse electron demand Diels-Alder reaction of triazines 
In case of the triazines all possible isomers in Figure 6 are well described dienes in the 
IEDDA reactions to form pyridines and pyrimidines after a DA/retro DA-rearomatization 
procedure with elimination of nitrogen or cyanides and a leaving group (Scheme 25). 
 
Figure 6. Triazines used in the IEDDA reaction. 
The first two members of the triazines have been well investigated around thirty years ago but 
the 1,2,3-triazine although known since the 80’s66 has only very recently been disclosed by 
Boger and co-workers.
67,68
 The triazines react on the positions marked by doted circles 
(Figure 6). The performance of the triazines in comparable reactions is as following, 1,2,4-
triazine ≈ 1,3,5-triazine > 1,2,3-triazine, although calculations predict different.68 It seems that 
1,2,3,-triazines react rather in a HOMO controlled reaction i.e. a normal DA reaction as the 
different reactivity of amidine 87 toward the 1,3,5-triazine 89 and 1,2,3-triazine 91 shows 
(Scheme 30).
68,69
 
Scheme 30. Different reactivity of 1,2,3-triazine and 1,3,5-triazine in the reaction with amidine. 
 
Besides the detailed studies of the scope of the IEDDA reaction of triazines, 1,2,4-triazines 
have been applied in total synthesis.
70
 The IEDDA reaction of 1,2,4-triazine is still used to 
generate highly substituted pyridines as displayed in the key step of the total synthesis of 
louisianin A (96) (Scheme 31).
71
 
Introduction 
15 
Scheme 31. Application of 1,2,5-triazine in the synthesis of louisianin A. 
 
1.4.4 Inverse electron demand Diels-Alder reaction of diazines 
The 1,2-diazine dienes are much less reactive than tetrazines and even less reactive than 
triazines in the IEDDA reaction. None the less, the IEDDA reaction of 1,2-diazene was 
initially described over three decades ago.
[5,6]
 However, due to the relatively high energy of 
the LUMO of diazines, the reaction requires harsh conditions that limit the utility of this 
valuable transformation. Therefore, this reactions are only scarcely disclosed and commonly 
only involve IEDDA reactions of activated diazines with very electron rich dienophiles such 
as propynamines or ethenamines (Figure 5).
50,51
 These reactions are described for all of the 
diazines in Figure 7. 
 
Figure 7. Diazines used in the IEDDA reaction. 
Pyrazine and pyrimidine react under extrusion of a cyanide to form pyridines after elimination 
of a leaving group. Because of the poor reactivity and since they lead to the same product as 
the more reactive triazines, the application of this diazines is very limited, although the 
methodology of pyrimidine especially in the intramolecular IEDDA was thoroughly explored 
in the 80’s by van der Plas.72–81 The method has been utilized to synthesis cerpegin (99) 
(Scheme 32).
82
 
Scheme 32. Intramolecular IEDDA reaction of pyrimidine for the synthesis of cerpegin. 
 
The first IEDDA reaction of electron deficient pyridazine was described by Neunhoeffer et al. 
almost forty years ago.
83
 The reaction follows the usual course (Scheme 25), where the 
pyridazine 100 first undergoes an IEDDA reaction with methoxy ethenamine 101 to obtain 
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cycloadduct 102, which after extrusion of molecular nitrogen and rearomatization by 
elimination yields aniline 104 (Scheme 33). 
Scheme 33. First IEDDA reaction of electron deficient pyridazine. 
 
This was followed later by the intramolecular approach by Jojima et al. where an alkene 
tethered to pyridazine 105 was reacted at 210°C in diethylaniline (DEA) to obtain 
hydroxyxanthene 107 (Scheme 34).
84
 
Scheme 34. First intramolecular IEDDA reaction of pyridazine. 
 
For preliminary studies towards a total synthesis Boger and co-worker developed a general 
indoline synthesis via pyridazine linked alkyne 108 (Scheme 35). Later they used the strategy 
in conjunction with an IEEDA reaction of 1,2,4,5-tetrazine 78 in the total synthesis of 
trikentrin A (83) (Scheme 28). 
Scheme 35. Indoline synthesis by an IEDDA reaction of alkyne linked to pyridazine. 
 
With the synthesis of the highly electron rich dienophile 2-alkylidene-imidazolidines 112, 
Heuschmann and Gruseck were able to react unsubstituted pyridazine and phthalazine 111 
although still at rather high temperatures (Scheme 36).
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Scheme 36. Highly electron rich dienophile in the IEDDA reaction with unsubstituted 1,2-diazines. 
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Further studies concerned different EWG substituted i.e. activated pyridazines such as 4,5-
dicyanopyridazine
86–89
 and intramolecular IEDDA reactions of pyridazine.
90–93
 Hence, the 
intramolecular IEDDA reaction found other applications in the total synthesis of 
amaryllidaceae alkaloids
94
 and in the formal synthesis of (±)-strychnine (118) (Scheme 37).
95
 
Scheme 37. Formal total synthesis of (±)-strychnine via indole linked to pyridazine. 
 
There is little known about the reactivity of phthalazines in the IEDDA reaction with electron 
rich dienophiles. Oishi and co-worker have reported the reaction of ynamines and enamines in 
the reaction of 1-substituted phthalazines. The reaction of enamine 120 with phthalazines 119 
proceeded only at high temperatures of 120 – 160 °C with the enamine as solvent to give the 
corresponding naphthalene 121 in yields of 33 – 86% depending on the level of electron 
withdrawal of the substituent (Scheme 38).
96
 
Scheme 38. IEDDA reaction of enamine with 1-substituted phthalazines. 
 
The sterically less hindered diethylethynamine is more reactive undergoing a cycloaddition 
with 1-substituted phthalazines 119 at 25 – 80 °C (Scheme 39). Since, compared to the 
enamines, some of the products did not match a concerted reaction path, a zwitterionic 
intermediate was suggested, which then leads to different products. The 1-chlorophthalazine 
119c underwent a second addition of diethylethynamine and a ring closure reaction to give a 
6-membered heterocycle 126, which by elimination of hydrogen chloride gives the 
phenylpyridine product 127 in 68% yield.
97
 The substituents which stabilize the negative 
charge in the 1-position led to the substituted naphthalene product 124 and in the case of the 
benzoyl residue the diazocin by-product 129 was observed in a 1:1 ratio (Scheme 39).
98
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Scheme 39. Reaction of phthalazines with diethylethynamine reacting by a zwitterionic intermediate. 
 
Very recently, a silver catalyzed formal IEDDA reaction of substituted and unsubstituted 
phthalazine 130 with triisopropylsilyloxyethyne 131 was reported by Rawal et al. to give 
substituted naphthalenes 135 with good yields at room temperature (Scheme 40).
99
 The 
mechanism of the reaction is very similar to the one discussed by Oishi (vide supra). The 
catalytic cycle starts with the complexation of the acetylene 131 and diazine 130 by silver 
which then undergoes a nucleophilic attack resulting in diazaenolate intermediate 133. Further 
intramolecular addition and elimination of molecular nitrogen produces the substituted 
naphthalene product 135 in good yields of 67 - 95% (Scheme 40). It is however interesting to 
mention that in the silver catalyzed formal IEDDA reaction, 1-chlorophthalazine instead of 
yielding phenylpyridine similar to 127 resulted in the desired 1-chloronaphthalene 135a. 
Scheme 40. Silver (I) catalyzed reaction of phthalazine with oyxethyne to produce substituted 
naphthalene. 
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1.5 Lewis acid catalysis 
A Lewis acid is a molecular entity that acts as an electron-pair acceptor, able to react with an 
Lewis-base to form an Lewis-adduct.
100
 This is a definition for acids and bases, formulated by 
G. N. Lewis in 1923. It is a more general view of acidity compared to the Brønsted model, 
which defines acid and base as proton donor and acceptor. In catalysis the Lewis acid presents 
one of the most widely used kind of catalysts. Lewis acids used in organic chemistry are alkali 
and alkaline earth metals such as Li, Na, Mg, and Ca, transition metals e.g. Sc, Ti, Zr, Hf, V, 
Mo, Cu, Ag, Au, Zn, and Hg, lanthanides for example La and Yb or post transition metals and 
metalloids such as B, Al and Si which can be employed in a hetero or homogenous fashion.
101
 
According to the above definition the Lewis acid acts as a promoter or catalyst by accepting 
an electron pair of a Lewis base i.e. an electrophile which by donation of electron density to 
the Lewis acid becomes electron deficient and, therefore, more reactive towards an electron 
rich reagent such as a nucleophile. In the FMO picture the Lewis acid catalyst acts by 
lowering the LUMO energy of the electrophile, the dienophile in the normal DA or the diene 
in the IEDDA reaction (Figure 8). 
 
Figure 8. Decrease of the energy of the LUMO of the Lewis base i.e. donor (D) by the interaction with 
a Lewis acid (LA).
30
 
The applica355tion of Lewis acids as catalysts or promoters encompasses a wide range of 
different reactions. Most prominently is the use of the Lewis acids AlCl3 or FeCl3 in the 
Friedel Crafts reaction. Lewis acids are used for the polymerization of alkenes. Ether cleavage 
of linear or cyclic ethers such as epoxides or oxethanes is also promoted by Lewis acids. A 
well known aldol reaction is the Mukaiyama reaction. This reaction is catalyzed by TiCl4 or 
by a chiral catalyst as shown in the total synthesis of taxol 143 where Mukaiyama used his 
method even two times (Scheme 41).
102
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Scheme 41. Total synthesis of Taxol by Mukaiyama with his catalyzed aldol reaction. 
 
A hot topic in the field of Lewis acid chemistry is the application of frustrated Lewis pairs, 
which is a pair of Lewis acid and base sterically too hindered to form a ‘classical’ Lewis acid-
base adducts. This was first noticed by Brown et al.
103
 in the mixture of BMe3 149 and 
lutidine 148 which did not react to form a complex 150 (Scheme 42).
104
 
Scheme 42. First notification of a frustrated Lewis pair. 
 
Recently, Stephan and co-worker presented a hydrogenation of olefins catalyzed by the 
frustrated Lewis pair combination of tris(perfluorophenyl)boron and (perfluorophenyl)-
diphenylphosphine at room temperature.
105
 
1.5.1 Lewis acids in the Diels-Alder reaction 
Also in the DA reaction Lewis acids have found intensive application for the activation of the 
dienophile in the normal DA reaction and the activation of diene, or heterodienes in the 
IEDDA reaction as depicted in Figure 9. 
 
Figure 9. Effect of Lewis acid on the dienophile or diene in the normal DA and the IEEDA reaction. 
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In the normal DA reaction the Lewis acid (LA) decreases the LUMO energy of the dienophile 
B and in the IEDDA reaction the LUMO of the diene A to assure a better interaction with 
either the HOMO of the electron rich diene A’ or the HOMO of a dienophile B. 
In the beginning of the 60’s Yates and Eaton recognized that AlCl3 is able to greatly enhance 
the activity of the dienophilic maleic anhydride 152 in the reaction of anthracene or 
dimethylnaphthalene 151 to give the DA adduct 153 (Scheme 43).
106
  
Scheme 43. Pioneering Lewis acid promoted DA reaction. 
 
Ten years later, Corey et al. were the first to utilized the concept of Lewis acid catalyzed DA 
in total synthesis for the preparation of the key intermediate 156 in the synthesis of 
prostaglandin 157 (Scheme 44).
107
 
Scheme 44. Copper(II) catalyzed DA key step in the total synthesis of prostaglandin. 
 
Consequently, they developed a highly enantioselective version of their Lewis acid catalyzed 
DA by the use of a (S)-pulegone derived acrylate 158 as an asymmetric inductor (Scheme 
45).
108
 
Scheme 45. Enantioselective formal synthesis of Prostaglandin Fα2 via Lewis acid catalyzed DA 
reaction. 
 
Following up on the preliminary results of Corey, Koga and co-workers apparently asked 
themselves if the chiral auxiliary can be part of the catalyst. So they conducted the first 
described enantioselective DA reaction catalyzed by a chiral Lewis acid, an aluminum 
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compound as well based on (S)-pulegone.
109
 This results constituted the initiation of the very 
attractive field, the enantioselective Lewis acid catalyzed DA reaction.
9-11,110-112 
1.5.2 Bifunctional Lewis acids in catalysis 
Nature’s highly complex catalytic proteins the enzymes are the true master of using multi 
point binding. A famous example is the catalytic triad of serine proteases such as trypsin. Or 
the very illustrative example of the chorismate mutase which catalyzes a [3,3]-sigmatropic 
rearrangement of chorismate to prephenate involving multidentate hydrogen binding events 
(Figure 10).
113–115
 
 
Figure 10. Complexation of a transition state analog in the active site of E. coli chorismate mutase.  
To use hydrogen bonding by Brønsted acids to activate substrates in a bidentate fashion is a 
still emerging field in catalysis. There are different examples, where double hydrogen 
bonding is the key principle of activation. As in the case of thiourea catalysis
116–121
 where 
Takemoto and co-workers developed a Michael addition of nitroolefins (161)
122
 as well as 
,-unsaturated imines to malonates (162).123 Another example is the Brønsted acid-catalyzed 
IEDDA reaction of azabutadiene (163) and electron-rich alkenes.
124
 In all these complexes a 
bidentate coordination of the two acid protons to two different sites, oxygen or nitrogen is 
proposed (Figure 11). 
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Figure 11. Brønsted acid catalysts acting as bidentate activators. 
As observed in the pioneering work of Yates and Eaton the Lewis acid has a tremendous 
effect on the reaction rate that is attributed to the decrease of the LUMO energy upon 
coordination to the dienophile, which improves the overlap and facilitates the reaction, 
leading to higher regioselectivity as well as milder reaction conditions (Scheme 43 and Figure 
9).
125
 However, in most of the cases of Lewis acid catalysis monodentate Lewis acids are 
employed. 
The first study of the reactivity of a bidentate Lewis acid was conducted 40 years ago by 
Biallas and Shriver.
126
 They examined the cleavage of bis(triphenylmethyl)ether by bidentate 
1,2-bis(difluoroboryl)ethane and the reactivity of the formed complex. For a long time no 
attention was given to bidentate Lewis acids until twenty years later, Wuest and co-workers 
began to intensively study the coordination chemistry of multidentate Lewis acids. They 
commenced with the investigation of dihalogen-1,2-phenylenedimercury compounds in the 
complexation with chloride anion (165)
127
 and dimethylformamide (166)
128
 (Scheme 46). 
Scheme 46. Bidentate mercury Lewis acid in the complexation of chloride and dimethylformamide 
 
This investigations showed that the association of carbonyl compounds with organomercury 
compounds are weak, but also that a double coordination involves stronger structural changes 
(bond lengthening) than single coordination. Although the target was to develop stronger 
multidentate Lewis acids for the application in chemical reactions they did not succeeded and 
have not reporting any progress in this field ever since.
129
 Reilly and Oh worked on the 
stronger bidentate boron Lewis acid, based on a naphthalene framework and showed in the 
90’s the application of their Lewis acid as chiral catalyst with chiral ligands in the DA 
reaction. They used chiral ligands such as amino acids 171 and diols with 10 mol% Lewis 
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acid 169 to catalyze the reaction of acrylaldehyde 167 and cyclopentadiene 168 (Scheme 
47).
130
 
Scheme 47. Example of bidentate Lewis acid with chiral ligand employed in the DA reaction. 
 
However, they did not compare their results with a monodentate Lewis acid and indicated that 
the structure and the mode of complexation is unknown. Further results of the complexation 
of their bidentate Lewis acid with a more Lewis basic substrate suggested an equilibrium of a 
mono and bidentate coordination mode.
131
 Eventual comparison of the bidentate 1,8-
bis(dichloroboryl)-naphthalene 169 with phenylboron dichloride in the DA reaction of butenal 
with cyclopentadiene resulted even in a slightly inferior performance of the bidentate Lewis 
acid.
132
 
Maybe inspired by Wuests late work, Maruoka showed for the first time the beneficial 
application of a bidentate aluminum Lewis acid BD in a chemical reaction.
133
 By the 
comparison of the bidentate Lewis acid BD together with a monodentate Lewis acid MD in 
promoting the reduction of ketone 172 with Bu3SnH, he showed the superiority of the 
bidentate Lewis acid BD in this transformation (Scheme 48). 
Scheme 48. First example of a superior bidentate Lewis acid in a chemical reaction. 
 
The transformation did hardly work in the presence of a monodentate Lewis acid MD which 
showed the further enhancement in electrophilicity of the ketone 172 by an additional bonding 
in the bidentate Lewis acid complex. In the same publication they showed the enhanced effect 
of BD on the Mukaiyama aldol reaction of silylenolates with Michael acceptors as well as on 
the Claisen rearrangement. Later on, the concept was also applied to the Meerwein–
Ponndorf–Verley (MPV) reaction (also in an asymmetric fashion), and the Tishchenko 
reaction.
134
 In view of a wider applicability of the bidentate Lewis acid in catalysis they 
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started to design titanium based Lewis acids able to catalyze the reduction of ketone with 
Bu3SnH by 10-20 mol% of catalyst.
135,136
 With the same catalyst also the catalytic cleavage of 
epoxides was shown. Also, they showed the application of a chiral titanium based bidentate 
Lewis catalyst in the asymmetric 1,3-dipolar cycloaddition.
137
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2 Objectives of the Thesis 
The IEDDA reaction of 1,2-diazines presents for instance a facile route to complex 
substituted aromatic compounds (Scheme 49). 
Scheme 49. A convenient access to complex substituted aromatic compounds via IEDDA reaction of 
1,2-diazines. 
 
Despite the immense effort devised into this field of research, the reaction of 1,2-diazines as 
the diene is only scarcely disclosed and focus mainly on 1,2-diazines substituted by electron 
withdrawing groups or intramolecular reactions. The reason for this is the very high laying 
LUMO energy of unsubstituted diazines, which makes them hardly reactive even towards 
electron rich dienophiles. To activate the diazine as the diene in a IEDDA reaction a catalyst 
had to be developed to serve the purpose of lowering the LUMO energy of the 1,2-diazine 
enabling the reaction with a electron rich dienophile. A general method to achieve the 
decrease of the energy of a LUMO is the utilization of a Lewis acid. Based on the pre-
evaluated bidentate Lewis acid as catalyst for the IEDDA reaction of 1,2-Diazines the method 
had to be developed, consequently leading to the following aims, set as cornerstones of this 
thesis: 
(1) The establishment of a new more direct and convenient route for the synthesis of 5,10-
dimethyl-5,10-dihydroboranthrene to obtain useful amounts of the catalyst. 
(2) The corroboration of catalysis of the IEDDA reaction of 1,2-diazines by the bidentate 
Lewis acid. 
(3) The investigation of the scope of the bidentate Lewis acid catalyzed IEDDA reaction on 
both the dienophile as well as on the diene side. 
(4) The elucidation of the mechanism of the Lewis acid catalyzed IEDDA reaction by 
experimental and computational techniques. 
(5) The examination of an application of the catalytic IEDDA reaction. 
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3 Results and Discussion 
3.1 The development of a catalyst for the IEDDA reaction of 1,2-diazines 
3.1.1 Introduction 
The IEDDA reaction of 1,2-diazines described above requires harsh conditions. The diazine 
needs to be substituted by one or more EWGs or the cycloaddition is conducted in an 
intramolecular fashion. Altogether, considerably limits the scope and, therefore, the 
applicability of the IEDDA reaction of 1,2-diazines. Consequently, a catalyzed version of this 
reaction would enter a versatile synthesis of highly substituted aromatics (Scheme 50). 
Scheme 50. IEDDA reaction of 1,2-diazines for the synthesis of substituted aromatics. 
 
Since the poor reactivity is associated with the high LUMO energy of the 1,2-diazine, its 
energy must be lowered. The task of decreasing the LUMO energy is commonly 
accomplished by coordination with a Lewis acid. Thus, the idea of activating the 1,2-diazine 
A by a simultaneous complexation of a bidentate Lewis acid B with both of the vicinal 
nitrogen atoms was formulated (Scheme 51). 
Scheme 51. Activation of a 1,2-dazine by multipoint complexation with a bidentate Lewis acid. 
 
Furthermore the catalytic cycle has been envisioned based on the widely accepted mechanism 
described in Scheme 52 as following: The bidentate Lewis acid B complexes the incoming 
1,2-diazine A, the formed complex C and dienophile D undergo a IEDDA reaction to the 
adduct E which further eliminates molecular nitrogen and consecutively the leaving group 
(LG) to yield the final aromatic product F and regenerating the Lewis acid catalyst B (Scheme 
52).
138–141
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Scheme 52. Envisioned Catalytic cycle of a bidentate Lewis acid catalyzed IEDDA reaction of 1,2-
diazine 
 
A variety of different binuclear complexes with pyridazine or phthalazine are known bearing 
Cu
142,143
, Fe
144
, Sn
145
, Rh
146
, Pt
147
 as Lewis acid. An indium based bidentate Lewis acid 174 
was utilized by Gabaï et al. to selectively bind 1,2-diazine 111 in the presents of the other two 
diazine isomers, 1,3- and 1,4-diazine.
148
 The reason for the higher affinity of the Lewis acid 
towards 1,2-diazine lies in the bidentate binding mode (Scheme 53). This was also observed 
in the solid state structure of the complex 175. 
Scheme 53. Bidentate complexation of an indium Lewis acid to a 1,2-diazine. 
 
A boron based bidentate Lewis acid/1,2-diazine complex 178 was synthesized by Piers and 
co-workers
149
 (Scheme 54). This intensely colored adduct is isoelectronic with triphenylene. 
DFT calculations reveal the localization of the LUMO mainly to be on the 2,2’-
diborabiphenyl moiety. 
Scheme 54. Complexation of pyridazine by a bidentate boron Lewis acid. 
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In parallel to this work, Wagner and co-workers demonstrated the synthesis of boron doped π-
conjugated polymers 182 via hydroboration of alkyne 181 with 9,10-diboraanthracene 179 
(Scheme 55).
150
 Furthermore, the formation of a complex 180 with 1,2-diazine 111 was 
shown. They expected an analogous complex of their polymer 182 to exhibit enhanced 
properties such as better stability with respect to oxidation and hydrolysis. But such a 
complex has not been described so far and complex 180 was not further investigated. 
Scheme 55. Dihydroboranthrene as versatile building block for boron doped π-conjugated polymers. 
 
In conclusion, literature suggested a boron based Lewis acid to be most promising. For the 
evaluation of potential boron based bidentate Lewis acids as catalysts for the IEDDA reaction 
of 1,2-diazines the three existing types 185, 186 and 187 have been calculated by DFT on 
b3lyp/6-31g(d,p) level of theory (Figure 12: selected examples).
151
 
 
Figure 12. Pyridazine and phthalazine in the complexation with Lewis acids with FMO energies in eV. 
The LUMO energies of all three types of complexes 185 – 187 exhibit a large decrease 
compared to the uncomplexed pyridazine. The same effect was also computed from the 
complex of boranthrene and phthalazine 184. The calculations revealed that not only the 
LUMO of complex 187 is rather located on the Lewis acid entity than on the diazine, but also 
its energy is higher than the LUMOs of the remaining complex. Since the FMO energies of 
complex 185 and 186 are similar and both of their LUMOs are located on the diazine, Lewis 
acid 192 was chosen to be studied as a catalyst due to its possible smaller spatial extend over 
the faces of the diazine moiety in complex 185. 
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3.1.2 Synthesis of the bidentate Lewis acid catalyst 
The dihydroboranthrene framework was first synthesized in the mid 60’s152 from a mercury 
compound and little later it was synthesized by Siebert et al. from a borate.
153
 Siebert and co-
workers used the dihydroboranthrenes to form complexes with a variety of different transition 
metals.
154–156
 The first practically appealing method to synthesize dichloro-
dihydroboranthrene 189 was devised by Kaufmann in the late 80’s by the dimerization of neat 
o-boryltrimethylsilylbenzene 188 at 135 °C.
157
 
Scheme 56. Dimerization of boron compound 188 to dichloro dihydroboranthrene 189. 
 
Kaufmanns approach was elected as the most suitable one. The dihydroboranthrene 192 was 
prepared in four steps (Scheme 57). The synthesis commenced with a Li/Br exchange and 
consecutive silylation to result in 1,2-bis(trimethylsilyl)benzene (191).
158
 One of the TMS-
groups was selectively substituted with BCl3 to give the monoboronated product 188 
according to a procedure published also by Kaufmann.
159
 The dimerization key step was 
conducted at 135 °C for 24 h as shown below
157
 and the final dimethyl dihydroboranthrene 
192 was achieved by methylation with methyl lithium.
154
 
Scheme 57. First generation synthesis of dimethyl dihydroboranthrene by a four step sequence. 
 
However, for the preparation of several hundred milligrams, the four-step sequence with an 
overall yield of less than 5% seemed not appropriate. Therefore, the synthesis was optimized 
to provide a very robust route that yielded the desired bidentate Lewis acid in only three steps 
(Scheme 58). By doing so, simple cheap starting materials are used and the reactions can be 
done on a gram scale. The preparation started with an Fe-catalyzed Grignard reaction of 1,2-
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dibromobenzene (190), which has been developed to suit herein purposes.
160
 Although this 
new protocol furnishes 1,2-bis-(TMS)-aryl compounds only in moderate yields, it allows for a 
much easier multi-gram preparation of the desired intermediate 191. Next, the original two-
step process to access the dichloroboranthrene 189 was shortened to one step. For this 
transformation it is critical to use 1,2-dichloroethane as solvent at high temperatures in a 
sealed pressure tube. After the reaction is complete and cooled to room temperature, the air 
and moisture sensitive product is obtained as white needles, which after washing with hexanes 
can be used without further purification. The final attachment of the Me-group is achieved by 
using AlMe3 to yield the desired bidentate Lewis acid 192. AlMe3 as methylation reagent for 
similar compounds was presented by Siebert et al.
161
 and it showed to be much more 
successful than MeLi. 
Scheme 58. Second generation three-step preparation of the bidentate Lewis acid 192. 
 
With the desired Lewis acid in hand complexation studies with 1,2-diazines were conducted 
to validate the electron withdrawing effect, predicted by the calculations. Titration of 
phthalazine 183 to a solution of 192 resulted in the formation of a 1:1 complex 184 of the 1,2-
diazine with the Lewis acid (Scheme 59). 
Scheme 59. Complexation experiment of the bidentate Lewis acid 192 and phthalazine 183. 
 
1
H-NMR spectroscopy confirmed the calculations: The electron withdrawal from the 1,2-
diazine can be observed in a low field shift of the diazine protons and, accordingly, a high 
field shift of the protons of the complexing Lewis acid (Figure 13). When an electron rich 
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dienophile such as the oxazolidine 195 is treated with the Lewis acid 192 also a complexation 
on the N-atom was observed. However, upon addition of phthalazine 183 the complexation is 
completely shifted to the 1,2-diazene. 
 
Figure 13. Stacked low field region of 
1
H-NMR spectra of complex 184 (in green), phthalazine 183 (in 
red), and free Lewis acid 192 (in blue). Singlet of THF-d8 (δ = 3.58 ppm) is used as the reference peak. 
Furthermore, the complex 184 of phthalazine with the bidentate Lewis acid was successfully 
crystallized and studied by X-ray analysis (Figure 14).
162
 While this does not definitively 
prove the bidentate nature of the coordination in solution, it is consistent with such findings 
described above. 
 
Figure 14. Solid state (left) and DFT (right) structures of the bidentate Lewis acid-phthalazine 
complex 184 with their overlap (middle). 
Beside a slight twist in the solid state structure the calculated structure is almost congruent. 
Furthermore, the overlay exhibits a very precise reproduction of the binding characteristic of 
boron and nitrogen with a deviation of only 0.013 Å in bond length (Figure 14). 
Both computation and experiment, in solution or in solid state, illustrated a bidentate binding. 
And this binding, as shown by DFT-calculations lowers the LUMO energy of the complexed 
1,2-diazine i.e. electron density is withdrawn from the 1,2-diazine which was further shown 
by a significant low-field shift of its protons in the 
1
H-NMR spectrum. 
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The above investigations, consequently showed that the chosen bidentate Lewis acid 192 
fulfilled the expectations formulated in Scheme 51. Therefore, the bidentate Lewis acid 192 
was tested as a catalyst in a model IEDDA reaction of phthalazine 183 with oxazolidine 195. 
Oxazolidine 195 was synthesized by methylation and successive elimination from 2-ethyl-4,5-
dihydrooxazole 193 (Scheme 60).
163–165
 
Scheme 60. Synthesis of (Z)-2-ethylidene-3-methyloxazolidine (195). 
 
Hünig’s base (DIEA) was added as a scavenger for protons, which might catalyze the acid 
promoted polymerization of the oxazolidine 195.
164,165
 The reaction was first tested with 10 
mol% of the Lewis acid 192. In parallel, the same reaction was also conducted with 5% and 
2.5 mol% of the catalyst 192 using 1.5 equivalent of the oxazolidine 195 (Scheme 61). 
Scheme 61. First catalysis of an IEDDA reaction of phthalazine 183 and 195  
 
 
Figure 15. Stacked aromatic region of 
1
H-NMR spectra (in CDCl3) of pure product (red), catalyzed 
reactions with 5.0 mol% (green) and 2.5 mol% (cyan), and the uncatalyzed reaction (purple). 
The comparison of the catalyzed reaction and the non-catalyzed reaction clearly shows the 
ability of the bidentate Lewis acid to promote the IEDDA reaction of phthalazine. After the 
same reaction time, when nearly no conversion is observed without the catalyst, the addition 
of only 5 mol% of Lewis acid 192 results in full conversion according to 
1
H-NMR (isolated 
yield: 42%). This proves an acceleration of the intended IEDDA reaction in the presence of 
the catalyst 192. 
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The reaction of phthalazine 183 with oxazolidine 195 in the presence of a monodentate Lewis 
acid such as BF3•Et2O followed a totally different reaction path. No IEDDA product 196 was 
detected in 
1
H-NMR nor GC-MS analysis. All results point to products resulting from a 
nucleophilic addition of the oxazolidine 195 similar to the described nucleophilic addition of 
alkyl lithium reagents mediated by BF3•Et2O.
166
 
3.1.3 Scope of the bidentate Lewis acid catalyzed IEDDA reaction of 1,2-diazines 
The success of the catalyzed IEDDA reaction of oxazolidine 195 and phthalazine 183 initiated 
the evaluation of the substrate scope. Therefore, a number of other electron rich dienophiles 
such as enolates, ketene acetals, enamines or even alkynes in case of activated phthalazine 
substrate have been used to access substituted naphthalenes. Due to the best results obtained 
by the addition of 5 mol% catalyst in Figure 15 this amount was as well taken for most of the 
following reactions. 
3.1.3.1 Enols as dienophiles 
Different dienophiles containing an enol moiety were subjected to the catalyzed IEDDA 
reaction with phthalazine (183) (Table 1). 
Scheme 62. Endo/exo-isomerization of the double bond of 197 resulting in two different isomers 
200da and 200db. 
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Besides the oxazolidine 195 less activated dienophiles such as dihydrofurans 197a-d can also 
be effectively transformed. In the case of 2-nBu-dihydrofurane 197d as dienophile an 
exo/endo isomerization
167
 occurs, where both isomers undergo an IEDDA reaction by 
different pathways (Scheme 62). Exo-197d follows the usual pathway, forming DA adduct 
198 and consecutive cycloreversion produces substituted naphthalene 200cb upon 
rearomatization. The endo-isomer 197d first also reacts via IEDDA and retro DA reaction to 
give 199 which was originally expected to be the isolated intermediate as shown by NMR 
spectroscopy, GC-MS and elementary analysis. 
Table 1. Different dienophiles in the Lewis acid catalyzed IEDDA reaction of phthalazine (183). 
 
Entry Enols Temp. / time Product
[a]
 (yield) 
1 
 
170 ºC / 72 h 
 
2[c] 
 
160 ºC / 48 h 
 
3 
 
160 ºC / 48 h 
 
4 
 
160 ºC / 48 h 
 
5 
 
160 ºC / 10 h 
 
6 
 
160 ºC / 48 h No reaction 
[a] Phthalazine (1.00 eq.), dienophile (2.00-3.00 eq.), catalyst (5 mol%), diglyme/Hünigs base 
(3:1); work-up included UV-irradiation. 
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However, no 2D-NMR spectra or a solid state structure has been reported. And since 199 
displays a very reactive o-quinodimethan species prone to undergo different rearrangements 
(Scheme 62). The isolated structure 199 is revised to be a constitutional isomer 199’ resulting 
from an [1,9]-sigmatropic rearrangement very unexpected at this time of the investigations 
(see Chap. 3.5). Via the “exo-route”, an according sigmatropic rearrangement is due to severe 
sterical hindrance not viable and therefore the elimination is favored. Treatment of a sample 
of isolated intermediate 199’ with light (Rayonett reactor, 300 nm) induced the elimination 
process to cleanly form the desired naphthalene product 200cb.
168
 Hence, in order to facilitate 
the purification all reactions involving enols were subjected to UV-light irradiation. 
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3.1.3.2 Enamines from ketones as dienophiles 
In contrast to enols, enamines are more activated for the IEDDA reaction. For example, Sauer 
et al. reported, that N,N-dimethylcyclopent-1-enamine is 2.2 x 10
3
 times more reactive than 
2,3-dihydrofuran (197a). Enamines give in good to very good yield the desired substituted 
naphthalenes in the bidentate Lewis acid catalyzed IEDDA reaction (Table 2, Entries 2-4). 
Table 2. Different enamines in the Lewis acid catalyzed IEDDA reaction of phthalazine. 
 
Entry Enamine
[b]
 Temp. / time Product
[a]
 (yield) 
1 
 
55 ºC / 2.5 d 
 
2[c] 
 
90 ºC / 2.5 d 
 
3 
 
80 ºC / 2.5 d 
 
4 
 
130 ºC / 2.5 d 
 
5 
 
110 ºC / 2.5 d 
 
6 
 
110 ºC / 2.5 d 
 
[a] Phthalazine (1.00 eq.), enamine (3.00 eq.), catalyst (5 mol%), diglyme; work-up with 
mCPBA. [b] All enamine were prepared in situ from the corresponding ketone and pyrrolidine 
unless stated otherwise. [c] The enamine was separately prepared prior to use. 
Also, in some of the enamines studied, products were isolated before re-aromatization 
occurred. For example, the reaction of phthalazine 183 and 203a gave the adduct 204 in 86% 
yield (Scheme 63). Similar results were reported by Boger and coworkers in the IEDDA 
reaction of 1,2,4-triazene with enamines.
169
 Treatment of the crude mixture with mCPBA 
induced a Cope-elimination to produce the desired naphthalene.
170
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Scheme 63. Reaction to intermediate 204 and rearomatization to the cycloaddition product 200e. 
 
It is noteworthy, that the enamines can be prepared in situ from the corresponding ketone and 
a secondary amine (in this case pyrrolidine), which allows the catalyzed IEDDA reaction of 
enamines that are difficult to isolate, such as enamine 203d.
171,172
 Therefore, the activity of 
the catalyst is not disturbed by the presence of the free amine or the water formed during this 
process. In fact, the addition of molecular sieves or MgSO4 to remove the water actually had 
adverse effects and inhibited the reaction. Thus, enamine 203d provided the corresponding 
2,3-substituted naphthalene 200h (Table 2, entry 4). With this procedure, basically any ketone 
that is able to form an enamine can be incorporated into an aromatic structure. For example, 
the catalyzed IEDDA reaction of enamines 203e and 203f derived from 1- and 2-indanone 
give, in one step, access to tetracyclic ring structures (Table 2, entries 5 & 6) that display the 
core of the natural product kinafluorenone (205).
173
 
 
Figure 16. Accessible fluorene core structure of natural product. 
In addition to enamines, N,O-ketene acetal 206 also served as excellent substrate for the 
catalyzed IEDDA reaction (Scheme 64). Although elimination of either the N or the O residue 
is feasible, only the extrusion of ethanol was observed, giving rise to annelated 
tetrahydroquinoline 200j in quantitative yield. 
Scheme 64. Cycloaddition of N,O-ketene acetal 206 and phthalazine 183. 
 
The structural theme of tetrahydroquinoline 200j is present in compounds, such as 
kalasinamide
174
 (208) etc. (Figure 17), which was isolated in 2000 from the acetone extract of 
Polyalthia suberosa and a total synthesis occurred recently.
175
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Figure 17. Core structures accessible via catalyzed IEDDA reaction featured in natural products. 
3.1.3.3 Enamines from aldehydes as dienophiles 
Since the in situ formation of enamines from ketones did not interfere with the catalyst’s 
activity the catalyzed IEDDA reaction of aldehyde derived enamine was carried out. And to 
verify the utility of aldehydes different substitution pattern were chosen and submitted to the 
catalyzed IEDDA reaction. Besides alkyl chains also aromatic groups were introduced. All 
aldehydes were transformed to the corresponding naphthalene (Table 3). 
Table 3. Aldehyde as substrates for the bidentate Lewis acid catalyzed IEDDA reaction. 
 
Entry Aldehyde Product (yield) 
1 
  
2 
  
3[a] 
  
4 
 
 
5 
  
[a] The enamine was derived from N1,N2-dimethylethane-1,2-diamine. 
Interestingly, n-alkyl aldehydes gave the desired product only in low yield. The phthalazine 
(183) starting material, however, was consumed. Additionally, considerable gas evolution was 
observed, which hints to a successful IEDDA reaction. Therefore, the explanation for the low 
yield seems not to be the direct catalyzed IEDDA reaction but rather due to side reaction in 
the enamine formation or the subsequent IEDDA reaction with stable intermediates.
176
 A 
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slightly improved outcome could be observed for substrate 210d, which is distinguished by a 
Me-substituent in -position. The additional steric hindrance might slow down the side 
reaction and favor the desired IEDDA transformation. For heptanal (210c) only traces of 
product were found by GCMS, if the standard, pyrrolidine was used for the enamine 
formation. The use of N
1
,N
2
-dimethylethane-1,2-diamine,
177
 however, gave the desired 2-n-
penylnaphthalene (211c) in an improved yield of 30% as the required elimination is 
accelerated due to an intramolecular pathway. Therefore, other aldehydes were assayed in the 
bidentate Lewis acid catalyzed IEDDA reaction, which contained a Me-substituent in -
position (Table 4). 
Table 4. β-Branched aldehydes as substrates for the bidentate Lewis acid catalyzed IEDDA reaction. 
 
Entry Aldehyde Product[a] (yield) 
1 
 
 
2 
 
 
3[b] 
  
4 
 
 
5 
 
 
[a] 5.0 mol% catalyst, if not stated other wise. [b] 2.5 mol% catalyst.  
With this arrangement, elimination to the corresponding naphthalene skeleton is still possible. 
However, the corresponding enamine will contain an isopropyl-type substitution, increasing 
the steric demand considerably. In the case of the Me-analog of 210f the desired naphthalene 
derivative could be isolated in 64% (Table 4, entry 1). Additionally, other functional groups 
have been introduced, which also bear the potential of interaction with the Lewis acid 
catalyst. The tertiary alcohol can be problematic in Lewis acid catalysis as they could 
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eliminate. However, in the presence of the bidentate Lewis acid the substrate derived from 
210g is converted in good yield to the desired product (Table 4, entry 2). Also an ester group 
was included as a side chain (Table 4, entry 3). Such a substrate also has the potential to 
coordinate with its two oxygen atoms to the bidentate Lewis acid. Nevertheless, the product 
was isolated in 41%, supporting the high specificity of the bidentate binding event of the 
catalyst with the 1,2-diazine moiety. A more challenging starting material is the furan analog, 
as it is itself a good diene in the normal Diels-Alder reaction. Although the product 211i is 
observed, the yield is rather low (Table 4, entry 4). Thioether 210j was tested as well and 
although all phthalazine was consumed, no product 211j could be isolated. Similar attempts to 
promote the IEDDA reaction with -hydroxy aldehyde 210k also failed. As mentioned above, 
the reason is not the reactivity in the IEDDA reaction. The aldehyde itself undergoes a variety 
of transformations, which proceed before the cycloaddition event. All these side products are 
now themselves substrates for the IEDDA reaction. Therefore, although phthalazine 183 was 
consumed no product could be isolated. 
Furthermore, terpene based structures have been chosen as substrates for the catalyzed 
IEDDA reaction. Such dienophiles should give access to an interesting alkenyl-aryl motive, 
which has been prepared before in multiple steps.
178–182
 Citronellal has been tested in the 
bidentate Lewis acid catalyzed IEDDA reaction with phthalazine 183 (Scheme 65). The 
reaction proceeded smoothly and after 1 d no starting materials was observable anymore. The 
product showed in this case a mixture of the aromatized naphthalene derivative 211l and 
products, which still contain the amine functionality (by GC/MS). After column 
chromatography the desired product 211l could be isolated in 27% yield, the remaining 
fraction being amine products. Increasing the reaction temperature did favor the elimination to 
the expected naphthalene 211l resulting in a yield of 37%. Interestingly, the byproduct 
mixture was not mainly composed by the usual non-eliminated amine 213. Careful 2D-NMR 
analysis (i.a. HSQC-TOCSY) revealed a complex tricyclic structure 214 (2:2.5 ratio of 
endo:exo isomer of the amine) as the major component (>50% of the aromatic fraction).
12
 
Such a scaffold can be readily explained by the following rational: Elimination of N2 leads to 
the o-quinodimethan type intermediate 213, which can now undergo a normal Diels-Alder 
reaction with the olefin moiety. 
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Scheme 65. Catalyzed IEDDA reaction of citronellal. 
 
The interesting tricycle 214 is featured in a number of natural products (Figure 18). For 
instance, valerianoid A-C 215,
183,184
 constituents of folk medicine for sedative and 
antispasmodic purposes, as well as patchouli alcohol 216,
185–188
 used in fragrances, map the 
complete saturated carbon framework of 214 without the additional aromatic ring. 
 
Figure 18. Natural products as structural analogues of product 214. 
The examples presented above illustrate the utility of the bidentate Lewis acid catalyzed 
IEDDA reaction to introduce aromatic scaffolds into highly complex and functionalized 
molecules. Especially hydroxy as well as ester substitution in the substrates do not disturb the 
reaction and furnish cleanly the desired cycloadducts. Linear aldehydes suffer from side 
reactions during the enamine-forming step limiting its applicability. Usage of methyl ethylene 
diamine can partially circumvent this difficulty allowing to access the desired naphthalenes in 
moderate yield. When citronellal was employed in the catalyzed IEDDA reaction an 
interesting tricyclic compound was observed besides expected naphthalene derivative. 
Therefore, this cascade of transformation will offer an efficient access to the complex 
frameworks, which are found in natural products, as shown above.  
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3.1.3.4 Substituted 1,2-diazines 
In addition to exploring the scope of the dienophiles, different 1,2-diazenes were also 
investigated. Besides the parent phthalazine (183), substituted derivatives were screened 
(Table 5). 
Table 5. Substituted 1,2-diazines in the Lewis acid catalyzed IEDDA reaction of phthalazine. 
 
Entry 1,2-Diazene Dienophile Temp. / time Product (yield) 
1 
  
40 ºC / 2.5 d 
 
2 
 
 
100 ºC / 24 h 
 
3[b] 
 
 
100 ºC / 48 h 
 
4 
 
 
rt / 48 h 
 
5 
 
 
140 ºC / 24 h No reaction 
6 
  
80 ºC / 2 d No reaction 
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For example, substitution with chlorine in 183a was found to facilitate the process (Table 5, 
entry 1). The electron withdrawing properties of chlorine cause a reduction of electron density 
at the phthalazine moiety, leading to a decreased LUMO energy, which is beneficial for its 
part as diene in the IEDDA reaction. Surprisingly, groups that are also able to coordinate to 
the bidentate Lewis acid gave moderate yields of the desired naphthalene derivative. For 
example, 5-nitrophthalazine (183b) can be reacted with different dihydrofurans to furnish the 
substituted products 217b and 217c. It is noteworthy that the reaction can even be performed 
at room temperature albeit with lower yield (Table 5, Entry 4). In this case the reduction of 
product formation might be caused by the high tendency of the dienophile to polymerize. 
Pyridazine, however, did not show any reaction in the bidentate Lewis acid catalyzed IEDDA 
reaction (Table 5, entry 5). Attachment of an electron withdrawing group (Cl) also did not 
enable the transformation (Table 5, entry 6), which by calculation of the according complex 
of methylchloropyridazine 218 and bidentate Lewis acid is obvious (Figure 19). Especially 
the methyl group allows only a very weak asymmetric coordination due to steric repulsion (B-
N bond distances are 3.44 Å and 3.52 Å). 
 
Figure 19. Calculated complex of methylchloropyridazine 218 and bidentate Lewis acid 192. 
The unreactivity of pyridazine 177 can be rationalized by the loss of aromaticity during the 
initial cycloaddition step. In contrast, when phthalazine is used, the aromaticity is broken in 
only one of the rings during the course of the reaction what accounts for much less than the 
full aromatic stabilization energy of pyridazine. 
In conclusion, the investigation was set out with the idea of lowering the high LUMO energy 
of 1,2-diazine by a bidentate complexation of the vicinal nitrogen atoms to being able to 
undergo a IEDDA reaction with else weakly reactive dienophiles. Eventually, the initial idea 
was verified with the first IEDDA reaction of oxazolidine 195 and phthalazine 183 with the 
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most promising bidentate boron based Lewis acid candidate. This Lewis acid 192 was pre-
evaluated via computational studies, complexation studies in solution, and acquirement of a 
solid state structure. Further experimental studies of the scope of dienophiles in this novel 
catalyzed IEDDA reaction gave insight into its potential. It was now possible to react not only 
the one or two most active dienophiles (as ranked by Sauer et al.
58
) but also dienophiles 
ranging from enolethers, enamins derived from ketones as well as from aldehydes to 
keteneacetals. Furthermore, substituted 1,2-diazines have been shown as well to undergo the 
bidentate Lewis acid catalyzed IEDDA reaction. As a result, the investigations led to the 
following listing of reactivity of dienophiles in the catalyzed reaction with phthalazine 183 
(Figure 20). 
 
Figure 20. Reactivity order of dienophiles in the bidentate Lewis acid catalyzed IEDDA reaction with 
phthalazine. Figures indicate HOMO energies in eV. 
The calculated HOMO energies correlate fine with the experimental data where the sterical 
demand is comparable. Hence, where the numbers deviate from the reactivity order the 
sterical demand makes the difference. 
As well it has to be emphasized that the reaction is not promoted in the presence of a 
monodentate Lewis acid, such as BF3. If a monodentate Lewis acid is employed none of the 
desired cycloadducts could be observed. Instead, all data suggest a nucleophilic addition 
pathway to the phthalazine, similar to the reported addition of BuLi to phthalazine catalyzed 
by the monodentate Lewis acid.
[17]
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3.1.4 Mechanistic considerations 
Consequently, the final proposal of the catalytic cycle (Scheme 66) is as following: (1) The 
complexation of the bidentate Lewis acid with phthalazine A lowers the LUMO of the 
dienophile (2) allowing the IEDDA reaction to form adduct D which (3) eliminates molecular 
nitrogen to result in the o-quinodimethane type intermediate E and (4) spontaneous or induced 
rearomatization leads to the final naphthalene product F. 
Scheme 66. Proposal of the general catalytic cycle of the IEDDA reaction of dienophiles and 
phthalazines catalyzed by the bidentate Lewis acid. 
 
The lowering of the LUMO energy in step (1) is so significant that it decrease from -1.76 to -
3.05 eV now ranging in the regime of the very activated 1,4-dicyanophthalazine (-3.42 eV) 
which even reacts with N-methylindole, inert under above conditions.
189
 And the 
1
H-NMR 
spectra of the complex showed a severe downfield shift of the protons of the complexed 
phthalazine moiety as well as the solid state structure showed B-N bonding (1.67 Å) almost as 
tight as in H3N-BF3 (1.60 Å).
190
 On the other side, neither a diene nor a dienophile baring 
Lewis basic sites did influence the activity of the catalyst. 
In step (3) it was shown that some produced intermediates although thermodynamically 
favored do not proceed to the aromatized product and can sometimes be isolated. So that total 
elimination to the naphthalene product has to be induced by UV irradiation in the case of 
enols and by cope elimination with mCPBA in the case of enamines.  
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3.2 One-pot synthesis of phthalazines and pyridazino-aromatics 
Above, the versatility of the dienophile substrate scope in the catalyzed IEDDA reaction was 
shown but the scope of 1,2-diazines was very limited so far. This was mainly due to the 
unavailability of a general procedure for the direct and convenient access of substituted 
phthalazines and pyridazino-aromatics. 
3.2.1 Introduction 
Nitrogen containing heterocycles are of tremendous importance in medicinal as well as 
material sciences. Phthalazines and pyridazino annulated aromatics represent a special class 
of compounds. In these materials two nitrogen atoms are placed adjacent to each other 
resulting in distinct properties. In nature this functional entity has been scarcely found,
191–193
 
yet in the last decade diverse bioactivity and medical applications of phthalazines or 
pyridazino heteroaromatics emerged ranging from bronchodilatatory and anti-inflammatory 
effects,
194–196
 antitumor activity,
197,198
 DNA-intercalation,
199,200
 anticonvulsant activity,
201
 and 
as a vasorelaxant.
202
Also, phthalazine derivatives have been used in material sciences
203,204
 or 
employed as ligands for a variety of transition metals.
147,205–210
 Some of them are important 
catalysts,
211,212
 most prominently in the asymmetric dihydroxylation
213
 of alkenes. 
The synthesis of phthalazine derivatives commonly involves multi-step procedures 
concluding with either ring closing reactions, ring enlargement or aromatization of 1,2-
dihydro- or 1,2,4,5-tetrahydrophthalazines.
214,215,216
 
Also reported are inverse electron demand Diels-Alder (IEDDA) reactions of 1,2,4,5-
tetrazines 219 with arynes 220
217–220
, and arenes 222
220
 or pyridazino[4,5-d]pyridazine with 
enamines
221,222
 as method for the synthesis of phthalazine derivatives 221 and 224 (Scheme 
67). 
Scheme 67. Phthalazine synthesis via IEDDA reaction from 1,2,4,5-tetrazine. 
 
The first synthesis of phthalazine 183 in 1893 by Gabriel and co-workers
223,224
 was done by 
ring closing reaction of phthalaldehyde 225 or 1,2-bis-dichloromethylbenzene 226 with 
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hydrazine (Scheme 68). This transformation, the ring closure of ortho-dicarbonyls with 
hydrazine, still comprises the standard route for the preparation of phthalazines.
225–231
 
Scheme 68. First synthesis of phthalazine 183 by Gabriel and co-worker. 
 
Phthalazines with halogen substituents in 1,4-position are usually synthesized via 
halogenation of 2,3-dihydrophthalazine-1,4-dione.
232–235
 Both methods, however, are often 
preceded by many synthetic steps, depending on the degree of substitution in position 5 to 8 
of the resulting phthalazine. For example, Tsoungas and co-workers reported such a 
procedure of six steps starting from 5-methoxy-2-nitrobenzaldehyde via final reaction of the 
formed dialdehyde 231 with hydrazine to give 6-methoxyphthalazine (237) in a overall yield 
of less than 20% (Scheme 69).
226
 Another ring closing reaction is the cyclization of aromatic 
aldazines, which is conducted in liquid AlCl3/AlBr3, comprising rather harsh conditions.
236
 
Scheme 69. Synthesis of benzo-substituted phthalazine 237 via an inadequately complex procedure. 
 
Despite these efforts no approaches of a direct method of a wide range of substituted 
phthalazines in one pot from simple starting materials are reported to the best of my 
knowledge. As 1,2-diazines represent a valuable starting material for the aforementioned 
bidentate Lewis-acid catalyzed IEDDA reaction, it was set out to close this gap in the 
synthesis portfolio of heterocycles. Herein, a general method is present, by which not only 4- 
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to 8-substituted phthalazines, but also pyridazino-heteroaromatics are prepared in a one-pot 
procedure from simple aromatic aldehydes in good to excellent yields. 
The key-step of this new method is the transformation of an aromatic aldehyde into a directed 
ortho-metalation group (DMG). Directed ortho-lithiation is a very elegant method to form 
ortho-substituted aromatics and has been widely applied (Scheme 70).
237,238
  
Scheme 70. General scheme of ortho-lithiation via complexation by a ortho-metalation group (DMG). 
 
Although an aldehyde 238 is per-se no directing group they it can react with lithium amide 
LiA to form α-aminoalkoxide 239, which in turn is a moderate to good DMGs.239–243 Based 
on this principle first applied by Comins and co-workers,
239,240
 a new highly efficient protocol 
for this strategy was developed (Scheme 71).  
Scheme 71. Ortho metalation strategy for a one-pot synthesis of phthalazines 
 
Commonly, the auxiliary N,N,N’-trimethylethylenediamine (TMDA) A1, is used as lithium 
amide LiA1 for the formation of α-aminoalkoxides 239. Herein, is report for the first time the 
application of bis(2-methoxyethyl)amine (BMEA) A2 for this purpose constituting a much 
cheaper solution as A1. The bis(2-methoxyethyl)-amino group itself is a chelating ligand 
intensively studied in the lithiation of N,N-bis(2-methoxyethyl)-2-methylprop-2-en-1-amine 
(Scheme 72).
244,245
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Scheme 72. Ortho-lithiation of allyl moyety in 242 directed by its bis(2-methoxyethyl)-amino group. 
 
After the in situ formation of the DMG by either LiA1 or LiA2 the dianion 240 is formed via 
ortho-lithiation with n-BuLi. Consecutive reaction with dimethylformamide (DMF) gives the 
ortho-bis(aminoalkoxide) 241. Final hydrolysis with an aqueous solution of ammonium 
chloride and hydrazine furnishes phthalazine 183 in good yield. 
3.2.2 Optimization of reaction conditions 
The development of the method involved the optimization of each aforementioned step, 
mainly the ortho-lithiation. Existing protocols for the ortho-lithiation of aminoalkoxides were 
commonly conducted with a large amount of lithiating agent (3 equivalents of n-BuLi) and an 
inconvenient reaction temperature of ‒20 °C over an extended period of 3 h for 
chlorobenzaldehydes, 24 h for benzaldehyde and up to 48 h for p-tolualdehyde.
240
 The 
applicability to a one-pot procedure demanded a considerable decrease of reaction time, 
amounts of n-BuLi and enhancement of the efficiency of each elementary transformation. 
Since n-BuLi in pure THF has a half-life time of only 1.78 h at 20 °C a change of the reaction 
media was crucial for the optimization.
246
 Recently, it was shown that already one equivalent 
of THF in a 1 M solution of n-BuLi in cyclohexane at 25 °C holds similar deoligomerization 
potential of the lithium organyl as pure THF but only minor decomposition of the THF was 
observed after 24 h.
247
 In herein case 3.3 equivalents of THF in an approximately 0.5 M 
solution of n-BuLi in hexane gave the best results. In the THF/hexane solvent mixture it was 
possible to perform the directed ortho-metalation step at room temperature. Simultaneously, 
the amount of lithiation agent was significantly lower to only 1.5 equivalents of n-BuLi. 
Consequently, significantly shorter reaction times were achieved: 1.5 - 2.5 h at room 
temperature (25 - 30 °C) if the auxiliary A1 and 2 - 5 h at 0 °C if A2 was applied  
Benzaldehyde 238 was used as test substrate for the optimization. The use of both, the 
common auxiliary TMDA A1 and BMEA A2 allowed the comparison of the performance in 
the ortho-metalation of benzaldehyde (Table 6). 
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Table 6. Optimization of the ortho-lithiation conditions. 
 
entry time Temp. yield (method) 
 A  B 
1 2 h 25 °C 74% 35% 
2 3 h 10 °C – 39% 
3 4 h 0 °C 73% 56% 
4 5 h 0 °C – 72% 
 
Thus, after 4 h of lithiation at 0 °C the one-pot reaction applying TMDA A1 yielded 73% and 
BMEA A2 gave 56% of phthalazine 183. TMDA A1 performs slightly better than BMEA A2, 
but in some cases, especially for the more acidic substrates, gives comparable or even better 
results. It is important to mention, that the yield of phthalazine in the case of BMEA A2 as the 
auxiliary augments to 72% after a lithiation time of 5 h at 0 °C. If the ortho-lithiation step was 
conducted at room temperature (25 °C) for 2 h, using TMDA A1 a yield of 74% was 
obtained. Using BMEA A2 the yield decreases substantially to only 35%. Even with an ortho-
lithiation at 10 °C for 3 h the loss in yield was significant compared with a lithiation 
temperature of 0 °C. This results concerning BMEA A2 as the ortho directing auxiliary, point 
towards an accelerated decomposition of the α-aminoalkoxide 231a at temperatures above 0 
°C. 
3.2.3 Scope of the one-pot reaction for the synthesis of pthalazines 
The optimized protocol on the basis of benzaldehyde 238 was shown to be applicable to a 
broad range of substituted benzaldehydes producing benzo-substituted phthalazines with good 
to excellent yields of up to 91% (Table 7). Not only electron withdrawing fluoro, chloro, 
trifluoromethyl substituents (Table 7, entry 3-7), but also electron donating substituents such 
as methoxy, methylthio (Table 7, entry 9-11, 14-16) and even dimethylamino groups (Table 7, 
entry 12) are well tolerated.  
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Table 7. Synthesis of substituted phthalazines. 
 
entry ArCHO 1,2-diazine yield (method) 
A B 
1 
  
74% 72% 
2 
  
84% – 
3   
53% 67% 
4 
  
– 75% 
5   
79% 91% 
6 
  
75% – 
7   
89% – 
8   
80% – 
9 
  
81% – 
10 
  
79% 50% 
11 
  
51% – 
Results and Discussion 
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12 
  
62% – 
13 
  
66% – 
14 
  
61% – 
15 
  
44% – 
16 
  
36% – 
17 
  
68% – 
 
Also benzoketons omitting α-protons can be successfully employed in a one-pot reaction 
resulting in 1-substituted phthalazines, as demonstrated with benzophenone 245 resulting in 
1-phenylphthalazine 246 in a 70% yield (Scheme 73). 
Scheme 73. Synthesis of 1-substituted phthalazine. 
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3.2.4 Scope of the one-pot reaction for the synthesis of pyridazino-aromatics 
Since pyridine as well as five-membered heteroaromatics are more acidic than benzene 
derivatives, they require milder lithiation conditions (Table 8). 
Table 8. Synthesis of pyridazino-heteroaromatics. 
 
entry ArCHO 1,2-diazine method time Temp yield 
1 
 
 
 
A 2 h 0 °C 48% 
B 2.5 h –20 °C 66% 
2 
 
B 1 h –20 °C 81% 
3 
 
 
A 2 h 0 °C 55% 
B 2.5 h –20 °C 53% 
4 
  
A 2 h –20 °C 63% 
B 2 h –20 °C 50% 
5 
  
A 2 h 0 °C 52% 
B 2.5 h –20 °C 53% 
6 
  
B 1.3 h –20 °C 59% 
 
Hence, lithiation at 0 °C employing BMEA A2 as auxiliary for the directed ortho-lithiation 
was satisfying. In these cases decreasing the temperature from 0 °C further to –20 °C and 
shortening of the reaction times compared to benzaldehyde 238a gave even better results 
(Table 8), most pronounced in case of thiophene-3-aldehyde 247b (from 61% to 81%). At 
similar conditions the auxiliary TMDA A1 performed slightly better than BMEA though; 
BMEA in turn presents a much more cost-effective solution (Table 8, Entry 3-5). 
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3.3 A novel two-step strategy for the synthesis of substituted naphthalenes 
As presented above, the bidentate Lewis acid catalyzed IEDDA reaction using phthalazines as 
electron deficient dienes with a variety of dienophiles, produces 2,3-substituted naphthalenes 
in a highly efficient way. Joining the herein introduced one-pot synthesis of pyridazino-
aromatics with the catalyzed IEDDA reaction concludes an extremely short and very 
convenient two-step synthesis of, for example, complex, highly substituted naphthalenes 
(Scheme 74). 
Scheme 74. Two-step protocol for the synthesis of substituted naphthalenes. 
 
3.3.1 Application for the synthesis of Naproxen 
In order to put this powerful approach into context a prominent naphthalene candidate, (±)-
Naproxen 250a has been chosen to demonstrate the utility of the methodology. (±)-Naproxen 
250a, one of the most common non-steroidal anti-inflammatory drugs,
248
 can be accessed in 
one-pot from the according diazine 244i and aldehyde 249a with a yield of 53% after basic 
work-up (Scheme 75). 
Scheme 75. Preparation of Naproxen in two consecutive steps via one-pot phthalazine synthesis and 
bidentate Lewis acid catalyzed IEDDA reaction. 
 
Interestingly, the desired 2,6-substitution pattern (compared to the 1,7-isomer) is obtained in a 
selectivity greater 9:1 (by 
1
H-NMR). Such an outcome is in accordance with the FMO theory, 
which rationalizes the result based on the analysis of the orbital coefficients of the 
participating HOMO and the LUMO. 
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3.3.2 Application for the synthesis of silylnaphthalenes 
By the synthesis of more electron poor phthalazine such as chloro and fluoro naphthalenes it 
was possible to further broaden the scope of dienophiles to the least reactive ones described 
by Sauer and co-workers.
58
 
Bis-TMS aromatics are attractive intermediates not only for the synthesis of the herein 
described catalyst 192 but also for example the boron-doped polymers
150,162
 or the preparation 
of benzyne precursors
249
 (Scheme 76).
250
 
Scheme 76. Preparation of bis-TMS naphthalenes; valuable intermediates for various applications. 
 
Additionally, DFT calculations of complex of phthalazine 183 and 
dimethyldibenzodihydroboranthrene 254 have revealed that this type of bidentate Lewis acids 
are even more potent than dihydroboranthrene 192 (Figure 21).  
 
Figure 21. Additional lowering of computed LUMO energies of phthalazine/dimethyldibenzodihydro-
boranthrene complex 
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The synthesis of bis-TMS naphthalenes via catalyzed IEDDA reaction was carried out with 
bis TMS acetylene 252 and the two most reactive substituted phthalazines 253r and 253s 
(Table 9). 
Table 9. Synthesis of bis-TMS naphthalenes via catalyzed IEDDA reaction. 
 
entry 1,2-diazine naphthalene time Temp yield 
1 
  
7 d 160 °C 51% 
2 
  
10 d 150 °C 50% 
 
The naphthalenes have been obtained in mediocre yields reflecting pre-optimized conditions, 
where the reaction was terminated although it was still ongoing. This shows the stability of 
the catalyst even at elevated temperatures. 
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3.4 Catalyzed domino IEDDA/cyclopropanation reaction of diazines 
Nowadays, the efficient use of resources, as well as the minimization of waste and production 
costs is more important than ever. Therefore, an organic synthesis procedure where one could 
form several bonds in one sequence would lead to a tremendous benefit over usual stepwise 
procedures. Domino reactions represent a highly potential approach to address the above 
mentioned criteria.
251,252
 Especially the incorporation of Diels-Alder reactions into Domino 
sequences allows to quickly access molecular complexity.
253
 The inverse electron-demand 
Diels-Alder (IEDDA) reaction emerged in the last decades
66,254
 as powerful synthetic tool 
featured in the preparation of complex molecules. 
255–260,261
 As presented above, the first 
catalytic activation of 1,2-diazines by a bidentate Lewis acid for an IEDDA reaction with a 
broad application spectrum was shown. 
3.4.1 Introduction 
During the investigations of electron rich furan 257a in the catalytic IEDDA reaction a novel 
bidentate Lewis acid catalyzed domino IEDDA/cyclopropanation reaction was discovered 
(Scheme 77). 
Scheme 77. Reaction path of the catalyzed domino IEDDA/cyclopropanation reaction of an electron 
rich furan and a diazine. 
 
The application of these dienophiles did not yield the anticipated annelated ring system 259. 
Instead the cycloaddition intermediate was further transformed to the cyclopropane annelated 
benzonorcaradiene 258a. In Nature the benzonorcaradiene framework is for instance found in 
salvipuberulin 260 (Figure 22).
262,263
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Figure 22. Salvipuberulin constitutes of a benzonorcaradiene framework. 
Additionally, such highly functionalized compounds containing small rings are useful 
building blocks for further transformations, to quickly access complex target structures, 
especially in the context of new drugs. Lately, three different methods have been published 
forming benzonorcaradiene with either no or limited range of aromatic substituents. 
Toste and co-workers published a gold(I)-catalyzed tandem cyclopropanation/hydroarylation 
reaction producing formal [4+3] annulation products from vinyl arenes and propargyl esters 
(Scheme 78).
264
 
Scheme 78. Tandem cyclopropanation/hydroarylation reaction to produce benzonorcaradienes. 
 
Very recently, Tenaglia et al. presented a ruthenium-catalyzed coupling of oxabenzo-
norbornadienes and propargyl alcohols to obtain benzonorcaradienes (Scheme 79).
265
 
Scheme 79. Ruthenium-catalyzed coupling reaction to obtain benzonorcaradienes. 
 
The third synthesis proceeds by a DA reaction of an o-quinodimethan tungsten complex and 
methoxyfuran. The tungsten complex is prepared from ethinylphenylketone and three 
equivalents of W(CO)5∙THF.
266,267
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Scheme 80. Benzonorcaradiene synthesis by two steps from ethinylphenylketone 268 via o-
quinodimethan tungsten complex. 
 
3.4.2 Scope of the catalyzed domino IEDDA/cyclopropanation reaction 
The investigations started with the reaction of phthalazine and differently substituted 
oxyfurans 257a-e, to display the scope of dienophiles in the Lewis acid catalyzed domino 
reaction (Table 10). 
Table 10. Scope of dienophiles in the domino IEDDA/cyclopropanation reaction. 
 
entry 257 244 product t T yield 
R
4
 R
5
     
1 
 
H H 
 
3.5 d 125 °C 88% 
2 
 
H H 
 
4 d 140 °C 80% 
3 
 
H H 
 
2.5 d 155 °C 99% 
4 
 
H H 
 
1.5 d 115 °C 90% 
5 
 
Cl Cl 
 
1.5 d 115 °C 90% 
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Thereby, all substrates did not show any reaction in the absence of catalyst even if heated to 
160 °C for one day. Both steric as well as electronic factors play an important role in the 
reactivity of oxyfurans. The most reactive oxy-substituent is the trimethylsilyl (TMS) moiety 
due to polar effects followed by the methyl substituent and the least reactive, the 
triisopropylsilyl (TIPS)-group due to steric reasons (Table 10, entry 1-3). Oxyfuran 257a 
directly yielded the free acid 258a after purification on silica gel (SiO2), while 257b and 257c 
gave access to stable esters 258b and 258c. The methyl substituent on the furan core accounts 
for another positive inductive effect while also adding steric bulk, which counteract 
depending on the position of the Me group. A methyl-substituent in 3-position as in 257d is 
beneficial for the reaction allowing to run the reaction at lower temperature in a shorter time 
compared to the unsubstituted analog 257a (Table 10, entry 4). If the methyl substituent is 
placed in position 5 it seems to sterically interfere with the reactive site resulting in permitting 
the reaction only with the more reactive dichlorophthalazine 244r (Table 10, entry 5). No 
reaction was observed with less electron deficient phthalazine 244a. This sterical interference 
can be explained by the repulsive sterical interaction of the methyl residue in furan 257e with 
the Lewis acid 192 in complex 184
176
 during the IEDDA reaction (Figure 23). 
 
Figure 23. Steric interaction of methyl group in 257e with Lewis acid moiety of complex 184. 
To demonstrate the scope of dienes, a variety of differently substituted diazines and 
trimethylsilyloxyfuran 257a have been employed in the Lewis acid catalyzed domino 
IEDDA/cyclopropanation reaction (Table 11). The substituted diazines can be accessed by an 
one-pot synthesis from aldehydes, as mentioned above. Moreover, alkyl lithium chemistry 
was used to form dichloro- and difluorophthalazine 244r and 244s, also in one-pot in good 
yields (Scheme 81). 
Scheme 81. Dihalogeno phthalazine synthesis via ortho-lithiation and Br/Li exchange. 
 
Results and Discussion 
67 
Table 11. Scope of dienes in the domino IEDDA/cyclopropanation reaction. 
 
entry diazine products t T yield (a:b) 
1 
 
 
1 d 105 °C 88% (1.1:1) 
2 
 
 
14 h 95 °C quant. 
3 
 
 
1 d 130 °C quant. (1:1.1) 
4 
 
 
4 d 120 °C quant. (1:1.3) 
5 
 
 
1.5 d 80 °C 98% 
6 
 
 
3 d 120 °C 78% (1:1.5) 
7 
 
 
11 d 160 °C 93% 
8 
 
 
3.5 d 145 °C 95% (1.2:1) 
9 
 
 
3.5 d 150 °C 92% (1:1) 
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10 
 
 
1 d 105 °C 92% (1:1.4) 
11 
 
 
3 d 160 °C 83% (2:1) 
Since in an IEDDA reaction an electron deficient diene is preferred over an electron rich one, 
the reactivity of substituted phthalazines decreases in the following order of substituents: 
F≈Cl>MeS≈Me>MeO (Table 11). 
Table 12. Domino IEDDA/cyclopropanation reaction forming isolable esters. 
 
entry diazine product t T yield (a:b) 
1 
 
 
1 d 130 °C 96% (1.3:1) 
2 
 
 
1 d 135 °C 99% (1.1:1) 
3 
 
 
1 d 90 °C 91% 
4 
 
 
0.5 d 120 °C 91% (1:1.1) 
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Therefore, the reaction temperature can be lowered to 80 °C in the case of dichlorophthalazine 
244s and had to be risen to 160 °C with a prolonged duration in the case of 
dimethoxyphthalazine 244p. Even pyridopyridazine 248f and benzophthalazine 244q showed 
to be reactive in this transformation. The complete desilylation of the labile trimethylsilyl 
ester was accomplished by slightly acidic eluation on silica forming the carboxylic acid. 
Furthermore, other TIPS-ester 258q - 258s have been synthesized, showing the good 
applicability of 257c in the reaction of electron poor phthalazine 244d, 244f and 244r (Table 
12, entry 1-3). The reaction of methoxyfuran 257b with pyridopyridazine 248f gave the 
methylester 258t (Table 12, entry 4). These additional examples demonstrate not only the 
high atom economy merely producing N2 as a side product but also the versatility of the 
procedure. 
In cases of non-symmetrical phthalazine substrates the IEDDA/cyclopropanation reaction 
produces mostly regioisomers of both DA adduct in similar amounts (Table 11 and Table 12). 
Substitution in 5 – 8 position on the phthalazine hardly influences the ratio of the 
regioisomers. 
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3.4.3 Mechanistic considerations 
The proposed catalytic cycle as shown in Scheme 66 derived from Heuschmann and co-
workers
85,138–140
 starts with the complexation of phthalazine 244a by the bidentate Lewis acid 
192 to activate the diazine for the following IEDDA reaction. The cycloaddition of complex 
184 with methoxyfuran 257b gives intermediary complex 273. The elimination of molecular 
nitrogen regenerates the Lewis acid catalyst 192 and the proposed dihydronaphthalene 
intermediate 274 is formed. Intermediate 274 rearranges to endo-cyclopropane 258b’ and 
endo-to-exo isomerization
268–270
 leads to the final product 258b (Scheme 82).  
Scheme 82 Proposed catalytic cycle of the IEDDA/cyclopropanation reaction. 
 
By the nature of the IEDDA cycloaddition the domino reaction is diastereoselective resulting 
in only the exo-cyclopropane proven by 2D-NMR as well as x-ray analysis (Figure 24). 
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Figure 24. Solid state structures of dimethoxyphthalazine 258l and difluorophthalazine 258g. 
The intermediary formed dihydronaphthalene 274 represents an o-quinodimethane-type, 
which are well known highly reactive intermediates.
271–275
 As shown above, it was possible to 
trap such a o-quinodimethane intermediate by an intramolecular Diels-Alder reaction 
consecutive to the Lewis acid catalyzed IEDDA reaction (Scheme 65). Stable o-
quinodimethanes have been unambiguously characterized and expose substantial double bond 
with some biradical character indicated by calculations (Figure 25).
276,277
 
 
Figure 25. Isolable o-quinodimethan derivatives. 
Dihydronaphthalene 274 reacting as tetraene-species undergoes the final rearrangement to 
form the cyclopropanaphthalene 258b. The same observations were made starting from a 
tungsten-tetraenecomplex (Scheme 80).
266,267
 In detail, Iwasawa et al. describe the mechanism 
as following: (1) DA reaction of tungsten complex 269 and furan 257b gives intermediate 
278, which, by elimination of W(CO)6 forms the o-quinodimethan type intermediate 279, 
almost identical with 274, that undergoes a “intramolecular nucleophilic attack” to form 
cyclopropane 270 (Scheme 83).
267
 However, nothing more was mentioned about the 
mechanism of this “intramolecular nucleophilic attack”. 
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Scheme 83. Reproduced mechanism from Iwasawa et al.
267
 
 
From dihydronaphthalene 274 the occurrence of a sigmatropic rearrangement according to the 
Woodward-Hoffmann rules was proposed.
278,279
 A -bond is moved from position 1 to 3 on 
one site and from 1’ to 9’ on the other side (Scheme 84). The simplified 3-atom and 9-atom 
fragments can be divided into their topologies. On the 3-atom fragment the migration of the 
-bond occurs on the opposite face and on the 9-membered fragment on the same leading to 
an ‘allowed’ antara-suprafacial [3,9]-sigmatropic rearrangement involving 4n (n = 3) 
electrons. Alternatively, the transformation can be described by the model according to 
Dewar
40
 and Zimmerman.
41
 This way one phase dislocation occurs, representing a Möbius 
topology which in the case of 4n electrons describes an ‘allowed’ transition state. 
Scheme 84. Proposed [3,9]-sigmatropic rearrangement. 
 
The antarafacial [3,9]-sigmatropic rearrangement of furan 274 to cyclopropane 258b’ is 
supported via DFT calculations on B3LYP level with a basis set of 6-31g(d,p). Since, furan 
274 occurs in two conformers distinguished by the position of the methoxy group which are 
very close in energy (Scheme 85). 
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Scheme 85. Different conformers of furan 274 by the rotation of the methoxy group. Gibbs free energy 
difference in brackets. 
 
The transition state of both conformers have been located in the gas phase resulting in two 
energetically different pathways. The “cis-furan” lead to an activation energy as low as 
Δ‡G°(T=298)= 9.3 kcal/mol and to a high Gibbs free energy of reaction ΔrG°(T=298)= –39.1. In 
turn, “trans-furan” leads to a slightly more congested transition state resulting in a higher free 
energy of activation of Δ‡G°(T=298)= 11.9 kcal/mol and the next local minima (trans-ester) is 
reached at Gibbs free energy of reaction ΔrG°(T=298)= 30.3 kcal/mol (Figure 26). The high 
thermodynamic driving force of the rearrangement results from the formation of the ester 
resonance and the aromatic stabilization which has been lost in the dihydronaphthalene 
intermediate 274 by the elimination of molecular nitrogen springloading the molecule and 
easily accounting for the strain energy of the cyclopropane formation. Despite the evidence 
for a rearrangement an ionic mechanism cannot be ruled out. 
 
Figure 26. Intrinsic reaction coordinates of the sigmatropic rearrangement. To the left, reaction path to 
the cis-ester and right, to the trans-ester. 
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3.4.4 Enantioselective catalysis in the IEDDA/[9,3]-sigmatropic rearrangement 
One of the most elementary way to obtain organoboranes is the hydroboration reaction as 
intensively investigated by H.C. Brown and co-workers.
280,281
 The reaction involves the 
addition of borane to the alkene or alkyne in an anti-Markovnikov fashion. This method is as 
well used to obtain chiral boron compounds, such as alpine-borane prepared from naturally 
occurring monoterpene pinene (Scheme 86). 
Scheme 86. Hydroboration reaction of α-pinene and borabicyclononane. 
 
Alpine-borane is widely used for the asymmetric reduction of ketones, also called the 
Midland reduction
282
, recently featured in the total synthesis of (–)-galanthamine (Scheme 
87).
283
 
Scheme 87. The Midland Alpine-borane reduction in the total synthesis of (–)-galanthamine. 
 
Herein the above described methods have been adapted to acquire direct access to chiral 
catalysts via hydroboration with commercially available terpenes. Dihydroboranthrene 287 
was synthesized by the reaction of the dichloroboranthrene 188 with Et3SiH in DCE.
150
 The 
so obtained dihydroboranthrene 287 can react with unsaturated alkanes via hydroboration. 
Scheme 88. Synthesis of dihydroboranthrene via dichloro dihydroboranthrene. 
 
Four different monoterpenes have been tested as additives with dihydroboranthrene to form 
the chiral catalyst in situ (Figure 27). 
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Figure 27. Monoterpnenes for the in situ formation of chiral catalyst via hydroboration. 
Except for α-pinene 290 all reactions with additives showed turnover. Although the highest 
turnover was achieved by using β-pinene in the reaction of phthalazine 244a and 
methoxyfuran 257b, the yield is modest (Scheme 89). 
Scheme 89. Enantioselective catalyzed IEDDA/cyclopropanation reaction. 
 
The enantiomeric excess (ee) of the reaction was found to be 15.7%. The small ee could be 
explained by the little sterical distinction of the sites of the double bond, where on one side 
there is a hydrogen atom and on the other side a lone pair (Figure 28).  
 
Figure 28. Sterical distinction of the sites of the reacting furan double bond. 
Even though the yield together with the ee is low, it shows a potential approach for a chiral 
catalyst in the IEDDA/cyclopropanation reaction. 
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3.5 Catalyzed domino IEDDA/[1,9]-sigmatropic rearrangement of diazines 
In a different experiment, the pathway of the reaction was investigated when no 
rearomatization can occur. By the use of an alkyl furan 292 in the catalyzed IEDDA reaction 
with phthalazine 244a the reaction was expected to lead to the o-qinodimethane intermediate 
293 as in the proposed catalytic cycle for electron rich furans (Scheme 82). But from then on, 
non of the above encountered reaction pathways are credible. Whether elimination nor a [3,9]-
sigmatropic rearrangement can occur (Scheme 90). 
Scheme 90. Cycloaddition of dienophile without the credible possibility of rearomatization. 
 
Alkyl dihydrofuran 292 was synthesized from lactone 294 in two consecutive steps by 
reduction with DIBAL-H and elimination with MsCl (Scheme 91). 
Scheme 91. Two step reduction elimination procedure to synthesize 4-substituted dihydrofuran. 
 
The final catalyzed IEDDA reaction of dihydrofuran 292a and phthalazine 244a resulted in 
tetrahydrofuran 296a, a new type of products (Scheme 92). The structure was verified via 2D-
NMR. The rather low yield of the reaction can be attributed to pre-optimized reaction 
conditions. 
Scheme 92. Catalyzed IEDDA reaction of 4-substituted dihydrofuran and phthalazine. 
 
A similar dihydrofuran 297a was derived from 292a by deprotonation and reaction with 
disulfane (Scheme 93). 
Scheme 93. Sulfurylation of dihydrofuran 292a. 
 
The following IEDDA reaction of methylthiodihydrofuran 297a with phthalazine at 160°C 
showed no turnover after one day. But employing the much more reactive difluorophthalazine 
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244s in the catalyzed cycloaddition reaction at 125 °C smoothly proceeded to the 
tetrahydrofuran 298 with a yield of 95% (Scheme 94). Also in this case, 2D-NMR techniques 
have been used to confirm the structure. 
Scheme 94. Catalyzed IEDDA reaction of 5-methylthiodihydrofuran 297a with difluorophthalazine. 
 
As in Scheme 92 the reaction proceeds to the tetrahydrofuran 298a but in this case also the 
sulfur residue could have migrated which was not the case. 
3.5.1 Mechanistic considerations 
In analogy to the above mentioned cyclopropanation reaction, phthalazine 244 enters the 
catalytic cycle to form complex 184 which undergoes the cycloaddition with dihydrofuran 
292a to from adduct 299 which eliminates nitrogen and releases the catalyst 192 back into the 
cycle. The so formed highly reactive o-quinodimethan type intermediate 293a rearranges in a 
novel fashion to create the tetrahydrofuran product 296a , very different to those seen above 
(Scheme 95). 
Scheme 95. Proposed catalytic cycle of the IEDDA reaction with 4-substituted dihydrofurans. 
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Again, a sigmatropic rearrangement is predicted on the basis of the Woodward-Hoffmann 
rules.
278,279
 Only this time, the -bond is broken and created on the oxygen atom and on the 
dihydronaphthalene fragment the alkoxy moiety migrates from position 1’ to 9’ (Scheme 96). 
Scheme 96. Proposed [1,9]-sigmatropic rearrangement. 
 
The topology of both, the alkoxy fragment and dihydronaphthalene fragment is supra facial, 
which leads to an ‘allowed’ supra-suprafacial [1,9]-sigmatropic rearrangement involving 
4n+2 (n = 2) electrons. And according to the Dewar
40
-Zimmerman
41
 model no phase 
dislocation occurs constituting a Hückel topology which is ‘allowed’ in the case of 4n+2 
electrons. 
Furthermore, calculations have been conducted on the basis of an simplified model with a 
reduced alkyl side chain (hexyl → methyl). The located transition state showed an activation 
energy of Δ‡G0(T=298)= 35.9 kcal and a Gibbs free energy of reaction ΔrG
0
(T=298)= −21.3 kcal. 
The activation energy is high but still feasible especially at a reaction temperature of 160°C. 
The obtained activation energy is in the range of the [1,5]-sigmatropic hydrogen shift or the 
cope rearrangement, both well reviewed experimentally and computationally.
284–286
 The same 
calculations have been performed for the reaction of 2-methylthiodihydrofuran 297a (R = Me) 
and difluorophthalazine 244s (R = Me), resulting in a lower activation energy of Δ‡G0(T=298)= 
34.0 kcal and a higher Gibbs free energy of reaction ΔrG
0
(T=298)= −24.9 kcal. 
The transition structures of both reactions (Scheme 92 and Scheme 94) reflect very well the 
suggested sigmatropic rearrangement (Figure 29). 
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Figure 29. Transition state structures of [1,9]-sigmatropic rearrangement. 
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3.6 Development of an air stable catalyst for the IEDDA reaction 
The catalyst 192 utilized so far is a highly oxygen sensitive compound as it is in general the 
case for organoboranes. But in the absence of oxygen trialkylboranes are surprisingly stable. 
For example, a solution of triethylborane in protic solvents such as water or methanol can be 
stored for months under argon atmosphere without decomposition.
287
 The autoxidation of 
boranes is a well studied process, initiated by homolytic substitution (SH2) reaction between 
triplet oxygen and trialkylborane releasing an alkyl radical (Scheme 97). 
Scheme 97. Autoxidation of alkylboranes in the presence of oxygen. 
 
The production of radical intermediates in the autoxidation process of boranes has been 
widely applied as initiator in radical chemistry.
288–290
 Alkylboranes allow the radical initiation 
even at temperatures well below 0 °C compared to some of the common thermal radical 
initiators like 1,1’-azobisisobutyronitril (AIBN) or benzoyl peroxide. One of the first uses of 
organoboranes in radiacl chemistry was the oxygen induced conjugate addition to enones and 
enals by Brown and Kabalka (Scheme 98).
291,292
 
Scheme 98. Brown’s mechanism for the conjugate addition of organoboranes to vinyl ketone.288 
 
To avoid the autoxidation reaction to take place the empty p-orbital of boron has to be 
sterically shielding or occupied by a donor compound (Figure 30). 
 
Figure 30. Boron compounds inert to air, stabilized by different principles. 
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The sterical shielding of boron was investigated in the late 50’s by Brown and co-workers293, 
obtaining air-stable trimesylborane 300. This method is still widely applied as seen in the air-
stable borane 301.
294
 A novel concept, is the stabilization of organoboranes by structurally 
constraining boron in a planar conformation
295
 as shown in the air-stable boradibenzopyrene 
302.
296
 By complexation with a Lewis base the Lewis acid gets stabilized as exemplified in 
the air-stable 1,2,3-triazol-borane complex 303.
297
 
The downside of all of these principles is the considerable reduction in Lewis acidity. But the 
most obvious and promising for herein purposes was the stabilization by complexation, since 
an intermediary complexation of catalyst 192 with phthalazine 244a was needed anyways. 
But as complex 184 itself is prone to undergo an IEDDA reaction the diazine had to be 
changed to an under the reaction conditions inert compound. For this reason the nearby choice 
was the unreactive pyridazine 177. Although the resulting complex is inert to the IEDDA 
reaction conditions it is believed that rapid exchange with phthalazine is maintaining the 
activity of the catalyst at the same time stabilizing against oxidation (Scheme 99). 
Scheme 99. Concept of stabilization of catalyst 192 by pyridazine, while maintaining reactivity. 
 
The complex 185 was prepared by complexation of 192 with pyridazine 177 in THF and 
following evaporation of THF and excessive pyridazine. The occurrence of an equilibrium 
between the pyridazine complex 185 and phthalazine complex 184 was tested by the addition 
of phthalazine 244 to complex 185 (Scheme 99). The recorded 
1
H-NMR spectra show such an 
exchange in the mixture of complex 185 and phthalazine 244 by broad signals (arrows), 
which are in accordance with another equilibrium between the newly formed complex 184 
and uncoordinated phthalazine 244 (Figure 31). 
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Figure 31. Stacked low field region of 
1
H-NMR spectra of complex 185 (in blue), mixture of complex 
185 and phthalazine 244a (in red), complex 184 (in purple), and free phthalazine 244a (in green). 
Singlet of THF-d8 (δ = 3.58 ppm) is used as the reference peak. 
Furthermore, the solid complex 185 was exposed to air and the 
1
H-NMR spectrum has been 
recorded at intervals to investigate its air stability (Figure 32). 
 
Figure 32. Stacked low field region of 
1
H-NMR spectra of complex 185 exposed to air and measured 
after a certain time (t). 
The complex 185 showed an unexpected high stability under air exposure, where after 20 
days only slight decomposition occurs and even after 80 days major amounts of complex are 
remaining. This states a good tolerability towards air. In addition, after 20 days an IEDDA 
reaction was carried out with complex 185 as catalyst in the reaction of phthalazine 244a and 
TIPS-oxyfuran 257c (Scheme 100). The performance of complex 185 is retained and it almost 
attains full turnover similar to catalyst 192 shown in Table 10, which confirms the initial 
outset. 
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Scheme 100. IEDDA/cyclopropanation reaction catalyzed by complex 185 after air-exposure for 20 
days. 
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4 Summary and Conclusion 
Herein, a new and very successful principle of activation of 1,2-diazine with a bidentate 
Lewis acid catalyst for the IEDDA reaction is presented. A new, very direct method for the 
synthesis of 5,10-dimethyl-5,10-dihydroboranthrene as the catalyst in the IEDDA reaction of 
1,2-diazines was devised, enabling the preparation on a gram scale (Scheme 101). 
Scheme 101. Convenient three step procedure for the synthesis of 5,10-dimethyl-5,10-dihydro-
boranthrene. 
 
In addition, on a exploratory basis, the in situ derivatization with chiral additives has been 
studied as well as an air-tolerable second generation catalyst was developed. 
The scope of dienophiles was examined reaching from silylacetylene, enolethers, O,O- or 
N,O-keteneacetals to enamines from ketone and aldehyde generated in situ (Scheme 102). 
Scheme 102. Catalyzed IEDDA reaction of phthalazine with a variety of different dienophiles. 
 
Since pyridazine did not react in the catalyzed IEDDA reaction, the scope of dienes was 
mainly focused on phthalazine derivatives. At first the unavailability of a general method for 
the synthesis of benzo-substituted phthalazines reduced the range of applied dienes. This gap 
was filled with the introduction of a one-pot synthesis of substituted phthalazines and 
pyridazino-aromatics starting from aromatic aldehydes (Scheme 103). 
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Scheme 103. One-pot synthesis of substituted phthalazines and pyridazino-aromatics. 
 
Thus, the developed method comprised a novel two-step strategy for the preparation of 
substituted naphthalenes, which was nicely displayed in the synthesis of (±)-Naproxen 
(Scheme 104). 
Scheme 104. Novel two step synthesis of substituted Naphthalenes starting from benzaldehydes, 
applied in the synthesis of (±)-Naproxen. 
 
By the application of electron rich furans, a novel domino IEDDA/cyclopropanation reaction 
occurred leading to cyclopropadihydronaphthalenes in excellent yields. The method was 
elaborated and the scope was illustrated by 20 examples (Scheme 105). Investigation of the 
mechanism via computational methods lead to the proposal of a concerted migration, 
formulated as [3,9]-sigmatropic rearrangement, on the basis of either the Woodward-
Hoffmann rules or the Dewar-Zimmerman model. 
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Scheme 105. Domino IEDDA/Cyclopropanation reaction of substituted phthalazines and oxyfurans, 
resulting in the proposed [3,9]-sigmatropic rearrangement. 
 
In addition, by submitting 4-substituted dihydrofuran to the catalytic IEDDA reaction the final 
rearomatization step via elimination was inhibited giving rise to a proposed [1,9]-sigmatropic 
rearrangement yielding tetrahydronaphthofuran (Scheme 106). 
Scheme 106. Domino IEDDA/[1,9]-sigmatropic rearrangement reaction of phthalazine with 4-
substituted dihydrofurans. 
 
The catalytic cycle of the IEDDA reaction of phthalazine and dienophiles was rationalized 
with the complexation of the catalyst with phthalazine to enable the IEDDA reaction, which 
after extrusion of nitrogen and regeneration of the catalyst leads to the formation of a high 
energetic intermediate. Therefore the o-quinodimethan intermediate is prone to undergo 
rearrangements or elimination to restore aromaticity. This results in an efficient catalytic route 
to give either dihydronaphthalene or naphthalene derivatives from easy obtainable phthalazine 
derivatives (Scheme 107). 
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Scheme 107. Summarized bidentate Lewis acid catalyzed IEDDA reaction of phthalazine with its 
catalytic cycle. 
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5 Experimental Part 
5.1 General information 
Reagents and Solvents: All reagents and solvents were obtained from either Sigma-Aldrich , 
Acros, Fluorochem, Alfa, VWR, Fluka, ABCR, Apollo or TCI and were used as received 
unless otherwise stated. Dry solvents were obtained from commercial sources, from a Pure-
Solv™ drying system or dried over molecular sieve. THF was predried over CaCl2 and 
distilled from potassium and benzophenone. Oxygen-free solvents for the catalytic reaction 
was obtained from commercial sources or via freeze-pump-thaw cycling. Technical grade 
solvents for extraction and column chromatography were bulb-to-bulb distilled prior to usage. 
Reactions: Moisture sensitive reactions were set up in dry glassware, which was heated up to 
200 °C and dried in several evacuation-flush-cycles or just flushed by nitrogen or argon. Air 
sensitive reactions were set up under nitrogen atmosphere, either in the hood or in a nitrogen 
glove-box. Especially all catalyzed reactions were set up in the glove-box. Pressurized 
reactions were set up in a glass pressure tube. 
Photolysis: For the rearomatization reaction was used either a 8 Watt 3UV lamp from UVP 
with 302 nm or a Rayonet photoreactor with 300 nm lamps. 
Chromatography: The thin layer chromatography was conducted on aluminum supported 
silica gel 60 F254 with a thickness of 0.2 mm from Merck and detected with a GAMAG UV 
cabinet at 254 or 365 nm or developed with KMnO4, vanillin, ninhydrin or iodine. For the 
preparative scale thin layer chromatography was used 1 or 2 mm silica gel coated glass plates 
(20 × 20 cm) from Analtech. For the column chromatography was used silica gel 60 (40 – 63 
μm) from Fluka, Sigma-Aldrich, Merck, SiliCycle Inc. 
1
H-, 
13
C-, 
11
B- and 
19
F-NMR: Experiments were performed on a Bruker Avance 500 
(500/125.8/57/376 MHz), Bruker DPX-NMR (400/100.6 MHz) or Bruker BZH-NMR (250 
MHz) at 25 °C. The 500 MHz NMR machine was utilized to measure two dimensional 
spectra. Chemical shifts are reported in parts per million (ppm) relative to solvent peek or 
trimethylsilane (TMS). Coupling constants (J) are reported in Hertz (Hz). NMR-solvents were 
purchased from Cambridge Isotope Laboratories, Inc. or ARMAR. The multiplicities are 
written as: s=singlet, sb=broad singlet, d=doublet, t=triplet, m=multiplet and their 
combinations, such as dd=doublet of a doublet. 
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Mass Spectrometry: Electron spray mass spectrometry was measured on a Bruker esquire 
3000 plus. For GC/MS-analysis a Hewlett Packard 5890 Series II gas chromatography 
system, with a Macherey Nagel OPTIMA 1 Me2Si column (25 m × 0.2 mm × 0.35 m), at 1 
ml/min He-flow rate (split = 20:1) with a Hewlett Packard 5971 Series mass selective detector 
(EI 70 eV) was used. And fast atom bombardment (FAB) mass spectrometry was measured 
by Dr. H. Nadig on a MAR 312. High resolution mass spectrometry was conducted by the 
Schürch group at the University of Bern on a LTQ Orbitrap XL. 
IR-Spectroscopy: Spectra were recorded on a Fourier transform infrared spectrometer 
Shimadzu FTIR-8400S by which the compounds were measured through a Specac Golden 
Gate ATR sampling system. 
Elementary analysis: The elemental analysis were performed by Mr. W. Kirsch on a Leco 
CHN-900 or by Mrs Sylvie Mittelheisser on a Vario Micro Cube. 
Melting Point: Measurements of melting points were made with a SRS EZ-Melt MPA 120 or 
Büchi 530 instrument. 
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5.2 First generation preparation of 5,10-dimethyl-5,10-dihydroboranthrene 
The following compound was prepared according to literature procedure: 1,2-
Bis(trimethylsilyl)benzene (191)
2
. 
5,10-Dichloro-5,10-dihydroboranthrene (189) 
 
The thermolysis of the trimethylsilyl dichloroborylbenzene 188 (5.41 mmol, 1.25 g) at 135 °C 
for 18 h and consecutive sublimation at 150 °C/0.3 mbar gave white crystals (240 mg, 36%). 
In consequence of the air sensitivity of the product only NMR-spectroscopy was conducted. 
1
H-NMR: (400 MHz, C6D6) δ 8.20 (dd, J = 3.3, 5.4 Hz, 4H, 1-H, 4-H, 6-H, 9-H), 7.17 
(dd, J = 3.2, 5.5 Hz, 4H, 2-H, 3-H, 7-H, 8-H). 
 (400 MHz, CDCl3) δ 8.35 – 8.28 (m, 4H), 7.73 – 7.67 (m, 4H). 
13
C-NMR: (101 MHz, C6D6) δ 136.6, 134.1 (4a, 5a, 9a, 10a not visible due to coupling 
with boron). 
 (101 MHz, CDCl3) δ 136.7, 134.4 (4a, 5a, 9a, 10a not visible due to coupling 
with boron). 
5,10-Dimethyl-5,10-dihydroboranthrene (192) 
 
To a suspension of the dihydroboranthrene 189 (0.52 mmol, 128 mg) in THF (5 ml) was 
added 1.6M MeLi (1.04 mmol, 660 µl) in Et2O for 10 min at –18 °C and after stirring for 1 h 
the reaction mixture turned to a colorless solution. The solution was warmed to r.t. and stirred 
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during 1 h, concentrated at r.t./20 – 0.02 mbar and sublimed at 150 °C/0.02 mbar to yield 
white colorless crystals (23.2 mg, 22%). 
1
H-NMR: (400 MHz, C6D6) δ 8.01 (dd, J = 3.3, 5.4 Hz, 4H, 1-H, 4-H, 6-H, 9-H), 7.34 
(dd, J = 3.3, 5.4 Hz, 4H, 2-H, 3-H, 7-H, 8-H), 1.32 (s, 6H, 1’-H, 1”-H). 
The analytic data are in accordance with the literature.
1
 
5.3 Second generation preparation of 5,10-dimethyl-5,10-dihydroboranthrene 
1,2-Bis(trimethylsilyl)benzene (191) 
 
Method A: Pulverized Mg (3.04 g, 125 mmol, 2.50 equiv) was dried under vacuum at ~300 
°C for 30 min. After cooling down and flushing with N2, THF (50 ml) and 2 mol% of 1M 
DIBAL-H in THF (1.0 ml) were added and refluxed for five minutes. After the addition of 
TMSCl (13.9 g, 16.3 ml, 125 mmol, 2.50 equiv), 1,2-dibromobenzene (190) (11.8 g, 6.03 ml, 
50.0 mmol, 1.00 equiv) was added drop wise within 45 min maintaining reflux. The mixture 
was stirred for additional 35 min. The reaction mixture was poured into a mixture of sat. 
NaHCO3 (125 ml) and ice (60 ml). Et2O (125 ml) was added and solids were filtered off. The 
aqueous phase was extracted with Et2O (1 × 125 ml, 1 × 100 ml, 1 × 60 ml) and the combined 
extract was dried over Na2SO4 and evaporated under reduced pressure. The crude product was 
purified by distillation over a Vigreux-column at 1.1 mbar and 72 – 81 °C to give 4.08 g 
(37%) of clear oil. 
Method B: Pulverized Mg (0.729 g, 30.0 mmol, 3.00 equiv) and anhydrous FeCl3 (48.7 mg, 
0.300 mmol, 3 mol%) were dried for 30 min under vacuum and heated to ~300 ºC for 5 min. 
After cooling down and flushing with N2, THF (10 ml), TMEDA (1.39 g, 1.81 ml, 12.0 mmol, 
1.20 equiv) and 2 mol% of 1M DIBAL-H in THF (0.2 ml) were added and stirred for five 
minutes. Then, TMSCl (3.26 g, 3.83 ml, 30.0 mmol, 3.00 equiv) was added and cooled to -10 
°C. 1,2-Dibromobenzene (190) (2.36 g, 1.21 ml, 10.0 mmol, 1.00 equiv) was added drop wise 
over six hours maintaining the temperature between –10 and 0 C. The mixture was stirred for 
additional 18 h at –10 to 0 °C. Then, the reaction was poured into a mixture of sat. NaHCO3 
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(25 ml) and ice (12 ml). Et2O (25 ml) was added and solids were filtered off. The aqueous 
phase was extracted with Et2O (1 × 25 ml, 1 × 20 ml, 1 × 12 ml) and the combined extract 
was dried over Na2SO4 and evaporated under reduced pressure. The crude product was 
purified by column chromatography over silica by hexane (+1% TEA) to yield a clear liquid 
(1.21 g). Volatile impurities were removed at high vacuum to give 0.909 g of clear oil in a 
41% yield. 
1
H-NMR: (400 MHz, C6D6) δ 7.67 (dd, J = 3.2 Hz, J = 2.4 Hz, 2H, 3-H, 6-H), 7.32 (dd, J 
= 3.2 Hz, J = 2.4 Hz, 2H, 4-H, 5-H), 0.36 (s, 18H, 7-H, 8-H, 9-H, 10-H, 11-H, 
12-H). 
The analytic data are in accordance with the literature.
2
 
5,10-Dichloro-5,10-dihydroboranthrene (189) 
 
To BCl3 (26.3 ml, 26.3 mmol, 1M in heptanes, 2.05 equiv) was added 1,2-dichloroethane (10 
ml), 1,2-bis(trimethylsilyl)benzene (191) (2.84 g, 12.8 mmol, 1.00 equiv) and the mixture was 
stirred at 140 °C for 3 d. The reaction mixture was then cooled to 0 °C and decanted, washed 
two times with hexane (5 ml and 2.5 ml) and the precipitate was dried at high vacuum to yield 
white needles (944 mg, 60%). By additionally evaporating and sublimation of the filtrate a 
total yield of (70%) could be achieved. 
1
H-NMR: (400 MHz, C6D6) δ 8.20 (m, 4H; 1-H, 4-H, 6-H, 9-H), 7.17 (m, 4H; 2-H, 3-H, 
7-H, 8-H) 
 
(400 MHz, CDCl3) δ 8.35–8.28 (m, 4H), 7.73–7.67 (m, 4H). 
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13
C-NMR: (101 MHz, C6D6) δ 136.6, 134.1 (4a, 5a, 9a, 10a not visible due to coupling 
with boron) 
 
(101 MHz, CDCl3) δ 136.7, 134.4 (4a, 5a, 9a, 10a not visible due to coupling 
with boron) 
11
B-NMR: (CDCl3, 57 MHz) δ 58.50. 
5,10-Dimethyl-5,10-dihydroboranthrene (192) 
 
To a suspension of dichloro dihydroboranthrene 189 (516 mg, 2.11 mmol, 1.00 equiv) in 
hexane (15 ml) was added AlMe3 (1.06 ml, 2.11 mmol, 2M in heptane, 1.00 equiv) within 5 
min at –40 °C and stirred for 1 h before allowing to warm to rt and stirring for 19 h. 
Sublimation at 120 °C/0.2 mbar yielded white crystals (394 mg, 92%). 
1
H-NMR: (400 MHz, C6D6) δ 8.01 (m, 4H; 1-H, 4-H, 6-H, 9-H), 7.34 (m, 4H; 2-H, 3-H, 
7-H, 8-H), 1.32 (s, 6H; 1’-H, 1”-H). 
The analytic data are in accordance with the literature.
1
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5.4 Complexation experiment 
Complex of 5,10-dimethyl-5,10-dihydroboranthrene with phthalazine (184) 
 
A 44mM solution of 5,10-dimethyl-5,10-dihydroboranthrene (192) in C6D6 (0.5 ml) was 
titrated stepwise with 10 × 5 µl of a 0.44M solution of phthalazine 183 in C6D6 to precipitate a 
yellowish solid, monitored by 
1
H-NMR. The complex was dried by N2 flow and dissolved in 
THF-d8 (0.5 ml). 
1
H-NMR: (400 MHz, THF-d8) δ 9.89 (s, 2H, 1’-H, 2’-H), 8.35 (dd, J = 3.2, 6.0 Hz, 2H, 
3’-H, 6’-H), 8.10 (dd, J = 3.2, 6.0 Hz, 2H, 4’-H, 5’-H), 7.35 (dd, J = 3.2, 5.2 
Hz, 4H, 1-H, 4-H, 5-H, 8-H), 6.76 (dd, J = 3.2, 5.2 Hz, 4H, 2-H, 3-H, 6-H, 7-
H), 1.05 (s, 6H, 9-H, 10-H). 
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5.5 Bidentate Lewis acid catalyzed IEDDA reaction 
5.5.1 First catalysis of model reaction 
2-Ethyl-3-methyl-4,5-dihydrooxazol-3-ium iodide (194) 
 
A solution of MeI (8.52 g, 3.73 ml, 60.0 mmol, 1.20 equiv) and 2-ethyl-2-oxazoline (193) 
(4.96 g, 50.0 mmol, 1.00 equiv) in CH3CN was stirred at rt for 30 h. The reaction mixture was 
evaporated at 45 °C/15 mbar and dried at rt/0.3 mbar to yield a yellowish sticky solid (10.6 g, 
88%). The product was very sensitive to air and therefore, it was directly used in the next 
reaction. 
1
H-NMR: (400 MHz, CD3CN) δ 4.85 (t, J = 9.9, 2H, 4-H), 4.08 (t, J = 9.9, 2H, 5-H), 
3.25 (s, 3H, 1”-H), 2.76 (q, J = 7.5, 2H, 1’-H), 1.12 (t, J = 7.5, 3H, 2’-H). 
2-Ethylidene-3-methyloxazolidine (195) 
 
To a dispersion of dihydrooxazolium iodide 194 (4.00 g, 16.6 mmol, 1.00 equiv) in THF (20 
ml) was added NaH (730 mg, 18.3 mmol, 60% in mineral oil, 1.10 equiv) at –18 °C within 1.5 
h and stirred for 30 min. The mixture was warmed to rt and stirred for 3 h. The white 
suspension was filtered, concentrated at 50 °C/50 mbar and Kugelrohr distilled at 100 °C/15 
mbar to obtain a yellowish clear liquid (973 mg, 52%), containing traces of THF. The product 
was very sensitive to air and handled only under nitrogen atmosphere. 
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1
H-NMR: (400 MHz, C6D6) δ 3.62 (t, J = 6.5, 2H, 4-H), 3.29 (q, J = 6.5, 1H, 1’-H), 2.45 
(t, J = 6.5, 2H, 5-H), 2.24 (s, 3H, 1”-H), 1.97 (d, J = 6.6, 3H, 2’-H). 
13
C-NMR: (101 MHz, C6D6) δ 158.0, 64.8, 64.7, 52.0, 34.7, 10.3. 
MS: (EI) m/z (%): 113 (M
+
, 70), 57 (100). 
2-[Methyl(3-methylnaphthalen-2-yl)amino]ethanol (196) 
 
NMR-Experiments: 
General procedure: A 44mM solution of 5,10-dimethyl-5,10-dihydroboranthrene (192) in 
benzene was added to phthalazine 183 (1.00 equiv). After concentrating with a nitrogen flow, 
diglyme (200 μl), followed by Hünig’s base (50 μl) and oxazolidine 195 (1-1.5 equiv) were 
added and the reaction mixture was stirred at 120 °C for 12 h and analyzed by NMR-
spectroscopy. 
In parallel a reference reaction containing all the same except catalyst 192 was set up under 
the same conditions. 
Reaction with 10 mol% of Catalyst: The catalyst 192 (100 μl, 4.4 μmol, 10 mol%), 
phthalazine 183 (5.7 mg, 44 µmol, 1.0 equiv) and oxazolidine 195 (5.0 mg, 44 µmol, 1.0 
equiv) were stirred for 12 h and diluted with C6D6 (0.5 ml).  
Reaction with 5 mol% of Catalyst: The catalyst 192 (50 μl, 2.2 μmol, 5.0 mol%), phthalazine 
183 (5.7 mg, 44 µmol, 1.0 equiv) and oxazolidine 195 (7.5 mg, 66 μmol, 1.5 equiv) were 
stirred for 22 h and diluted with CDCl3 (0.5 ml).  
Reaction with 2.5 mol% of Catalyst: Catalyst 192 (25 µl, 1.1 µmol, 2.5 mol%), phthalazine 
183 (5.7 mg, 44 µmol, 1.0 equiv) and oxazolidine 195 (7.5 mg, 66 μmol, 1.5 equiv) were 
stirred for 22 h and diluted with CDCl3 (0.5 ml).  
Reaction mixtures were evaluated by 
1
H-NMR. 
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Preparative Procedure: 
To a fine suspension of catalyst 192 (5.0 mg, 15.0 µmol, 5.00 mol%) and phthalazine (183) 
(39.0 mg, 0.300 mmol, 1.00 equiv) in diglyme (500 µl) and N,N-diisopropylethylamine (125 
µl) was added 2-ethylidene-3-methyloxazolidine (195) (50.9 mg, 0.450 mmol, 1.50 equiv). 
The reaction mixture was heated to 120 °C for 20 h. After evaporation at 50 °C/2 mbar it was 
purified by flash chromatography (silica gel; hexane/ethylacetate 19:1 → 4:1, stabilized with 
1% Et3N) to yield a colorless oil (28.4 mg, 42%). 
TLC: Rf = 0.44 (EtOAc: cyclohexane, 1:1 with 1% Et3N). 
1
H-NMR: (400 MHz, CDCl3) δ 7.73 – 7.70 (m, 2H, H-Ar), 7.64 (s, 1H, 4-H), 7.45 (s, 1H, 
1-H), 7.41 – 7.33 (m, 2H, H-Ar), 3.76 (t, J = 5.5 Hz, 2H, 1'-H), 3.20 (t, J = 5.5 
Hz, 2H, 2’-H), 2.76 (s, 3H, 1'''-H), 2.50 (bs, 1H, OH), 2.49 (s, 3H, 1''-H). 
13
C-NMR: (101 MHz, CDCl3) δ 150.99, 133.29, 132.98, 130.84, 129.68, 126.92, 126.87, 
125.44, 124.91, 117.60, 59.22, 57.97, 42.38, 18.94. 
MS: (EI) m/z (%): 215 (M
+
, 20), 184 (100). 
IR: (ν/cm-1): 3366 (w, νO-H), 2948 (m), 2920 (w), 2885 (w), 2846 (w), 2794 (w), 
1629 (m), 1589 (m), 1499 (s), 1486 (s), 1449 (m), 1418 (m), 1378 (s), 1336 
(m), 1334 (s). 
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5.5.2 Enols as dienophiles 
5.5.2.1 Preparation of the dienophile 
2-Methylenetetrahydrofuran (197c): 
 
To a suspension of pre-dried KOH (2.83 g, 45.4 mmol, 90%, 1.50 equiv) in furfurylalcohol (3 
ml) was added 2-(bromomethyl)tetrahydrofuran (5.00 g, 30.3 mmol, 1.00 equiv) over 5 min. 
After cooling to rt the reaction was stirred for 17 h to obtain a thick suspension which was 
distilled at 70-75 °C/250 mbar to yield a colorless liquid containing water. Re-distillation at 
60 °C/160 mbar over NaH (500 mg) gave a colorless liquid (1.08 g, 42%). 
1
H-NMR: (400 MHz, C6D6) δ 4.56 (s, 1H, Ha), 3.92 (s, 1H, Hb), 3.64 (t, J = 6.7 Hz, 2H, 
5-H), 2.10 (t, J = 7.6 Hz, 2H, 3-H), 1.35 – 1.26 (m, 2H, 4-H). 
The analytic data are in accordance with the literature.
3
 
5-Butyl-2,3-dihydrofuran (197d) 
 
A solution of 1.9M t-BuLi in pentane (20.0 ml, 38.0 mmol, 1.20 equiv) was added dropwise 
over 10 min to a solution of 2,3-dihydrofuran (197a) (3.20 g, 45.7 mmol, 1.44 equiv) in dry 
tetrahydrofuran (15 ml) at ca. –60 °C. The resulting yellow suspension was slowly allowed to 
warm to 0 °C and was stirred for further 30 min. The mixture was then cooled to –30 °C and 
iodobutane (5.83 g, 3.62 ml, 31.7 mmol, 1.00 equiv) was added over 10 min. The mixture was 
slowly allowed to warm to rt and was stirred for 36 h. The white suspension obtained was 
poured into a mixture of saturated ammonium hydroxide solution (4 ml) and saturated 
ammonium chloride solution (36 ml) and the organic layer was extracted with ether (3 × 40 
ml). The combined extracts were dried briefly (Na2SO4) and very carefully evaporated to 
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leave a yellow oil. Distillation over Vigreux at 44-45 °C/17 mbar yielded a colorless liquid 
(2.18 g, 55%). 
1
H-NMR: (400 MHz, C6D6) δ 4.52 – 4.47 (m, 1H, 3-H), 4.09 (t, J = 9.3 Hz, 2H, 5-H), 
2.39 – 2.30 (m, 2H, 1’-H), 2.15 – 2.08 (m, 2H, 4-H), 1.56 – 1.45 (m, 2H, 2’-H), 
1.31 – 1.21 (m, 2H, 3’-H), 0.91 (t, J = 7.4 Hz, 3H, 4’-H). 
The analytic data are in accordance with the literature.
4
 
2-(Methylene)-1,3-dioxolane (197e) 
 
To bromomethyl dioxolane (2.30 g, 13.8 mmol, 1.00 equiv) in Et2O (10 ml) was added NaH 
(828 mg, 20.7 mmol, 60% in mineral oil, 1.50 equiv) over 10 min at rt. The suspension was 
stirred for 17 h. Distillation (70 mbar/75 °C) yielded the desired product (632 mg, 53%). 
1
H-NMR: (C6D6, 400 MHz) δ 3.56 (s, 2H, 1’-H), 3.31 (s, 4H, 4-H, 5-H). 
The analytic data are in accordance with the literature.
5,6
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5.5.2.2 Catalyzed IEDDA reactions 
General procedure for furans and dioxolanes: To phthalazine 183 (0.440 mmol, 1.00 equiv) 
and catalyst 192 (7.3 mg, 22.0 μmol, 5.00 mol%) was added diglyme (0.45 ml), Hünig's base 
(75-150 μl) and dienophile (2.00-3.00 equiv). The mixture was stirred for the given time at 
the given temperature. After the addition of 1M HCl (5 ml) the reaction mixture was extracted 
(3 × 5 ml), dried over Na2SO4, evaporated, diluted with CDCl3 (0.75-1 ml), irradiated with 
UV light and distilled or purified by column chromatography. 
2-(Naphthalen-2-yl)ethanol (200a) 
 
According to the general procedure the catalyst 192 (7.3 mg, 21.8 μmol, 5.00 mol%), 
phthalazine 183 (56.7 mg, 0.436 mmol, 1.00 equiv), diglyme (450 μl), N,N-
diisopropylethylamine (150 μl) and dihydrofuran 197a (0.871 mmol, 61.1 mg, 1.98 equiv) 
were stirred for 3 d at 170 °C. After evaporation of the diglyme at 80 °C/10 mbar, the residue 
was purified by over 20 g silicagel (1:4 EtOAc/hexanes) to obtain the naphthalene (32.6 mg, 
43%).
 
1
H-NMR: (400 MHz, CDCl3) δ 7.86 – 7.76 (m, 3H, 4-H, 5-H, 8-H), 7.70 (s, 1H, 1-H), 
7.52 – 7.40 (m, 2H, 6-H, 7-H), 7.40 – 7.32 (dd, J = 8.3, 1.4 Hz, 1H, 3-H), 3.95 
(t, J = 6.0 Hz, 2H, 3’-H), 3.04 (t, J = 6.4 Hz, 2H, 2’-H), 1.68 (s, 1H). 
The analytic data are in accordance with the literature.
7
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3-(Naphthalen-2-yl)propan-1-ol (200ba), 2-(3-Methylnaphthalen-2-yl)ethanol (200bb) 
 
from 197b: According to the general procedure the phthalazine complex of catalyst 192 (7.3 
mg, 21.8 μmol, 5.00 mol-%), phthalazine (183) (56.7 mg, 0.436 mmol, 1.00 equiv), diglyme 
(450 μl), N,N-diisopropylethylamine (150 μl) and dihydrofuran 197b (73.3 mg, 0.872 mmol, 
2.00 equiv) were stirred for 2 d at 160 °C to obtain (63.9 mg, 75 %) of the naphthalenes 
200ba and 200bb in a 3:1 ratio after workup with hexane, 2.5 h irradiation and distillation at 
190 °C/0.5 mbar. 
From 197c: According to the general procedure the phthalazine complex of catalyst 192 (7.3 
mg, 21.8 μmol, 5.00 mol-%), phthalazine (183) (56.7 mg, 0.436 mmol, 1.00 equiv), diglyme 
(450 μl), N,N-diisopropylethylamine (150 μl) and dihydrofuran 197c (73.3 mg, 0.872 mmol, 
2.00 equiv) were stirred for 2 d at 160 °C. After workup with CH2Cl2, the residue was purified 
by chromatography over 15 g silica (1:4 EtOAc/Hex) to yield the naphthalenes 200ba and 
200bb in a 4.5:1 ratio (55.5 mg, 65 %). 
1
H-NMR: a: (400 MHz, CDCl3) δ 7.88 – 7.75 (m, 2H, 5-H, 8-H), 7.66 (s, 2H, 1-H, 4-H), 
7.53 – 7.43 (m, 2H, 6-H, 7-H), 7.37 (dd, J = 8.4, 1.6 Hz, 1H, 3-H), 3.70 (t, J = 
6.4 Hz, 2H, 3’-H), 2.89 (t, J = 8.0 Hz, 2H, 1’-H), 1.99 (tt, J = 13.0, 6.5 Hz, 2H, 
2’-H), 1.92 (s, 1H, O-H). 
1
H-NMR: b: (400 MHz, CDCl3) δ 7.88 – 7.75 (m, 2H, 5-H, 8-H), 7.66 (s, 2H, 1-H, 4-H), 
7.53 – 7.43 (m, 2H, 6-H, 7-H), 3.94 (t, J = 6.8 Hz, 2H, 2’-H), 3.06 (t, J = 6.8 
Hz, 2H, 1’-H), 2.51 (s, 3H, 1”-H), 1.92 (s, 1H, O-H). 
13
C-NMR: (101 MHz, CDCl3) δ 139.80, 135.82, 135.42, 134.08, 133.04, 132.69, 132.47, 
128.80, 128.41, 128.35, 128.07, 127.87, 127.74, 127.56, 127.32, 126.88, 
126.40, 125.96, 125.70, 125.64, 62.95, 62.61, 36.99, 34.50, 32.64, 20.39. 
MS: (EI) m/z (%): 186 (M
+
, 33), 142 (100).  
HRMS: (ESI) m/z calcd for [C13H15O]
+
: [M+H]
+
 187.1117; found 187.1124. 
The analytic data are in accordance with the literature.
7
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2-(3-Butylnaphthalen-2-yl)ethanol (200ca), 3-(3-Propylnaphthalen-2-yl)propan-1-ol (200cb) 
 
According to the general procedure the phthalazine complex of catalyst 192 (7.3 mg, 21.8 
μmol, 5.00 mol%), phthalazine (183) (56.7 mg, 0.436 mmol, 1.00 equiv), diglyme (450 μl), 
N,N-diisopropylethylamine (75 μl) and dihydrofuran 197d (111 mg, 0.880 mmol, 2.02 equiv) 
were stirred for 2 d at 160 °C to obtain (72.7 mg, 73 %) of the naphthalenes 200da and 200db 
in a 1.5:1 ratio after workup, 3.5 h irradiation and distillation at 200 °C/0.5 mbar.  
1
H-NMR: a: (400 MHz, CDCl3) δ 7.78–7.71 (m, 2H; 5-H, 8-H), 7.68 (s, 1H; 1-H*, 4-
H*), 7.67 (s, 1H; 1-H*, 4-H*), 7.43–7.35 (m, 2H; 6-H, 7-H), 3.77 (t, J=6.4 Hz, 
2H; 3’-H), 2.94–2.83 (t, J=7.7 Hz, 2H; 1’-H), 2.81–2.72 (t, J=7.7 Hz, 2H; 1”-
H), 1.97 (dq, J=14.2, 6.4 Hz, 2H; 2’-H), 1.73 (dd, J=15.3, 7.6 Hz, 2H; 2”-H), 
1.04 (t, J=7.3 Hz, 3H; 3’’-H). 
1
H-NMR: b: (400 MHz, CDCl3) δ 7.84–7.72 (m, 2H; 5-H, 8-H), 7.65 (s, 2H; 1-H, 4-H), 
7.49–7.37 (m, 2H; 6-H, 7-H), 3.94 (t, J=6.8 Hz, 2H; 2’-H), 3.08 (t, J=6.8 Hz, 
2H; 1’-H), 2.85–2.75 (t, J=6.6 Hz, 2H; 1”-H), 1.76–1.66 (m, 2H; 2”-H), 1.55–
1.44 (m, 2H; 3”-H), 0.98 (t, J=7.3 Hz, 3H; 4”-H). 
13
C-NMR: (101 MHz, CDCl3) δ 140.04, 139.66, 138.94, 135.21, 132.99, 132.69, 132.59, 
132.46, 128.53, 127.90, 127.60, 127.47, 127.45, 127.43 (2C), 127.40, 125.87, 
125.67, 125.55, 125.51, 63.59, 63.00, 36.34, 35.31, 34.20, 33.71, 33.12, 29.36, 
24.53, 23.21, 14.64, 14.46. 
MS: (EI, 70 eV) m/z (%): 228 (54) [M
+
], 155 (100). 
HRMS: (ESI): m/z calcd for [C16H21O]
+
: [M+H
+
] 229.1587; found: 229.1592. 
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2-(Naphthalen-2-yloxy)ethanol (200d) 
 
According to the general procedure the catalyst 192 (6.0 mg, 18.0 μmol, 5.00 mol%), 
phthalazine 183 (46.8 mg, 359 µmol, 1.00 equiv), solvent (450 μl), N,N-
diisopropylethylamine (150 μl) and dioxolane 197e (61.9 mg, 718 µmol, 2.00 equiv) were 
stirred for 10h at 160 °C. After evaporation of the solvent, the residue was purified by 
chromatography over 15 g silica (2:3 TBME/hexane) to yield yellow crystals (31.8 mg, 45%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.79 – 7.73 (m, 3H, Ar-H), 7.48 – 7.42 (m, 1H, Ar-H), 
7.38 – 7.33 (m, 1H, Ar-H), 7.21-7.13 (m, 2H, Ar-H), 4.24 – 4.16 (m, 2H, 1‘-
H), 4.03 (dd, J = 9.4, 5.2 Hz, 2‘-H), 2.16 (s, 1H, O-H). 
The analytic data are in accordance with the literature.
8
 
9a-butyl-2,3,3a,9a-tetrahydronaphtho[2,3-b]furan (199’) 
 
According to the general procedure the phthalazine complex of catalyst 192 (7.3 mg, 21.8 
μmol, 5.00 mol%), phthalazine (183) (56.7 mg, 0.436 mmol, 1.00 equiv), diglyme (450 μl), 
and dihydrofuran 197d (111 mg, 0.880 mmol, 2.02 equiv) were stirred for 2 d at 160 °C to 
obtain (17.8 mg, 18 %) of the tetrahydronaphthalene 199’ after workup, and chromatography 
over preparative TLC (1:19 TBME/hexane). 
1
H-NMR: (400 MHz, CDCl3) δ 7.45 – 7.41 (m, 1H, Ar-H), 7.25 – 7.16 (m, 2H, Ar-H), 
7.03 (dd, J = 7.1, 1.7 Hz, 1H, Ar-H), 6.17 (s, 1H, 9-H), 5.09 (d, J = 8.1 Hz, 1H, 
4-H), 3.83 (dd, J = 15.4, 7.4 Hz, 1H, 1-H), 3.75 (td, J = 8.0, 5.1 Hz, 1H, 1-H), 
2.93 (q, J = 8.1 Hz, 1H, 2a-H), 2.35 (dddd, J = 12.2, 8.4, 7.4, 5.1 Hz, 1H, 2-H), 
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2.22 (q, J = 7.8 Hz, 2H, 1’-H), 1.88 (dq, J = 12.2, 7.6 Hz, 1H, 2-H), 1.64 – 1.45 
(m, 2H, 2’-H), 1.44 – 1.29 (m, 2H, 3’-H), 0.98 – 0.92 (m, 3H, 4’-H). 
13
C-NMR: (127 MHz, CDCl3) δ 141.03, 132.97, 132.36, 128.18, 128.04, 126.92, 126.10, 
121.05, 77.82, 65.80, 41.65, 35.38, 32.55, 29.83, 22.57, 14.06. 
MS: (EI) m/z (%): 228 (M
+
, 88) 
HRMS: (ESI) m/z calcd for [C16H20ONa]
+
: [M+Na]
+
 251.1406; found 240.1401. 
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5.5.3 Enamines from ketones as dienophiles 
The following compounds were prepared according to literature procedures or obtained from 
Sigma-Aldrich: 1-Cyclohexenylpyrrolidine (203b)
3
 
General procedure for enamines from ketones: To phthalazine (183) (57.2 mg, 0.440 mmol, 
1.00 equiv) and catalyst 192 (4.5 mg, 22.0 μmol, 5 mol-%) was added diglyme (0.45 ml), 
enamine (3.00 equiv) or ketone and pyrrolidine (2.00 equiv). The mixture was stirred for the 
given time at the given temperature. To the mixture at –78 °C was added mCPBA (1.50-5.00 
equiv) and then it was left at room temperature over night. After the addition of H2O (5 ml) 
the reaction mixture was extracted with cyclohexane (3 × 5 ml), re-extracted with 1M NaOH, 
dried over Na2SO4, evaporated and purified by column chromatography. 
2,3-Dihydro-1H-cyclopenta[b]naphthalene (200e) 
 
According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 mol-%), 
phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), cyclopentanone (61.9 
mg, 718 µmol, 2.00 equiv) and pyrrolidine (62.8 mg, 883 µmol, 2.00 equiv) were stirred for 
2.5 d at 55 °C and treated with mCPBA (495 mg, 2.21 mmol, 77%, 5.00 equiv). After 
workup, the residue was purified by chromatography over 10 g silica (cyclohexane) to yield 
white crystals (38.5 mg, 52%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.81–7.76 (m, 2H; 5-H, 8-H), 7.68 (s, 2H; 4-H, 9-H), 
7.44–7.37 (m, 2H; 6-H, 7-H), 3.13–3.03 (m, 4H; 1-H, 3-H), 2.22–2.12 (m, 2H; 
2-H). 
The analytic data are in accordance with the literature.
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1,2,3,4-Tetrahydroanthracene (200f) 
 
According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 mol-%), 
phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), 1-
cyclohexenylpyrrolidine (203b) (200 mg, 1.32 mmol, 3.00 equiv) were stirred for 2.5 d at 90 
°C and treated with mCPBA (297 mg, 1.32 mmol, 77%, 3.00 equiv). After workup, the 
residue was purified by chromatography over 10 g silica (hexane) to yield white crystals (64.5 
mg, 80%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.76–7.68 (m, 2H; 6-H, 9-H), 7.55 (s, 2H; 5-H, 10-H), 
7.41–7.33 (m, 2H; 7-H, 8-H), 2.98 (s, 4H; 1-H, 4-H), 1.96–1.81 (m, 4H; 2-H, 
3-H). 
The analytic data are in accordance with the literature.
9
 
7,8,9,10-Tetrahydro-6H-cyclohepta[b]naphthalene (200g) 
 
According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 mol-%), 
phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), cycloheptanone  (99.0 
mg, 883 µmol, 2.00 equiv) and pyrrolidine (47.1 mg, 662 µmol, 2.00 equiv) were stirred for 
2.5 d at 80 °C and treated with mCPBA (297 mg, 1.32 mmol, 77%, 3.00 equiv). After 
workup, the residue was purified by chromatography over 10 g silica (cyclohexane) to yield 
white crystals (73.9 mg, 85%). 
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1
H-NMR: (400 MHz, CDCl3) δ 7.84–7.74 (m, 2H; 1-H, 4-H), 7.63 (s, 2H; 5-H, 11-H), 
7.50–7.39 (m, 2H; 2-H, 3-H), 3.08–2.94 (m, 4H; 6-H, 10-H), 2.00–1.85 (m, 
2H; 8-H), 1.85–1.68 (m, 4H; 7-H, 9-H). 
The analytic data are in accordance with the literature.
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2-Ethyl-3-methylnaphthalene (200h) 
 
According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 mol-%), 
phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), 3-pentanone (97 mg, 
1.10 mmol, 2.50 equiv) and pyrrolidine (62.8 mg, 883 µmol, 2.00 equiv) were stirred for 2.5 d 
at 130 °C and treated with mCPBA (198 mg, 882 µmol, 77%, 2.00 equiv). After workup, the 
residue was purified by chromatography over 10 g silica (cyclohexane) to yield white crystals 
(19.1 mg, 25%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.81–7.70 (m, 2H; 5-H, 8-H), 7.61 (s, 2H; 1-H, 4-H), 
7.43–7.36 (m, 2H; 6-H, 7-H), 2.80 (q, J=7.5 Hz, 2H; 1’-H), 2.48 (s, 3H; 1’’-H), 
1.33 (t, J=7.5 Hz, 3H; 2’-H). 
The analytic data are in accordance with the literature.
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11H-Benzo[b]fluorene (200i) 
 
from 203e: According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 
mol-%), phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), 1-indanone 
(117 mg, 882 µmol, 2.00 equiv) and pyrrolidine (62.8 mg, 882 µmol, 2.00 equiv) were stirred 
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for 14 h at 100 °C and treated with mCPBA (198 mg, 882 µmol, 77%, 2.00 equiv). After 
workup, the residue was purified by chromatography over 15 g silica (cyclohexane) to yield 
white crystals (37 mg, 39%). 
From 203f: According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 
mol-%), phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), 2-indanone 
(117 mg, 882 µmol, 2.00 equiv) and pyrrolidine (94.2 mg, 1.32 mmol, 2.50 equiv) were 
stirred for 2.5 d at 110 °C and treated with mCPBA (297 mg, 1.32 mmol, 77%, 3.00 equiv). 
After workup, the residue was purified by chromatography over 15 g silica (cyclohexane) to 
yield white crystals (25.9 mg, 26%). 
1
H-NMR: (400 MHz, CDCl3) δ 8.21 (s, 1H; 5-H), 8.03–7.85 (m, 4H), 7.85 (d, J=7.4, 1H), 
7.51–7.33 (m, 4H), 4.09 (s, 2H; 11-H). 
13
C-NMR: (400 MHz, CDCl3) δ 144.19, 141.63, 141.54, 140.95, 133.52, 133.44, 128.58, 
128.22, 127.97, 127.39, 125.80, 125.75, 125.70, 123.78, 121.02, 118.21, 36.83. 
The analytic data are in accordance with the literature.
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1-(2,3,3a,4-Tetrahydro-1H-cyclopenta[b]naphthalen-3a-yl)pyrrolidine (204) 
 
According to the general procedure the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 mol-%), 
phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), solvent (450 μl), cyclopentanone (61.9 
mg, 718 µmol, 2.00 equiv) and pyrrolidine (62.8 mg, 883 µmol, 2.00 equiv) were stirred for 
2.5 d at 50 °C. After workup, the residue was purified by chromatography over 10 g silica 
(1:9 EtOAc/cyclohexane) to yield white crystals (91.1 mg, 86%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.57 (s, 1 H), 7.22 – 7.07 (m, 2 H), 7.07 – 6.90 (m, 1 H), 
6.26 (s, 1 H), 3.99 (d, J = 13.3 Hz, 1 H), 2.96 (s, 2 H), 2.89 – 2.65 (m, 3 H), 
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2.55 (dd, J = 17.9, 7.9 Hz, 1 H), 2.48 – 2.32 (m, 1 H), 2.31 – 2.12 (m, 1 H), 
2.02 – 1.75 (m, 5 H), 1.63 – 1.42 (m, 2 H). 
13
C-NMR: (101 MHz, CDCl3) δ 136.83, 126.89, 126.52, 125.87, 125.63, 118.75, 63.41, 
48.30 (2 C), 43.13, 34.20, 30.45, 25.26, 24.54 (2 C). 
MS: (EI, 70 eV) m/z (%): 239 (M
+
, 50). 
HRMS: (ESI) m/z calcd for [C17H22N]
+
: [M+H]
+
 240.1747; found 240.1755. 
5.5.4 N,O-Ketene acetal in the catalyzed IEDDA reaction 
5.5.4.1 Preparation of the dienophile 
6-Ethoxy-1-methyl-1,2,3,4-tetrahydropyridine (206g) 
 
A suspension of Et3O
+
BF4
-
 (18.6 mmol, 3.53 g) and 1-methylpiperidin-2-one (17.7 mmol, 
2.00 g) was stirred at rt for 16 h. The brownish suspension was treated with NaH (22.1 mmol, 
884 mg, 60%) at rt and stirred for 5 h. The solvent was removed and the residue distilled at 50 
°C/10 mbar to yield a colorless liquid 1.85 g (75%). 
1
H-NMR: (400 MHz, CDCl3) δ 3.78 (t, J = 3.8 Hz, 1H, 2-H), 3.58 (q, J = 7.0 Hz, 2H, 
OCH2), 2.88 – 2.78 (m, 2H, 5-H), 2.60 (s, 3H, NCH3), 2.13 (td, J = 6.3, 3.8 Hz, 
3H, 3-H), 1.69 – 1.55 (m, 2H, 4-H), 1.08 (t, J = 7.0 Hz, 3H, OCH2CH3). 
13
C-NMR: (400 MHz, CDCl3) δ 157.01, 72.97, 62.66, 51.96, 37.89, 22.88, 22.04, 14.96.  
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1-Methyl-1,2,3,4-tetrahydrobenzo[g]quinoline (200j) 
 
Phthalazine (183) (57.5 mg, 0.441 mmol), the catalyst 192 (4.5 mg, 22.0 μmol, 5.00 mol%), 
6-ethoxy-1-methyl-1,2,3,4-tetrahydropyridine (206) (125 mg, 0.883 mmol) have been stirred 
in diglyme (0.50 ml) for 14 h at 80 °C. The reaction mixture was purified over silica (1:19 
EtOAc/cyclohexane +1% TEA) to obtain the product (87 mg, quant.). 
1
H-NMR: (400 MHz, CDCl3) δ 7.69–7.61 (m, 2H; 6-H, 9-H), 7.44 (s, 1H; 10-H), 7.38–
7.32 (m, 1H; 8-H), 7.23–7.17 (m, 1H; 7-H), 6.82 (s, 1H; 5-H), 3.37 (t, J=5.9 
Hz, 2H; 2-H), 3.05 (s, 3H; 1’-H), 2.98 (t, J=6.3 Hz, 2H; 4-H), 2.11–2.02 (m, 
2H; 3-H). 
13
C-NMR: (101 MHz, CDCl3) δ 145.71, 134.84, 127.24 (2C), 127.03, 126.79, 126.01, 
125.76, 121.98, 104.29, 51.66, 39.59, 28.94, 23.05. 
MS: (EI, 70 eV) m/z (%): 197 (100) [M
+
]. 
HRMS: (ESI) m/z calcd for [C14H16N]
+
: [M+H
+
] 198.1277; found: 198.1276. 
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5.5.5 Enamines from aldehydes as dienophiles 
General procedure for enamines from aldehydes: Phthalazine (183) (40.0 mg, 0.307 mmol, 
1.00 equiv) with catalyst 192 (3.13 mg, 0.0154 mmol, 5.00 mol %/1.57 mg, 0.0077 mmol, 
2.50 mol %) was dissolved in THF (0.5 ml) and stirred. The aldehyde (0.768 mmol, 2.50 
equiv) and pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were added. In most cases 
immediate N2 formation at rt was observed. The reaction was stirred at 60 °C for 20 h; the 
NMR analysis showed total conversion of the phtalazine (183). The solvent was removed 
under reduced pressure and purified by flash column chromatography to give the pure 
product. 
2-Methylnaphthalene (211a)
 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210a and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield colorless 
oil 13.1 mg (30%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.83 (d, J = 8.0 Hz, 1 H), 7.65 (s, 1H), 7.81 – 7.75 (m, 
2H), 7.52 – 7.40 (m, 2H), 7.35 (dd, J = 8.3, 0.9 Hz, 1H), 2.55 (s, 3H).   
13
C-NMR: (126 MHz, CDCl3) δ 135.5, 133.7, 131.7, 128.1, 127.7, 127.6, 127.2, 
126.9,125.9, 125.0, 21.8.  
MS: (EI): m/z (%) = 142 (100) [M]
+
. 
The analytic data are in accordance with the literature.
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2-n-Propylnaphthalene (211b) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210b and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield colorless 
oil 6.0 mg (12%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.84 – 7.75 (m, 3H), 7.61(s, 1H), 7.49 –7.38 (m, 2H), 
7.36 – 7.32 (m, 1H), 2.87 – 2.63 (m, 2H), 1.89 – 1.65 (m, 2H), 0.98 (t, J = 7.3 
Hz, 3H). 
13
C-NMR: (126 MHz, CDCl3) δ 140.3, 133.8, 132.1, 127.8, 127.7, 127.6, 127.5, 126.5, 
125.9, 125.1, 38.3, 24.6,14.0. 
MS: (EI): m/z (%) = 170 (30) [M]
+
, 141 (100). 
The analytic data are in accordance with the literature.
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2-Pentylnaphthalene (211c) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210c and 
methylethylenediamine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to 
yield colorless oil 18.0 mg (30%). 
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1
H-NMR: (400 MHz, CDCl3) δ 7.85 – 7.73 (m, 3H), 7.62 (s, 1H), 7.51 – 7.38 (m, 2H), 
7.35 (dd, J = 8.4, 1.7 Hz, 1H), 2.78 (t, J = 7.5 Hz, 2H), 1.79 – 1.64 (m, 2H), 
1.42 – 1.34 (m, 4H), 0.95 – 0.87 (m, 3H). 
13
C-NMR: (126 MHz, CDCl3) δ 140.5, 133.7, 131.9, 127.7, 127.6, 127.5, 127.4, 126.3, 
125.8, 125.0, 36.1, 31.6, 31.1, 22.6, 14.1. 
MS: (EI): m/z (%) = 198 (26) [M]
+
, 141 (100). 
2-iso-Propylnaphthalene (211d) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210d and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield colorless 
oil 22.8 mg (44%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.84 – 7.77 (m, 3H), 7.66 (s, 1H), 7.48 – 7.38 (m, 3H), 
3.13 – 3.04 (m, 9 Hz, 1H), 1.36 (d, J = 7.0 Hz, 6H). 
13
C-NMR: (126 MHz, CDCl3) δ 146.5, 133.8, 132.2, 128.0, 127.7, 127.7, 125.9, 125.9, 
125.2, 124.2, 34.4, 24.1 (2 C). 
MS: (EI): m/z (%) = 170 (31) [M]
+
, 155 (100). 
The analytic data are in accordance with the literature.
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2-Benzylnaphthalene (211e) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210e and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield colorless 
oil 6.2 mg (9%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.86 – 7.70 (m, 3H), 7.64 (s, 1H), 7.48 –7.40 (m, 2H), 
7.34 – 7.28 (m, 3H), 7.25 – 7.20 (m, 3H), 4.16 (s, 2H).  
13
C-NMR: (126 MHz, CDCl3) δ 141.1, 138.7, 133.7, 132.2, 129.2, 128.6 (2 C), 128.2, 
127.78, 127.76, 127.7, 127.2, 126.3, 126.1, 125.5 (2 C), 42.3. 
MS: (EI) m/z (%) = 218 (100) [M]
+
. 
The analytic data are in accordance with the literature.
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2-(1-Phenylethyl)naphthalene (211f) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (3.13 mg, 0.0154 mmol, 5.00 mol %), solvent (0.5 ml), aldehyde 210f and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield yellow 
oil 45.9 mg (64%). 
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1
H-NMR: (400 MHz, CDCl3) δ 7.86 – 7.78 (m, 2H), 7.75 (d, J = 8.5 Hz, 1H), 7.71 (s, 
1H), 7.50 – 7.40 (m, 2H), 7.36 – 7.26 (m, 5H), 7.24 – 7.16 (m, 1H), 4.33 (q, J 
= 7.2 Hz, 1H), 1.75 (d, J = 7.2 Hz, 3H). 
13
C-NMR: (126 MHz, CDCl3) δ 146.4, 143.9, 133.8, 132.3, 128.5 (2 C), 128.1, 127.90 (2 
C), 127.86, 127.7, 127.0, 126.2, 126.1, 125.5 (2 C), 45.0, 21.9. 
MS: (EI): m/z (%)=232 (49) [M]
+
, 217 (100). 
The analytic data are in accordance with the literature.
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2-Methyl-6-(naphthalen-2-yl)heptan-2-ol (211g) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (3.13 mg, 0.0154 mmol, 5.00 mol %), solvent (0.5 ml), aldehyde 210g and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield colorless 
oil 46.3 mg (59%). 
1
H-NMR: (400 MHz, CDCl3) δ 7.80 (t, J = 8.8 Hz, 3H), 7.61 (d, J = 0.8 Hz, 1H), 7.48 – 
7.40 (m, 2H), 7.35 (dd, J = 8.5, 1.8 Hz, 1H), 2.94 – 2.83 (m, 1H), 1.76 – 1.60 
(m, 2H), 1.54 – 1.40 (m, 2H), 1.33 – 1.21 (m, 6H), 1.15 (s, 6H). 
13
C-NMR: (126 MHz, CDCl3) δ 145.2, 133.8, 132.3, 128.1, 127.71, 127.68, 125.93, 
125.89, 125.3, 125.2, 71.1, 44.1, 40.2, 38.9, 29.4, 29.3, 22.6, 22.5. 
MS: (EI): m/z (%) = 256 (14) [M]
+
, 155 (100). 
HRMS: (EI) calcd for [C18H24O]
+
: [M]
+
 256.1827 found; 256.1823. 
Ethyl 2-(naphthalen-2-yl)propanoate (211h) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210h and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield yellow 
oil 29.0 mg (41%). 
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1
H-NMR: (400 MHz, CDCl3) δ 7.89 – 7.81 (m, 3H), 7.77 (s, 1H), 7.54 – 7.44 (m, 3H), 
4.24 – 4.09 (m, 2H), 3.91 (q, J = 7.1 Hz, 1H), 1.62 (d, J = 7.2 Hz, 3H), 1.23 (t, 
J = 7.1 Hz, 3H). 
13
C-NMR: (126 MHz, CDCl3) δ 174.6, 138.2, 133.5, 132.6, 128.3, 127.8, 127.6, 126.1, 
126.1, 125.8 (2 C), 60.8, 45.7, 18.6, 14.2. 
MS: (EI): m/z (%) = 228 (22) [M]
+
, 155 (100). 
HRMS (ESI) m/z calcd for [C15H16O2]
+
: [M + H]
+
 229.1223; found: 229.1224. 
2-Methyl-5-(1-(naphthalen-2-yl)ethyl)furan (211i) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (3.13 mg, 0.0154 mmol, 5.00 mol %), solvent (0.5 ml), aldehyde 210i and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield yellow 
oil 7.8 mg (11%). 
1
H-NMR: (500 MHz, CDCl3) δ 7.86 – 7.77 (m, 3H), 7.68 (d, J = 0.9 Hz, 1H), 7.51 – 7.41 
(m, 2H), 7.39 (dd, J = 8.4, 1.8 Hz, 1H), 5.98 (dd, J = 3.0, 0.5 Hz, 1H), 5.92 – 
5.89 (m, 1H), 4.26 (q, J = 7.2 Hz, 1H), 2.25 (s, 3H), 1.67 (d, J = 7.2 Hz, 3H).  
13
C-NMR: (126 MHz, CDCl3) δ 157.2, 151.1, 142.1, 133.7, 132.5, 128.2, 127.9, 127.7, 
126.2, 126.0, 125.7, 125.5, 105.9, 105.9, 39.5, 20.7, 13.7. 
MS: (EI) m/z (%) = 236 (28) [M]
+
, 221 (100). 
HRMS: (ESI) m/z calcd for [C17H16O]
+
: [M]
+
 236.1201; found: 236.1198 
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2-(6-Methylhept-5-en-2-yl)naphthalene (211l) 
 
According to the general procedure phthalazine (183) (57.5 mg, 441 µmol, 1.00 equiv), 
catalyst 192 (1.57 mg, 0.0077 mmol, 2.50 mol %), solvent (0.5 ml), aldehyde 210l and 
pyrrolidine (26.2 mg, 0.369 mmol, 1.20 equiv) were stirred for 20 h at 60 °C to yield colorless 
oil 19.7 mg (27%). The yield was risen to 37% by rising the reaction temperature to 100° C. 
1
H-NMR: (400 MHz, CDCl3) δ 7.86 – 7.74  (m, 3H), 7.62 (s, 1H), 7.52 – 7.39 (m, 2H), 
7.37 (dd, J = 8.5, 1.5 Hz, 1H) 5.18 – 5.08 (m, 1H), 2.96 – 2.81 (m, 1H), 2.07 – 
1.82 (m, 2H), 1.82 – 1.64 (m, 5H), 1.52 (s, 3H), 1.34 (d, J = 6.9 Hz, 3H). 
13
C-NMR: (101 MHz, CDCl3) δ 145.3, 133.8, 132.3, 131.7, 128.0, 127.72, 127.68, 126.0, 
125.9, 125.4, 125.2, 124.6, 39.7, 38.4, 26.4, 25.9, 22.5, 17.8. 
MS: (EI): m/z (%) = 238 (28) [M]
+
, 156 (100). 
HRMS: (ESI) m/z calcd for [C18H22]
+
: [M]
+
 238.1722; found: 238.1720. 
2D-NMR analysis of the by-product mixture (i.e., HSQC-TOCSY) revealed the complex 
tricyclic species 214 (2:2.5 ratio of endo/exo isomer of the amine) as the major component 
(>50% of the aromatic fraction). 
Assignment of 
1
H and 
13
C-NMR: shifts for tricycle 214: 
 
N
7.08
130.3
7.13
125.5
7.16
126.3
7.10
123.5
142.6
2.90
38.5
1.26
44.4
2.02
31.1
1.14
18.9
2.43
49.6
141.7
2.62
51.9
1.27
39.9
35.7
1.24
22.90.30
34.6
1.65/1.68
22.1
1.26
1.29
24.7
2.47
66.0
2.43
49.9 1.64
22.9
1.64
22.9
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5.5.6 Substituted 1,2-diazines as dienes 
4,9-Dichloro-2,3-dihydro-1H-cyclopenta[b]naphthalene (217a) 
 
According to the general procedure the catalyst 192 (3.00 mg, 14.7 μmol, 5.00 mol-%), 
dichlorophthalazine 183a (58.6 mg, 294 µmol, 1.00 equiv), diglyme (450 μl), enamine 203a 
(80.8 mg, 589 µmol, 2.00 equiv) were stirred for 2.5 d at 40 °C. After workup, the residue 
was purified by chromatography over 15 g silica (cyclohexane) to yield white crystals (43.3 
mg, 62%). 
1
H-NMR: (400 MHz, CDCl3) δ 8.29–8.20 (m, 2H; 5-H, 8-H), 7.63–7.56 (m, 2H; 6-H, 7-
H), 3.27–3.18 (m, 4H; 1-H, 3-H), 2.26–2.16 (m, 2H; 2-H). 
13
C-NMR: (101 MHz, CDCl3) δ 142.02, 131.51, 126.99, 125.91, 124.53, 34.05, 24.51. 
MS: (70 eV) m/z (%): 236 (85) [M
+
], 165 (100). 
The compound has been prepared before.
17
 
3-(8-Nitronaphthalen-2-yl)propan-1-ol (217ba), 3-(5-Nitronaphthalen-2-yl)propan-1-ol 
(217bb) 
 
From 197b: According to the general procedure the phthalazine complex of catalyst 192 (7.3 
mg, 21.8 μmol, 5.00 mol-%), 5-nitrophthalazine (183b) (76.3 mg, 0.437 mmol, 1.00 equiv), 
diglyme (450 μl), N,N-diisopropylethylamine (75 μl) and methyl dihydrofuran 197b (74.0 mg, 
0.880 mmol, 2.00 equiv) were stirred for 1 d at 100 °C, worked-up with TBME/hexane (1:1) 
Experimental Part – Synthesis 
127 
and distilled at 210 °C/0.4 mbar to obtain (44.3 mg, 44 %) of a mixture of regioisomers 217ba 
and 217bb in a 1.5:1 ratio. 
From 197c: According to the general procedure the phthalazine complex of catalyst 192 (7.3 
mg, 21.8 μmol, 5.00 mol-%), 5-nitrophthalazine (183b) (76.3 mg, 0.437 mmol, 1.00 equiv), 
diglyme (450 μl), N,N-diisopropylethylamine (75 μl) and methyl dihydrofuran 197c (74.0 mg, 
0.880 mmol,  2.00 equiv) were stirred for 2 d at 100 °C, worked-up with TBME/hexane (1:1) 
and distilled at 200 °C/0.5 mbar to obtain (34.0 mg, 41%) of a mixture of regioisomers 217ba 
and 217bb in a 1.5:1 ratio. 
1
H-NMR: a: (400 MHz, CDCl3) δ 8.36 (s, 1H; 1-H), 8.19 (dd, J=7.6, 1.0 Hz, 1H; 4-H), 
8.06 (d, J=8.2 Hz, 1H; 5-H), 7.87 (d, J=8.4 Hz, 1H; 7-H), 7.51–7.44 (m, 2H, 3-
H, 6-H), 3.77–3.67 (m, 2H; 1’-H), 2.99–2.85 (m, 2H; 3’-H), 2.05–1.93 (m, 2H; 
2’-H). 
1
H-NMR: b: (400 MHz, CDCl3) δ 8.49 (d, J=8.9 Hz, 1H; 4-H), 8.16 (dd, J=7.7, 1.2 Hz, 
1H; 1-H), 8.03 (d, J=8.4 Hz, 1H; 8-H), 7.74 (s, 1H; 6-H), 7.57 (dd, J=8.9, 1.7 
Hz, 1H; 7-H), 7.51–7.44 (m, 1H; 3-H), 3.77–3.67 (m, J=6.4 Hz, 2H, 1’-H), 
2.99–2.85 (m, 2H; 3’-H), 2.05–1.93 (m, 2H; 2’-H). 
13
C-NMR: (101 MHz, CDCl3) δ 146.91, 146.62, 144.19, 141.63, 135.11, 134.81, 134.63, 
133.47, 131.36, 129.22, 129.10, 127.52, 125.78, 124.64, 124.57, 124.12, 
123.80, 123.76, 123.68, 122.07, 62.49, 62.38, 34.38, 34.13, 33.19, 32.27. 
MS: (70 eV) m/z (%): 231 (9) [M
+
], 139 (100). 
HRMS: (ESI): m/z calcd for [C13H14O3N]
+
: [M+H]
+
 232.0968; found: 232.0976. 
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2-(8-Nitronaphthalen-2-yloxy)ethanol (217c) 
 
The phthalazine complex of catalyst 192 (3.7 mg, 12 μmol, 5.0 mol-%), 5-nitrophthalazine 
(183b) (41.9 mg, 239 µmol, 1.00 equiv), diglyme (300 μl), N,N-diisopropylethylamine (100 
μl) and dioxolane 197e (41.2 mg, 479 µmol, 2.00 equiv) were stirred for 12 h at rt. After 
evaporation of the diglyme, the residue was purified by preparative TLC chromatography 
(silica; 2:3 hexane/EtOAc) to yield a solid (5.6 mg, 10%). 
1
H-NMR: (400 MHz, CDCl3) δ 8.35–8.29 (m, 1H), 8.11–8.02 (m, 2H), 7.92–7.83 (m, 
1H), 7.46–7.39 (m, 1H), 7.36–7.30 (m, 1H), 4.33–4.22 (m, 2H; 1’-H), 4.13–
4.02 (m, 2H; 2’-H). 
13
C-NMR: (101 MHz, CDCl3) δ 160.10, 135.15, 133.76, 130.86, 130.72, 127.27, 125.69, 
122.35, 120.78, 102.92, 69.90, 61.69. 
HRMS: (ESI) m/z calcd for [C12H12NO4]
+
: [M+H]
+
 234.0761; found: 234.0767. 
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5.6 One-pot synthesis of phthalazines and pyridazino-aromatics 
General procedure: n-BuLi (4.00 ml, 6.40 mmol, 1.6 M in hexane, 1.07 equiv.) was added 
drop wise under nitrogen to a stirred solution of amine (Method A: A1 = N,N,N’-
trimethylethyldiamine, method B: A2 = bis(2-methoxyethyl)amine; 6.60 mmol, 1.10 equiv.) 
in a mixture of dry hexane (10 ml) and THF (2.5 ml) at ‒25 °C. After the addition the mixture 
was stirred at ‒20 °C for 30 min to form the lithium amide LiA. Aldehyde 238 (6.00 mmol, 
1.00 equiv.) was added drop wise or portion wise at ‒20 °C. The reaction mixture was stirred 
for 45 min and more n-BuLi (5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added at 
‒20 °C. The mixture was allowed to warm to 0°-30 °C for 10-20 min and stirred for 1.5-5 h. 
After cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added 
and stirred for 10 min before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. 
The reaction was quenched after 1.5 h with a solution of NH4Cl (0.96 g, 18.0 mmol, 3.00 
equiv.) and N2H4∙H2O (0.70 ml, 11.5 mmol, 80% in H2O, 1.90 equiv.) in H2O (5 ml). The 
reaction was allowed to warm to rt and stirred for 14 h, diluted with ethyl acetate (15 ml) 
separated, extracted with ethyl acetate (3 × 20 ml) dried over MgSO4 and purified by column 
chromatography over SiO2 (acetone/cyclohexane) to obtain the product. 
Phthalazine (244a) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with benzaldehyde 
238a (0.61 ml, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
6:4) to obtain the crystalline product (579 mg, 74%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with benzaldehyde 
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238a (0.61 ml, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was allowed 
to warm to 0 °C for 10 min and stirred for 5 h. After cooling to ‒78 °C, THF (5 ml) and DMF 
(1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 minutes before the mixture 
was allowed to warm to 0 °C. The reaction was quenched, stirred for 14 h, worked up and 
purified over SiO2 (50g, acetone/cyclohexane 6:4) to obtain the crystalline product (563 mg, 
72%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.53 (s, 2H, 1-H, 4-H), 8.05 – 7.86 (m, 4H, 5-H, 6-H, 7-
H, 8-H). 
MS: (EI) m/z (%): 130 (M+, 100). 
MP: 89.0 – 90.1 °C 
The analytic data are in accordance with a commercial sample. 
6-Methylphthalazine (244b) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with p-tolualdehyde 
238b (721 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (30 °C) for 20 min and stirred at rt for 1.5 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C. The reaction was quenched, stirred 
for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 7:3) to obtain the 
crystalline product (730 mg, 84%). 
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1
H-NMR: (500 MHz, CDCl3) δ 9.46 – 9.42 (m, 2H, 1-H, 4-H), 7.84 (d, J = 8.3 Hz, 1H, 8-
H), 7.75 – 7.71 (m, 1H, 7-H), 7.71 – 7.69 (m, 1H, 5-H), 2.60 (s, 3H, CH3). 
13
C-NMR: (126 MHz, CDCl3) δ 150.89, 150.78, 143.55, 134.65, 126.78, 126.07, 125.22, 
124.88, 22.25. 
MS: (EI) m/z (%): 144 (M
+
, 100). 
HRMS: (ESI) m/z calcd for [C9H9N2]
+
: [M+H]
+
 145.0760; found 145.0761. 
MP: 71.8 – 73.3 °C. 
6-Fluorophthalazine (244c) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
fluorobenzaldehyde 238c (745 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h and stirred for 
1.5 h. The reaction was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, 
acetone/cyclohexane 1:1) to obtain the crystalline product (468 mg, 53%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
fluorobenzaldehyde 238c (745 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
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was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
1:1) to obtain the crystalline product (598 mg, 67%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.52 (d, J = 9.2 Hz, 2H, 4-H, 1-H), 8.02 (dd, J = 8.9, 5.1 
Hz, 1H, 8-H), 7.67 (td, J = 8.9, 2.5 Hz, 1H, 7-H), 7.62 – 7.53 (m, 1H, 5-H). 
13C-NMR: (101 MHz, CDCl3) δ 165.35, 162.80, 150.72, 150.67, 150.23, 129.70, 129.61, 
128.05, 127.96, 123.63, 123.05, 122.80, 110.37, 110.15. 
19
F NMR: (376 MHz, CDCl3) δ -101.59 (td, J = 8.3, 5.1 Hz). 
19
F NMR: (376 MHz, CDCl3) δ -101.59. 
MS: (ESI) m/z: 149 [M+H]
+
. 
HRMS: (ESI) m/z calcd for [C8H6N2F]
+
: [M+H]
+
 149.0510; found 149.0508. 
MP: 131.8 -136 °C. 
5-Fluorophthalazine (244d) 
 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with 2-
fluorobenzaldehyde 238d (745 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
1:1) to obtain the crystalline product (773 mg, 87%). Further purification by precipitation with 
cyclohexane from boiling acetone gave (662 mg, 75%). 
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1
H-NMR: (400 MHz, CDCl3) δ 9.78 (dd, J = 1.6, 0.8 Hz, 1H, 4-H), 9.56 (t, J = 1.6 Hz, 
1H, 1-H), 7.89 (td, J = 8.0, 5.1 Hz, 1H, 7-H), 7.77 (dt, J = 8.0, 0.8 Hz, 1H, 8-
H), 7.57 (ddd, J = 9.3, 8.0, 0.8 Hz, 1H, 6-H). 
13
C-NMR: (101 MHz, CDCl3) δ 158.77 (s), 156.20 (s), 150.19 (d, J = 2.8 Hz), 144.56 (d, J 
= 2.7 Hz), 133.39 (d, J = 7.9 Hz), 127.16 (d, J = 3.4 Hz), 122.13 (d, J = 4.7 
Hz), 116.93 (dd, J = 17.7, 14.0 Hz). 
19
F NMR: (376 MHz, CDCl3) δ -121.89 (ddd, J = 9.3, 5.1, 1.7 Hz). 
19
F NMR (376 MHz, CDCl3) δ -121.89. 
MS: (ESI) m/z: 149 [M+H]
+ 
HRMS: (ESI) m/z calcd for [C8H6N2F]
+
: [M+H]
+
 149.0510; found 149.0513. 
MP: 116.8 – 117.8 °C 
6-Chlorophthalazine (244e) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
chlorobenzaldehyde 238e (843 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒25 °C. The 
mixture stirred for 3 h. After cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 
3.00 equiv.) were added and stirred for 10 minutes before the mixture was allowed to warm to 
0 °C and stirred for 1.5 h. The reaction was quenched, stirred for 14 h, worked up and purified 
over SiO2 (50g, acetone/cyclohexane 6:4) to obtain the crystalline product (784 mg, 79%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
chlorobenzaldehyde 238e (843 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
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mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
6:4) to obtain the crystalline product (903 mg, 91%). 
1
H-NMR: (500 MHz, CDCl3) δ 9.52 (s, 1H, 1-H), 9.49 (s, 1H, 4-H), 8.01 – 7.95 (m, 1H, 
5-H), 7.93 (dt, J = 8.6 Hz, 0.7 Hz, 1H, 8-H), 7.87 (dd, J = 8.6, 2.0 Hz, 1H, 7-
H).  
13
C-NMR: (101 MHz, CDCl3) 150.49, 150.07, 138.71, 133.74, 128.06, 127.18, 125.38, 
124.70. 
MS: (EI) m/z (%): 164 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C8H6N2Cl]
+
: [M+H]
+
 165.0214; found 165.0216. 
MP: 132.9 – 135.2 °C 
5-Chlorophthalazine (244f) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 2-
chlorobenzaldehyde 238f (843 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
6:4) to obtain the crystalline product (739 mg, 75%). 
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1
H-NMR: (500 MHz, CDCl3) δ 9.88 (dd, J = 1.4, 0.9 Hz, 1H, 4-H), 9.53 (d, J = 1.4 Hz, 
1H, 1-H), 7.93 (dd, J = 7.4, 1.3 Hz, 1H, 6-H), 7.91 – 7.87 (m, 1H, 8-H), 7.84 
(dd, J = 8.1, 7.4 Hz, 1H, 7-H). 
13
C-NMR: (101 MHz, CDCl3) δ 150.34, 147.52, 132.89, 132.72, 131.74, 127.60, 125.20, 
124.18. 
MS: (EI) m/z (%): 164 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C8H6N2Cl]
+
: [M+H]
+
 165.0214; found 165.0216. 
MP: 126.8 – 127.4 °C 
6-(Trifluoromethyl)phthalazine (244g) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
(trifluoromethyl)benzaldehyde (238g) (1.04 g, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C 
and more n-BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at 
‒20 °C. The mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. After 
cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and 
stirred for 10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. 
The reaction was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, 
acetone/cyclohexane 1:1) to obtain the crystalline product (1053 mg, 89%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.66 (s, 2H, 1-H, 4-H), 8.30 (s, 1H, 5-H), 8.18 – 8.10 (m, 
2H, 7-H, 8-H). 
13
C-NMR: (101 MHz, CDCl3) δ 151.11 (s), 150.75 (s), 134.34 (d, J = 33.4 Hz), 128.60 (q, 
J = 3.0 Hz), 127.66 (s), 127.47 (s), 125.72 (s), 124.15 (q, J = 4.3 Hz), 123.06 
(d, J = 273.0 Hz). 
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19
F NMR: (376 MHz, CDCl3) δ -63.09. 
MS: (ESI) m/z: 199 [M+H]
+ 
HRMS: (ESI) m/z calcd for [C9H6N2F3]
+
: [M+H]
+
 199.0478; found 199.0477 
MP: 132.3 – 135.2 °C 
6-Phenylphthalazine (244h) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
biphenylaldehyde 238h (1.09 g, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2.5 h. After cooling 
to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 
10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
2:1) to obtain the crystalline product (989 mg, 80%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.57 (dd, J = 1.4, 0.8 Hz, 1H, 4-H), 9.54 (dd, J = 1.4, 0.8 
Hz, 1H, 1-H), 8.15 (dd, J = 8.4, 1.7 Hz, 1H, 7-H), 8.12 – 8.07 (m, 1H, 5-H), 
8.02 (d, J = 8.4 Hz, 1H, 8-H), 7.76 – 7.65 (m, 2H, o-PhH), 7.57 – 7.49 (m, 2H, 
m-PhH), 7.49 – 7.39 (m, 1H, p-PhH). 
13
C-NMR: (126 MHz, CDCl3) δ 151.35, 150.84, 145.61, 139.17, 132.22, 129.29, 128.84, 
127.60, 126.96, 126.83, 125.48, 123.84. 
HRMS: (ESI) m/z calcd for [C14H11N2]
+
: [M+H]
+
 207.0917; found 207.0915. 
MP: 140.7 – 141.6 °C 
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6-Methoxyphthalazine (244i) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with p-anisaldehyde 
238i (817 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (30 °C) for 20 min and stirred at rt for 1.5 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
6:4) to obtain the crystalline product (781 mg, 81%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.45 (dd, J = 1.4, 0.8 Hz, 1H, 4-H), 9.37 (dd, J = 1.4, 0.8 
Hz, 1H, 1-H), 7.85 (d, J = 8.9 Hz, 1H, 8-H), 7.49 (dd, J = 8.9, 2.4 Hz, 1H, 7-
H), 7.17 (d, J = 2.4 Hz, 1H, 5-H), 3.99 (s, 3H, OCH3). 
13
C-NMR: (101 MHz, CDCl3) δ 162.46, 150.67, 150.10, 128.57, 128.10, 124.97, 122.08, 
104.03, 55.86. 
MS: (EI) m/z (%): 160 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C9H9ON2]
+
: [M+H]
+
 161.0709; found 161.0711. 
MP: 123.0 – 123.8 °C 
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5-Methoxyphthalazine (244j) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with m-anisaldehyde 
238j (817 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (30 °C) for 20 min and stirred at rt for 1.5 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
6:4) to obtain the crystalline product (759 mg, 79%). 
1
H-NMR: (500 MHz, CDCl3) δ 9.83 (dd, J = 1.5, 0.8 Hz, 1H, 4-H), 9.47 (d, J = 1.5 Hz, 
1H, 1-H), 7.81 (t, J = 8.0 Hz, 1H, 7-H), 7.48 (dt, J = 8.0, 0.8 Hz, 1H, 8-H), 
7.21 (d, J = 8.0 Hz, 1H, 6-H), 4.06 (s, 3H, OCH3). 
13
C-NMR: (126 MHz, CDCl3) δ 155.13, 150.57, 146.18, 133.40, 127.27, 118.38, 117.57, 
110.69, 55.94. 
MS: (EI) m/z (%): 160 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C9H9ON2]
+
: [M+H]
+
 161.0709; found 161.0716. 
MP: 131.7 – 133.0 °C 
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6-(Methylthio)phthalazine (244k) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
(Methylthio)benzaldehyde (238k) (913 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and 
more n-BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 
°C. The mixture was allowed to warm to rt (30 °C) for 20 min and stirred at rt for 1.5 h. After 
cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and 
stirred for 10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. 
The reaction was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, 
acetone/cyclohexane 6:4) to obtain the crystalline product (540 mg, 51%). 
1
H-NMR: (500 MHz, CDCl3) δ 9.44 (dd, J = 1.5, 0.8 Hz, 1H, 4-H), 9.42 (dd, J = 1.5, 0.8 
Hz, 1H, 1-H), 7.83 – 7.79 (m, 1H, 8-H), 7.73 (dd, J = 8.6, 1.9 Hz, 1H, 7-H), 
7.58 – 7.55 (m, 1H, 5-H), 2.64 (s, 3H, SCH3). 
13
C-NMR: (126 MHz, CDCl3) δ 150.54, 150.13, 146.11, 131.20, 127.05, 126.10, 123.93, 
119.21, 14.89. 
MS: (EI) m/z (%): 176 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C9H9N2S]
+
: [M+H]
+
 177.0481; found 177.0481. 
MP: 87.5 – 88.6 °C 
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N,N-Dimethylphthalazin-6-amine (244l) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 4-
(dimethylamino)benzaldehyde (238l) (895 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C 
and more n-BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at 
‒20 °C. The mixture was allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2.5 h. 
After cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added 
and stirred for 10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 
h. The reaction was quenched, stirred for 14 h, worked up and purified over SiO2 (25g, 
acetone/cyclohexane 7:3) to obtain the crystalline product (640 mg, 62%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.27 (s, 1H, 4-H), 9.16 (s, 1H, 1-H), 7.72 (d, J = 9.0 Hz, 
1H, 8-H), 7.32 (ddd, J = 9.0, 2.2, 1.3 Hz, 1H, 7-H), 6.76 (s, 1H, 5-H), 3.12 (d, 
6H, NMe2). 
13
C-NMR: (126 MHz, CDCl3) δ 152.41, 150.57, 149.85, 128.82, 127.49, 119.97, 118.84, 
102.40, 40.25. 
HRMS: (ESI) m/z calcd for [C10H12N2]
+
: [M+H]
+
 174.1026; found 174.1024 
MP: 127.2 – 127.8 °C 
[1,3]Dioxolo[4,5-f]phthalazine (244m) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with piperonal 238m 
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(901 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
7:3) to obtain the crystalline product (684 mg, 66%). 
1
H-NMR: (500 MHz, CDCl3) δ 9.50 (dd, J = 1.6, 0.8 Hz, 1H, 1-H), 9.33 (d, J = 1.6 Hz, 
1H, 4-H), 7.53 (dd, J = 8.5, 0.8 Hz, 1H, 8-H), 7.49 (d, J = 8.5 Hz, 1H, 7-H), 
6.31 (s, 2H, CH2). 
13
C-NMR: (126 MHz, CDCl3) δ 150.61, 149.56, 144.73, 141.05, 121.63, 121.34, 115.89, 
112.11, 103.47. 
MS: (EI) m/z (%): 174 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C9H7O2N2]
+
: [M+H]
+
 175.0502; 175.0504. 
MP: 169.4 – 170.6 °C (dec.) 
5,6,7-Trimethoxyphthalazine (244n) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 3,4,5-
trimethoxybenzaldehyde 238n (1.18 g, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and 
more n-BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 
°C. The mixture was allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2.5 h. After 
cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and 
stirred for 10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. 
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The reaction was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, 
acetone/cyclohexane 7:3) to obtain the crystalline product (810 mg, 61%). 
1H-NMR: (500 MHz, CDCl3) δ 9.61 (dd, J = 1.5, 0.7 Hz, 1H, 4-H), 9.35 (d, J = 1.5 Hz, 
1H, 1-H), 6.99 (s, 1H, 8-H), 4.13 (s, 3H, OCH3), 4.05 (s, 3H, OCH3), 4.01 (s, 
3H, OCH3). 
13
C-NMR: (126 MHz, CDCl3) δ 158.38, 149.45, 147.56, 145.38, 144.92, 124.19, 117.86, 
100.37, 61.96, 61.39, 56.46. 
MS: (EI) m/z (%): 220 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C11H13O3N2]
+
: [M+H]
+
 221.0921; found 221.0921. 
MP: 115.8 -116.5 °C 
5,6-Dimethoxyphthalazine (244o) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with veratraldehyde 
238o (997 g, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2.5 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
7:3) to obtain the crystalline product (499 mg, 44%). 
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1
H-NMR: (500 MHz, CDCl3) δ 9.75 (dd, J = 1.6, 0.8 Hz, 1H, 1-H), 9.34 (d, J = 1.6 Hz, 
1H, 4-H), 7.70 (dd, J = 8.8, 0.8 Hz, 1H, 8-H), 7.61 (d, J = 8.8 Hz, 1H, 7-H), 
4.06 (s, 3H, OCH3), 4.04 (s, 3H, OCH3). 
13
C-NMR: (126 MHz, CDCl3) δ 153.24, 149.98, 146.22, 142.37, 122.91, 121.91, 121.60, 
120.02, 61.86, 56.62. 
MS: (EI) m/z (%): 190 (M
+
, 100) 
HRMS: (ESI) m/z calcd for [C10H11O2N2]
+
: [M+H]
+
 191.0815; found 191.0816. 
MP: 103.1 – 103.8 °C 
5,8-Dimethoxyphthalazine (244p) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 2,5-
dimethoxybenzaldehyde 238p (997 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and 
more n-BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 
°C. The mixture was allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2 h. After 
cooling to ‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and 
stirred for 10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. 
The reaction was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, 
acetone/cyclohexane 1:1) to obtain the crystalline product (409 mg, 36%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.77 (s, 2H, 1-H, 4-H), 7.07 (s, 2H, 6-H, 7-H), 3.99 (s, 6 
H). 
13
C-NMR: (101 MHz, CDCl3) δ 148.42, 145.73, 118.49, 110.68, 55.97. 
MS: (EI) m/z (%): 190 (M
+
, 100) 
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HRMS: (ESI) m/z calcd for [C10H11O2N2]
+
: [M+H]
+
 191.0820; 191.0822. 
MP: 162.0 – 163.7 °C 
Benzo[f]phthalazine (244q) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 1-
naphthaldehyde 238q (937 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to rt (30 °C) for 20 min and stirred at rt for 2 h. After cooling to 
‒78 °C, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 
10 minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
6:4) to obtain the crystalline product (740 mg, 68%). 
1
H NMR: (400 MHz, CDCl3) δ 10.35 (d, J = 3.6 Hz, 1H), 9.63 (d, J = 3.1 Hz, 1H), 8.94 – 
8.69 (m, 1H), 8.20 (dd, J = 8.7, 4.5 Hz, 1H), 8.05 (dd, J = 4.8, 2.5 Hz, 1H), 
7.97 – 7.64 (m, 3H). 
13
C NMR: (101 MHz, CDCl3) δ 150.79, 146.52, 134.33, 133.98, 129.60, 129.24, 128.70, 
127.05, 125.86, 124.53, 122.64, 122.57. 
MS: (ESI) m/z 181 [M+H]
+ 
HRMS: (ESI) m/z calcd for [C12H9N2]
+
: [M+H]
+
 181.0760; found 181.0759. 
MP: 117.6 – 118.1 °C (dec.) 
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1-Phenylphthalazine (246) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with benzophenone 
245 (1.09 g, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was 
allowed to warm to rt (25 °C) for 20 min and stirred at rt for 2 h. After cooling to ‒78 °C, 
THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 10 
minutes before the mixture was allowed to warm to 0 °C and stirred for 1.5 h. The reaction 
was quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 
4:6) to obtain the crystalline product (869 mg, 70%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.54 (s, 1H, 4-H), 8.09 (d, J = 8.3 Hz, 1H, 8-H), 8.04 (d, J 
= 7.5 Hz, 1H, 5-H), 7.98 – 7.84 (m, 2H, 6-H, 7-H), 7.82 – 7.72 (m, 2H, o-
HPh), 7.63 – 7.52 (m, 3H, Ph). 
MS: (ESI) m/z 207 [M+H]
+ 
MP: 138.2 – 140.2 °C 
The analytic data are in accordance with the literature.
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Thieno[2,3-d]pyridazino (248a) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with thiophene-2-
carbaldehyde 247a (673 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi 
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(5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. Then THF (5 ml) and 
DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 1.5 h. The reaction was 
quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 2:1) 
to obtain the crystalline product (395 mg, 48%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with thiophene-2-
carbaldehyde 247a (673 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi 
(5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was stirred for 2.5 h. Then, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) 
were added and stirred for 10 minutes before the mixture was allowed to warm to 0 °C and 
stirred for 1.5 h. The reaction was quenched, stirred for 14 h, worked up and purified over 
SiO2 (50g, acetone/cyclohexane 2:1) to obtain the crystalline product (540 mg, 66%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with thiophene-3-
carbaldehyde 247b (673 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi 
(5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was stirred for 1 h. Then, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) 
were added and stirred for 10 minutes before the mixture was allowed to warm to 0 °C and 
stirred for 1.5 h. The reaction was quenched, stirred for 14 h, worked up and purified over 
SiO2 (50g, acetone/cyclohexane 2:1) to obtain the crystalline product (661 mg, 81%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.69 (s, 1H, 7-H), 9.58 (d, J = 1.5 Hz, 1H, 4-H), 7.88 (d, J 
= 5.3 Hz, 1H, 2-H), 7.54 (dd, J = 5.3, 0.6 Hz, 1H, 3-H). 
MP: 165.2 – 166.9 °C 
The analytic data are in accordance with the literature.
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Furo[2,3-d]pyridazino (248b) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with furan-3-
carbaldehyde 247c (576 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi 
(5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. Then THF (5 ml) and 
DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 1.5 h. The reaction was 
quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 6:4) 
to obtain the crystalline product (398 mg, 55%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with furan-3-
carbaldehyde 247c (673 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi 
(5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was stirred for 2.5 h. Then, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) 
were added and stirred for 10 minutes before the mixture was allowed to warm to 0 °C and 
stirred for 1.5 h. The reaction was quenched, stirred for 14 h, worked up and purified over 
SiO2 (50g, acetone/cyclohexane 6:4) to obtain the crystalline product (380 mg, 53%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.57 (d, J = 1.2 Hz, 1H, 7-H), 9.53 (s, 1H, 4-H), 7.87 (d, J 
= 2.1 Hz, 1H, 2-H), 6.94 (d, J = 1.9 Hz, 1H, 3-H). 
MS: (EI) m/z (%): 120 (M
+
, 100) 
MP: 108.0 – 108.7°C 
The analytic data are in accordance with the literature.
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Benzo[4,5]thieno[2,3-d]pyridazine (248c) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 
benzo[b]thiophene-3-carbaldehyde 247d (973 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 
°C and more n-BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise 
at ‒20 °C. The mixture was stirred for 2 h. Then THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 
3.00 equiv.) were added and stirred for 1.5 h. The reaction was quenched, stirred for 14 h, 
worked up and purified over SiO2 (50g, acetone/cyclohexane 1:1) to obtain the crystalline 
product (703 mg, 63%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with 
benzo[b]thiophene-3-carbaldehyde 247d (973 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 
°C and more n-BuLi (5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise 
at ‒20 °C. The mixture was stirred for 2.5 h. Then, THF (5 ml) and DMF (1.40 ml, 18.0 
mmol, 3.00 equiv.) were added and stirred for 10 minutes before the mixture was allowed to 
warm to 0 °C and stirred for 1.5 h. The reaction was quenched, stirred for 14 h, worked up 
and purified over SiO2 (50g, acetone/cyclohexane 1:1) to obtain the crystalline product (556 
mg, 50%). 
1
H-NMR: (400 MHz, CDCl3) δ 10.15 (s, 1H, 1-H), 8.68 (d, J = 7.9 Hz, 1H, 4-H), 8.32 (s, 
1H, 9-H), 7.89 (d, J = 7.9 Hz, 1H, 6-H), 7.58 – 7.42 (m, 2H, 7-H, 8-H). 
MS: (EI) m/z (%): 186 (M
+
, 100) 
MP: 128.0 – 129.0 °C 
The analytic data are in accordance with the literature.
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5-Methyl-5H-pyridazino[4,5-b]indole (248d) 
 
According to the general procedure (method A), lithium amide LiA1 prepared from N,N,N’-
trimethylethyldiamine A1 (0.86 ml, 6.60 mmol, 1.10 equiv.) was reacted with 1-methylindole-
3-carboxaldehyde 247e (955 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.60 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was allowed to warm to 0 °C for 10 min and stirred for 2 h. Then THF (5 ml) and 
DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and stirred for 1.5 h. The reaction was 
quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 8:2) 
to obtain the crystalline product (566 mg, 52%). 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with 1-methylindole-
3-carboxaldehyde 247e (955 mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-
BuLi (5.60 ml, 9.00 mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The 
mixture was stirred for 2.5 h. Then, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) 
were added and stirred for 10 minutes before the mixture was allowed to warm to 0 °C and 
stirred for 1.5 h. The reaction was quenched, stirred for 14 h, worked up and purified over 
SiO2 (50g, acetone/cyclohexane 8:2) to obtain the crystalline product (580 mg, 53%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.81 (d, J = 1.3 Hz, 1H, 1-H), 9.52 (d, J = 1.3 Hz, 1H, 4-
H), 8.24 (d, J = 7.9 Hz, 1H, 9-H), 7.77 – 7.67 (m, 1H, 6-H), 7.60 (d, J = 8.3 
Hz, 1H, 7-H), 7.47 (t, J = 7.5 Hz, 1H, 8-H), 4.03 (s, 3H, CH3). 
MS: (ESI) m/z: 184 [M+H]
+ 
MP: 152.4 – 154.8 °C 
The analytic data are in accordance with the literature.
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Pyrido[2,3-d]pyridazine (248e) 
 
According to the general procedure (method B), lithium amide LiA2 prepared from bis(2-
methoxyethyl)amine A2 (0.98 ml, 6.60 mmol, 1.10 equiv.) was reacted with picolinaldehyde 
247f (643mg, 6.00 mmol, 1.00 equiv.) for 45 min at ‒20 °C and more n-BuLi (5.60 ml, 9.00 
mmol, 1.6 M in hexane, 1.50 equiv.) was added drop wise at ‒20 °C. The mixture was stirred 
for 1.3 h. Then, THF (5 ml) and DMF (1.40 ml, 18.0 mmol, 3.00 equiv.) were added and 
stirred for 10 minutes before the mixture was allowed to warm to 0 °C. The reaction was 
quenched, stirred for 14 h, worked up and purified over SiO2 (50g, acetone/cyclohexane 1:3 – 
1:2) to obtain the crystalline product (770 mg, 69%). Further purification by precipitation with 
cyclohexane from boiling acetone gave (465 mg, 59%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.82 (s, 1H, 8-H), 9.60 (d, J = 1.3 Hz, 1H, 5-H), 9.29 (dd, 
J = 4.3, 1.6 Hz, 1H, 4-H), 8.32 (dd, J = 8.2, 0.6 Hz, 1H, 2-H), 7.85 (dd, J = 8.2, 
4.3 Hz, 1H, 3-H). 
MS: (ESI) m/z: 132 [M+H]
+
 
MP: 151.2 – 152.9 °C 
The analytic data are in accordance with the literature.
24
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5.7 Two step synthesis of substituted naphthalenes 
5.7.1 Two-step (±) Naproxen synthesis 
Ethyl 2-methyl-4-oxobutanoate (249a) 
 
O3 was bubbled through a stirred solution of olefin 251 (21.1 mmol, 3 g) in DCM (75 ml) at 
‒78 °C until a blue color persisted. The solution was purged until it became colorless, and 
PPh3 (25.3 mmol, 6.64 g) was added. The reaction was allowed to warm to room temperature 
and stirred for 18 h, concentrated to 30 ml and diluted with pentane. The suspension was 
filtered, the filtrate concentrated and bulb-to-bulb distillation afford a colorless liquid (2593 
mg, 85.3%). 
1
H-NMR: (500 MHz, CDCl3) δ 9.80 – 9.69 (m, 1H, 4-H), 4.20 – 4.06 (m, 2H, 1”-H), 3.02 
– 2.81 (m, 2H, 3-H), 2.58 – 2.46 (m, 1H, 2-H), 1.35 – 1.08 (m, 6H, 1’-H, 2”-
H). 
MS: (EI) m/z: 144 (M
+
, 0.02). 
The analytic data are in accordance with the literature.
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2-(6-Methoxynaphthalen-2-yl)propanoic acid (250a) 
 
To a suspension of 6-methoxyphthalazine 244i (47.1 mg, 294 µmol, 1.00 equiv) in THF (0.5 
ml) was added catalyst 192 (3.00 mg, 14.7 µmol, 0.05 equiv) stirred for 5 min. Aldehyde 
249a (106 mg, 736 µmol, 2.50 equiv) and pyrrolidine (25.1 mg, 353 µmol, 1.20 equiv) was 
added and the reaction was stirred for 16h at 60 °C. Then H2O (0.7 ml) and NaOH (141mg, 
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3.53 mmol, 12 equiv) were added stirred for 24h at 65 °C, acidified with 3M aq. HCl (1.5 ml), 
extracted with DCM (3 × 1.5 ml), dried over Na2SO4 and purified over SiO2 (15g, 
ethylacetate/cyclohexane 1:1) to obtain the crystalline product (35.8 mg, 53%). 
1
H-NMR: (500 MHz, CDCl3) δ 11.30 (s, 1H), 7.80 – 7.65 (m, 3H), 7.44 (dd, J = 8.5, 1.7 
Hz, 1H), 7.16 (dd, J = 8.9, 2.5 Hz, 1H), 7.13 (d, J = 2.1 Hz, 1H), 3.93 (s, 4H), 
3.89 (q, J = 7.1 Hz, 1H), 1.61 (d, J = 7.2 Hz, 4H). 
MS: (EI) m/z: 230 (M
+
, 58). 
MP: 148.7 - 149.9 °C 
The analytic data are in accordance with the literature.
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5.7.2 Two step synthesis of silylnaphthalenes 
(5,8-Difluoronaphthalene-2,3-diyl)bis(trimethylsilane) (253a) 
 
To a suspension of 5,8-difluorophthalazine 244s (65.2 mg, 392 µmol, 1.00 equiv) in diglyme 
(0.5 ml) was added catalyst 192 (4.00 mg, 19.6 µmol, 0.05 equiv) stirred for 5 min. 
Bis(trimethylsilyl)acetylene 252 (100 mg, 589 µmol, 1.50 equiv) was added and the reaction 
was stirred for 7 d at 160 °C. The reaction mixture was evaporated and purified over SiO2 (10 
g, cyclohexane) to obtain the product as a white solid (61.2 mg, 51%). 
1
H-NMR: (400 MHz, CDCl3) δ 8.42 – 8.36 (m, 2H, 1-H, 4-H), 7.09 – 7.00 (m, 2H, 6-H, 
7-H), 0.48 (s, 18H, TMS). 
13
C-NMR: (101 MHz, CDCl3) δ 152.61 (dd, J = 250.3, 5.4 Hz), 142.45, 125.49, 121.09 
(dd, J = 12.7, 10.0 Hz), 107.32 (dd, J = 18.2, 13.3 Hz), 0.00 (9 C). 
19
F-NMR:  (376 MHz, CDCl3) δ -129.01. 
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MS: (EI) m/z (%): 308 (M
+
, 32) 277 (100). 
(5,8-Dichloronaphthalene-2,3-diyl)bis(trimethylsilane) (253b) 
 
To a suspension of 5,8-dichlorophthalazine 244r (58.6 mg, 294 µmol, 1.00 equiv) in diglyme 
(0.5 ml) was added catalyst 192 (1.50 mg, 7.36 µmol, 0.025 equiv) stirred for 5 min. 
Bis(trimethylsilyl)acetylene 252 (75.2 mg, 441 µmol, 1.50 equiv) was added and the reaction 
was stirred for 10 d at 150 °C. The reaction mixture was evaporated and purified over SiO2 
(10 g, cyclohexane) to obtain the product as a white solid (49.9 mg, 50%). 
1
H-NMR: (400 MHz, CDCl3) δ 8.71 – 8.42 (m, 2H, 1-H, 4-H), 7.47 (s, 2H, 6-H, 7-H), 
0.49 (s, 18H, TMS). 
13
C-NMR: (101 MHz, CDCl3)
 δ 143.29, 130.05, 129.07, 128.38, 124.50, 0.00. 
MS: (EI) m/z (%): 340 (M
+
, 34) 309 (100). 
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5.8 Domino IEDDA/cyclopropanation reaction 
Furans 257a, 257b were purchased from Aldrich and 257c
27
, 257d
28
, 257e
29
 have been 
prepared in one step by standard literature procedures. Phthalazine 244a was purchased from 
Aldrich and 244c, 244e, 244f, 244g, 244h, 244i, 244j, 244k, 244l have been prepared 
according to above procedure and have additionally been purified via sublimation. Catalytic 
IEDDA/cyclopropanation reactions have been carried out under nitrogen atmosphere with 
degassed furans 257a – 257e. The solvent diglyme was used as purchased from Aldrich. 
5.8.1 Phthalazine Synthesis 
5,8-Dichlorophthalazine (244r) 
 
LDA (3.15 ml, 6.30 mmol, 2 M in THF/heptanes/ethylbenzene, 1.05 equiv) was added drop-
wise to bromodichlorobenzene 271r (1.36 g, 6.00 mmol, 1.00 equiv) in THF (10 ml) within 
10 min maintaining the temperature below ‒65 °C. After stirring for 2 h at ‒78 °C, DMF (0.51 
ml, 6.60 mmol, 1.10 equiv) was added. The mixture was stirred at ‒78 °C for 1 h and then n-
BuLi (7.50 ml, 12.0 mmol, 1.60 M in hexane, 2.00 equiv) was added drop-wise at ‒78 °C. 
After 1 h, DMF (1.62 ml, 21.0 mmol, 3.50 equiv) was added, the mixture was stirred at ‒78 
°C for 15 min and then allowed to warm during 20 min to 0 °C. After 2 h the reaction was 
quenched with a solution of NH4Cl (0.96 g, 18.0 mmol, 3.00 equiv) and N2H4∙H2O (1.82 ml, 
30.0 mmol, 80% in H2O, 5.00 equiv) in H2O (5 ml). The reaction mixture was allowed to 
warm to rt, stirred for 14 h, extracted with DCM (3 × 25 ml) dried over Na2SO4 and purified 
over SiO2 (50 g, acetone/cyclohexane 1:1) to obtain the crystalline product (651 mg, 55%). 
1
H NMR: (400 MHz, CDCl3) δ 9.90 (s, 2H, 1-H, 4-H), 7.87 (s, 2H, 6-H, 7-H). 
13
C NMR: (101 MHz, CDCl3) δ 147.0, 132.7, 130.5, 125.1. 
HRMS: (ESI) m/z calcd for [C8H5N2Cl2]
+
: [M+H]
+
 198.9824; found 198.9823. 
MS: (EI) m/z (%): 198 (M
+
, 100). 
MP: 215.2 – 216.2 °C. 
Cl
Cl
Br
Cl
Cl
Br
N
OLi
I) LDA, THF, -78°C, 1 h
II) DMF, 30 min
I)   n-BuLi, 1 h
II)  DMF, -78°C - 0°C, 2 h
III) N2H4xH2O, NH4Cl, 
     0°C - rt, 14 h
8 2b (55%)
6
7
8
5
1
N
N
4
Cl
Cl
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5,8-Difluorophthalazine (244s) 
 
LDA (3.15 ml, 6.30 mmol, 2 M in THF/heptanes/ethylbenzene, 1.05 equiv) was added drop-
wise to bromodifluorobenzene 271s (1.16 g, 6.00 mmol, 1.00 equiv) in THF (10 ml) within 10 
min maintaining the temperature below ‒65 °C. After stirring for 1 h at ‒78 °C, DMF (0.51 
ml, 6.60 mmol, 1.10 equiv) was added. The mixture was stirred at ‒78 °C for 30 min and then 
n-BuLi (4.30 ml, 6.90 mmol, 1.60 M in hexane, 1.15 equiv) was added drop-wise at ‒78 °C. 
After 1 h, DMF (0.70 ml, 9.00 mmol, 1.50 equiv) was added, the mixture was stirred at ‒78 
°C for 20 min and then allowed to warm to 0 °C. After 1.5 h the reaction was quenched with a 
solution of NH4Cl (0.96 g, 18.0 mmol, 3.00 equiv) and N2H4∙H2O (1.82 ml, 30.0 mmol, 80% 
in H2O, 5.00 equiv) in H2O (5 ml). The reaction mixture was allowed to warm to rt, stirred for 
14 h, extracted with DCM (3 × 25 ml) dried over Na2SO4 and purified over SiO2 (50 g, 
acetone/cyclohexane 1:1) to obtain the crystalline product (702 mg, 70%). 
1
H-NMR: (400 MHz, CDCl3) δ 9.77 (s, 2H, 1-H, 4-H), 7.54 (t, J = 6.2 Hz, 2H, 6-H, 7-H). 
13
C-NMR: (101 MHz, CDCl3) δ 153.4 (dd, J = 257.5, 6.2 Hz), 144.0 (t, J = 2.1 Hz), 117.3 
(dd, J = 17.7, 12.0 Hz), 116.7 (dd, J = 13.7, 9.1 Hz). 
19
F-NMR: (376 MHz, CDCl3) δ -126.5 (t, J = 6.2 Hz). 
EA: (%) for C8H4F2N2: calcd C, 57.84; H, 2.43; N, 16.86; found C, 58.03; H, 2.67; 
N, 16.88.  
MS: (EI) m/z (%):166 (M
+
, 100). 
MP: 172.9 – 173.4 °C. 
  
6
7
8
5
1
N
N
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F
F
F
Br
F
F
Br
N
OLi
I) LDA, THF, -78°C, 1 h
II) DMF, 30 min
I)   n-BuLi, 1 h
II)  DMF, -78°C - 0°C, 2 h
III) N2H4xH2O, NH4Cl, 
     0°C - rt, 14 h
9 2d (70%)
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5.8.2 Scope of dienophiles 
General procedure: Catalyst 192 (2 - 5 mol %) and phthalazine 244a (1.00 equiv) in diglyme 
(0.5 - 1.5 ml) were thoroughly stirred for 1 min. Furan 257 (1.25 - 1.75 equiv) was added, the 
reaction mixture was stirred at the given temp. for the given time, evaporated and purified by 
column chromatography over SiO2 (15 g, ethylacetate/cyclohexane) to obtain the product. 
1a,7b-Dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258a) 
 
According to the general procedure catalyst 192 (2.9 mg, 14.2 μmol, 3.00 mol %), phthalazine 
(244a) (61.7 mg, 474 µmol, 1.00 equiv) and silyloxyfuran 275a (94.5 mg, 593 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 3.5 d at 125 °C. The reaction mixture was 
evaporated and purified over SiO2 (8:2 cyclohexane/ethylacetate + 1% AcOH) to yield 77.8 
mg of crystalline product (88 %). 
1
H-NMR: (400 MHz, CDCl3) δ 11.27 (brs, 1H, OH), 7.51 – 7.39 (m, 1H, 4-H), 7.32 – 
7.21 (m, 2H, 5-H, 6-H), 7.21 – 7.11 (m, 1H, 7-H), 6.44 (d, J = 9.6 Hz, 1H, 3-
H), 6.32 (dd, J = 9.6, 5.1 Hz, 1H, 2-H), 3.18 (dd, J = 8.4, 4.0 Hz, 1H, 7b-H), 
2.74 (ddd, J = 8.5, 4.8, 3.9 Hz, 1H, 1a-H), 0.87 (t, J = 3.9 Hz, 1H, 1-H). 
13
C-NMR: (400 MHz, CDCl3) δ 182.7, 132.7, 131.1, 129.2, 128.5, 128.2, 127.5, 126.7, 
126.0, 31.9, 29.0, 23.2. 
MS: (EI) m/z (%): 186 (M
+
, 32), 141 (100). 
The analytic data are in accordance with the literature.
30
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Methyl-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylate (258b) 
 
According to the general procedure catalyst 192 (4.6 mg, 22.6 μmol, 5.00 mol %), phthalazine 
(244a) (58.7 mg, 451 µmol, 1.00 equiv) and silyloxyfuran 257b (66.4 mg, 677 µmol, 1.5 
equiv) in diglyme (0.50 ml) were stirred for 4 d at 140 °C. The reaction mixture was 
evaporated and purified over SiO2 (19:1 cyclohexane/ethylacetate) to yield 72.2 mg of liquid 
product (80 %). 
1
H-NMR: (400 MHz, CDCl3) δ 7.36 – 7.29 (m, 1H, 4-H), 7.19 – 7.09 (m, 2H, 5-H, 6-H), 
7.08 – 7.01 (m, 1H, 7-H), 6.32 (d, J = 9.6 Hz, 1H, 3-H), 6.21 (dd, J = 9.6, 5.1 
Hz, 1H, 2-H), 3.65 (s, 3H, CO2CH3), 3.00 (dd, J = 8.4, 4.0 Hz, 1H, 7b-H), 2.59 
– 2.52 (m, 1H, 1a-H), 0.78 (t, J = 3.9 Hz, 1H, 1-H). 
13
C-NMR: (400 MHz, CDCl3) δ 176.0, 132.6, 130.8, 128.8, 128.0, 127.7, 126.9, 126.0, 
125.9, 52.2, 30.6, 27.7, 22.7. 
MS: (EI) m/z (%): 200 (M
+
, 36), 141 (100). 
The analytic data are in accordance with the literature.
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Triisopropylsilyl-1a,7b-Dihydro-1H-cyclopropa[a]naphthalene-1-carboxylate (258c) 
 
According to the general procedure catalyst 192 (1.5 mg, 7.4 μmol, 2.50 mol %), phthalazine 
(244a) (38.3 mg, 294 µmol, 1.00 equiv) and silyloxyfuran 257c (88.4 mg, 368 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 2.5 d at 155 °C. The reaction mixture was 
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evaporated and purified over SiO2 (49:1 cyclohexane/ethylacetate) to yield 100 mg of liquid 
product (99 %). 
1
H-NMR: (500 MHz, CDCl3) δ 7.43 – 7.38 (m, 1H, 7-H), 7.27 – 7.19 (m, 2H, 5-H, 6-H), 
7.17 – 7.12 (m, 1H, 4-H), 6.41 (d, J = 9.6 Hz, 1H, 3-H), 6.32 (dd, J = 9.6, 5.0 
Hz, 1H, 2-H), 3.07 (dd, J = 8.4, 4.0 Hz, 1H, 7b-H), 2.65 (ddd, J = 8.5, 5.0, 3.6 
Hz, 1H, 1a-H), 1.32 (hept, J = 14.5, 7.4 Hz, 3H, SiCH), 1.10 (d, J = 7.4 Hz, 
18H, CH3), 0.87 (t, J = 3.8 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 175.4, 132.7, 130.7, 128.7, 127.9, 127.7, 126.8, 126.1, 
125.9, 31.0, 27.9, 24.1, 17.8 (6 C), 12.0 (3 C). 
EA: (%) for C21H30O2Si: calcd C, 73.63; H, 8.83; found C, 73.13; H, 8.69. 
MS: (EI) m/z (%): 342 (M
+
, 6), 299 (75), 141 (100). 
1-Methyl-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258d) 
 
According to the general procedure catalyst 192 (2.9 mg, 14.2 μmol, 3.00 mol %), phthalazine 
(244a) (61.7 mg, 474 µmol, 1.00 equiv) and silyloxyfuran 257d (101 mg, 593 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 1.5 d at 115 °C. The reaction mixture was 
evaporated and purified over SiO2 (8:2 cyclohexane/ethylacetate + 1% AcOH) to yield 85.1 
mg of crystalline product (90 %). 
1
H-NMR: (500 MHz, CDCl3) δ 12.52 (brs, 1H, OH), 7.41 – 7.35 (m, 1H, 7-H), 7.31 – 
7.24 (m, 2H, 5-H, 6-H), 7.23 – 7.17 (m, 1H, 4-H), 6.66 (d, J = 9.5 Hz, 1H, 3-
H), 6.12 (dd, J = 9.6, 5.3 Hz, 1H, 2-H), 3.29 (d, J = 8.8 Hz, 1H, 7b-H), 2.88 
(dd, J = 8.8, 5.3 Hz, 1H, 1a-H), 0.78 (s, 3H, CH3). 
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13
C-NMR: (126 MHz, CDCl3) δ 184.9, 132.7, 130.7, 130.0, 129.1, 127.8, 127.7, 127.1, 
123.3, 35. 5, 33.3, 16.5, 7.3. 
EA: (%) for C13H12O2: calcd C, 77.98; H, 6.04; found C, 77.91; H, 6.06. 
MS: (EI) m/z (%): 200 (M
+
, 48), 155 (100). 
MP: 139.7 – 140.6 °C 
4,7-Dichloro-2-methyl-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid 
(258e) 
 
According to the general procedure catalyst 192 (3.0 mg, 14.7 μmol, 5.00 mol %), phthalazine 
244r (58.6 mg, 294 µmol, 1.00 equiv) and silyloxyfuran 257e (68.1 mg, 368 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 1.5 d at 115 °C. The reaction mixture was 
evaporated and purified over SiO2 (8:2 cyclohexane/ethylacetate + 1% AcOH) to yield 71.3 
mg of crystalline product (90 %). 
1
H-NMR: (500 MHz, CDCl3) δ 11.85 (brs, 1H, OH), 7.22 – 7.14 (m, 2H, 5-H, 6-H), 6.64 
(s, 1H, 3-H), 3.49 (dd, J = 8.6, 4.1 Hz, 1H, 7b-H), 2.61 (dd, J = 8.7, 3.8 Hz, 
1H, 1a-H), 2.18 (d, J = 1.5 Hz, 3H, CH3), 0.93 (t, J = 3.9 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 181.6, 138.8, 132.8, 130.8, 130.7, 129.9, 128.5, 127.6, 
117.0, 31.6, 29.4, 23.4, 21.0. 
EA: (%) for C13H10Cl2O2: calcd C, 58.02; H, 3.75; found C, 58.24; H, 3.87. 
MS: (EI) m/z (%): 268 (M
+
, 51), 223 (100). 
MP: 204.9 – 206.4 °C 
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5.8.3 Scope of dienes 
4-Fluoro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258fa), 4-Fluoro-
1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258fb) 
 
According to the general procedure catalyst 192 (3.0 mg, 14.7 μmol, 2.50 mol %), phthalazine 
244c (87.2 mg, 589 µmol, 1.00 equiv) and silyloxyfuran 275a (115 mg, 736 µmol, 1.25 
equiv) in diglyme (1.50 ml) were stirred for 1 d at 105 °C. The reaction mixture was 
evaporated and purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 106 
mg of crystalline product (88 %, 1.1:1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 11.19 (brs, 1H, OH), 7.25 – 7.22 (m, 1H, 7-H), 7.22 – 
7.15 (m, 1H, 6-H), 6.97 – 6.95 (m, 1H, 5-H), 6.73 (d, J = 9.8 Hz, 1H, 1-H), 
6.40 (dd, J = 9.8, 5.1 Hz, 1H, 1-H), 3.16 (ddd, J = 8.3, 4.0, 1.1 Hz, 1H, 7b-H), 
2.82 – 2.65 (m, 1H, 1a-H), 0.93 – 0.87 (m, 1H, 1-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 11.19 (brs, 1H, OH), 7.22 – 7.15 (m, 1H, 5-H), 7.00 
(ddd, J = 9.5, 8.2, 1.1 Hz, 1H, 6-H), 6.94 (dd, J = 7.8, 1.4 Hz, 1H, 4-H), 6.44 
(dd, J = 9.7, 1.9 Hz, 1H, 3-H), 6.37 (dd, J = 9.7, 5.0 Hz, 1H, 2-H), 3.37 (dd, J = 
8.6, 4.0 Hz, 1H, 7b-H), 2.82 – 2.65 (m, 1H, 1a-H), 0.93 – 0.87 (m, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 181.8, 181.7, 161.3 (d, J = 246.4 Hz), 159.1 (d, J = 249.6 
Hz), 134.2 (d, J = 4.4 Hz), 132.9 (d, J = 4.4 Hz), 128.5 (d, J = 8.8 Hz), 127.8 
(d, J = 8.5 Hz), 126.6, 126.4 (d, J = 2.3 Hz), 125.6 (d, J = 3.8 Hz), 124.4 (d, J = 
3.2 Hz), 123.5 (d, J = 3.1 Hz), 119.5 (d, J = 16.3 Hz), 118.9 (d, J = 14.7 Hz), 
117.7 (d, J = 6.1 Hz), 114.4 (d, J = 21.8 Hz), 113.5 (d, J = 21.4 Hz), 30.8 (d, J 
= 2.8 Hz), 28.3, 27.3, 24.4 (d, J = 5.6 Hz), 22.8, 21.8. 
EA: (%) for C12H9FO2: calcd C, 70.58; H, 4.44; found C, 70.51; H, 4.57. 
MS: (EI) m/z (%): 204 (M
+
, 33), 159 (100). 
MP: 126.8 – 131.5 °C 
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4,7-Difluoro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258g) 
 
According to the general procedure catalyst 192 (3.0 mg, 14.7 μmol, 2.50 mol %), phthalazine 
244d (97.8 mg, 589 µmol, 1.00 equiv) and silyloxyfuran 275a (115 mg, 736 µmol, 1.25 
equiv) in diglyme (1.50 ml) were stirred for 14 h at 95 °C. The reaction mixture was 
evaporated and purified over SiO2 (8:2 cyclohexane/ethylacetate + 1% AcOH) to yield 130 
mg of crystalline product (quant.). 
1
H-NMR: (400 MHz, CDCl3) δ 12.17 (brs, 1H, OH), 7.02 – 6.83 (m, 2H, 5-H, 6-H), 6.70 
(dd, J = 9.8, 1.9 Hz, 1H, 3-H), 6.45 (dd, J = 9.8, 5.1 Hz, 1H, 2-H), 3.40 – 3.27 
(m, 1H, 7b-H), 2.82 – 2.65 (m, 1H, 1a-H), 0.92 (t, J = 3.9 Hz, 1H, 1-H). 
13
C-NMR: (101 MHz, CDCl3) δ 181.3, 157.3 (dd, J = 222.7, 1.9 Hz), 154.8 (dd, J = 226.2, 
2.0 Hz), 127.3 (d, J = 2.4 Hz), 120.8 (dd, J = 18.6, 4.6 Hz), 120.3 (dd, J = 16.8, 
4.2 Hz), 117.5 (dd, J = 5.3, 3.0 Hz), 114.5 (dd, J = 24.5, 8.9 Hz), 113.8 (dd, J = 
24.2, 8.6 Hz), 27.1, 24.2 (dd, J = 4.8, 2.1 Hz), 21.8. 
19
F-NMR: (376 MHz, CDCl3) -126.6 (d, J = 18.7 Hz), -127.2 (d, J = 18.6 Hz). 
EA: (%) for C12H8F2O2: calcd C, 64.87; H, 3.63; found C, 65.00; H, 3.66. 
MS: (EI) m/z (%): 222 (M
+
, 31),177 (100). 
MP: 181.7 – 182.3 °C 
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4-Chloro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258ha), 7-Chloro-
1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258hb) 
 
According to the general procedure catalyst 192 (3.0 mg, 14.7 μmol, 2.50 mol %), phthalazine 
244e (96.9 mg, 589 µmol, 1.00 equiv) and silyloxyfuran 275a (115 mg, 736 µmol, 1.25 
equiv) in diglyme (1.50 ml) were stirred for 1 d at 130 °C. The reaction mixture was 
evaporated and purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 134 
mg of crystalline product (quant., 1:1.1). 
1
H-NMR: a: (400 MHz, CDCl3) δ 11.93 (brs, 1H, OH), 7.35 (d, J = 7.5 Hz, 1H, 5-H), 
7.30 (d, J = 7.9 Hz, 1H, 7-H), 7.17 (t, J = 7.7 Hz, 1H, 6-H), 6.93 (d, J = 9.8 Hz, 
1H, 3-H), 6.45 (dd, J = 9.8, 5.1 Hz, 1H, 2-H), 3.17 (dd, J = 8.4, 4.0 Hz, 1H, 7b-
H), 2.77 (dt, J = 8.3, 4.2 Hz, 1H, 1a-H), 0.87 (t, J = 3.8 Hz, 1H, 1-H). 
1
H-NMR: b: (400 MHz, CDCl3) δ 10.97 (brs, 1H, OH), 7.33 (dd, J = 7.9, 1.3 Hz, 1H, 6-
H), 7.18 (t, J = 7.8 Hz, 1H, 5-H), 7.07 (dd, J = 7.6, 1.3 Hz, 1H, 4-H), 6.43 (d, J 
= 9.5 Hz, 1H, 3-H), 6.37 (dd, J = 9.6, 4.9 Hz, 1H, 2-H), 3.52 (dd, J = 8.6, 4.1 
Hz, 1H, 7b-H), 2.76 (dt, J = 8.7, 4.4 Hz, 1H, 1a-H), 0.93 (t, J = 3.9 Hz, 1H, 1-
H). 
13
C-NMR: (126 MHz, CDCl3) δ 181.7, 181.7, 134.6, 134.3, 132.7, 132.6, 130.2, 128.5, 
128.2, 128.2, 128.1, 127.7, 127.6, 127.5, 126.5, 126.5, 125.9, 121.8, 31.5, 28.7, 
28.4, 28.3, 22.7, 21.4. 
EA: (%) for C12H9ClO2: calcd C, 65.32; H, 4.11; found C, 65.20; H, 4.28. 
MS: (EI) m/z (%): 220 (M
+
, 42),175 (100). 
MP: 138.3 – 142.0 °C 
Experimental Part – Synthesis 
163 
5-Chloro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258ia), 6-Chloro-
1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258ib) 
 
According to the general procedure catalyst 192 (3.0 mg, 14.7 μmol, 2.50 mol %), phthalazine 
244f (96.9 mg, 589 µmol, 1.00 equiv) and silyloxyfuran 275a (138 mg, 883 µmol, 1.50 
equiv)in diglyme (1.50 ml) were stirred for 3.5 d at 125 °C. The reaction mixture was 
evaporated and purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 132 
mg of crystalline product (quant., 1:1.3). 
1
H-NMR: a: (400 MHz, CD2Cl2) δ 10.66 (s, 1H, OH), 7.40 (d, J = 8.1 Hz, 1H, 7-H), 7.23 
(dd, J = 8.1, 2.2 Hz, 1H, 6-H), 7.17 (d, J = 2.2 Hz, 1H, 4-H), 6.48 – 6.39 (m, 
2H, 2-H, 3-H), 3.20 – 3.06 (m, 1H, 7b-H), 2.80 – 2.66 (m, 1H, 1a-H), 0.85 (t, J 
= 3.8 Hz, 1H, 1-H). 
1
H-NMR: b: (400 MHz, CD2Cl2) δ 10.66 (s, 1H, OH), 7.45 (d, J = 2.2 Hz, 1H, 7-H), 7.22 
(dd, J = 8.2, 2.2 Hz, 1H, 5-H), 7.12 (d, J = 8.2 Hz, 1H, 4-H), 6.48 – 6.39 (m, 
1H, 3-H), 6.36 (dd, J = 9.6, 5.0 Hz, 1H, 2-H), 3.20 – 3.06 (m, 1H, 7b-H), 2.80 
– 2.66 (m, 1H, 1a-H), 0.87 (t, J = 3.8 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CD2Cl2) δ 181.5, 181.4, 134.1, 132.8, 132.4, 132.4, 130.8, 130.0, 
129.3, 129.2, 128.6, 127.5, 127.5, 127.3, 127.1, 126.1, 125.2, 125.1, 30.8, 30.8, 
28.4, 28.3, 22.7, 22.7. 
HRMS: (ESI) m/z calcd for [C12H8ClO2]
-
: [M-H]
-
 219.0218; found 219.0214. 
MS: (EI) m/z (%): 220 (M
+
, 33), 175 (100). 
MP: 158.9 – 171.3 °C 
  
Experimental Part – Synthesis 
164 
4,7-Dichloro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258j) 
 
According to the general procedure catalyst 192 (1.2 mg, 5.89 μmol, 2.00 mol %), phthalazine 
244b (58.6 mg, 294 µmol, 1.00 equiv) and silyloxyfuran 275a (58.7 mg, 368 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 1.5 d at 80 °C. The reaction mixture was 
evaporated and purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 73.4 
mg of crystalline product (98 %). 
1
H-NMR: (500 MHz, CDCl3) δ 11.85 (brs, 1H, OH), 7.26 – 7.20 (m, 2H, 5-H, 6-H), 6.88 
(d, J = 9.9 Hz, 1H, 3-H), 6.49 (dd, J = 9.8, 5.0 Hz, 1H, 2-H), 3.49 (dd, J = 8.4, 
4.1 Hz, 1H, 7b-H), 2.75 (ddd, J = 8.7, 5.1, 3.8 Hz, 1H, 1a-H), 0.90 (t, J = 4.0 
Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 181.4, 133.0, 132.0, 130.9, 129.9, 128.7, 128.5 (2 C), 
121.6, 28.6, 28.3, 21.5. 
EA: (%) for C12H8Cl2O2: calcd C, 56.50; H, 3.16; found C, 56.63; H, 3.42. 
MS: (EI) m/z (%): 254 (M
+
, 46), 209 (100). 
MP: 189.1 – 191.9 °C 
  
Experimental Part – Synthesis 
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8,8a-Dihydro-7aH-cyclopropa[7,8]naphtho[1,2-d][1,3]dioxole-8-carboxylic acid (258ka), 
6,6a-Dihydro-5aH-cyclopropa[5,6]naphtho[1,2-d][1,3]dioxole-6-carboxylic acid (258kb) 
 
According to the general procedure catalyst 192 (5 mg, 24.5 μmol, 5.00 mol %), phthalazine 
244g (85.4 mg, 490 µmol, 1.00 equiv) and silyloxyfuran 275a (134 mg, 858 µmol, 1.75 
equiv) in diglyme (1.50 ml) were stirred for 3 d at 120 °C. The reaction mixture was 
evaporated and purified over SiO2 (1:1 cyclohexane/ethylacetate + 1% AcOH) to yield 88.2 
mg of crystalline product (78 %, 1:1.5). 
1
H-NMR: a: (500 MHz, CDCl3) δ 11.41 (brs, 1H, OH), 6.70 (s, 1H, 5-H), 6.66 (d, J = 7.9 
Hz, 1H, 4-H), 6.41 – 6.29 (m, 1H, 6-H), 6.15 (dd, J = 9.7, 5.0 Hz, 1H, 7-H), 
6.10 – 5.98 (m, 2H, 2-H), 3.20 (dd, J = 8.5, 3.9 Hz, 1H, 8a-H), 2.71 – 2.61 (m, 
2H, 7a-H), 0.98 (t, J = 3.8 Hz, 1H, 8-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 11.41 (brs, 1H, OH) 6.90 (d, J = 7.9 Hz, 1H, 7-H), 
6.73 (d, J = 7.9 Hz, 1H, 8-H), 6.55 (d, J = 9.7 Hz, 1H, 4-H), 6.41 – 6.29 (m, 
1H, 5-H), 6.01 – 5.94 (m, 2H, 2-H), 3.09 (dd, J = 8.5, 4.0 Hz, 1H, 6a-H), 2.71 
– 2.61 (m, 1H, 5a-H), 0.92 (t, J = 3.9 Hz, 1H, 6-H). 
13
C-NMR: (126 MHz, CDCl3) δ 181.7, 181.6, 146.9, 146.3, 146.0, 143.8, 126.1 (C 2), 
125.7, 125.7, 122.8, 121.5, 121.5, 118.6, 114.2, 114.0, 107.7, 106.9, 101.4, 
101.3, 30.8, 27.9, 26.9, 25.0, 23.8, 22.8. 
EA: (%) for C13H10O4: calcd C, 67.82; H, 4.38; found C, 67.71; H, 4.70. 
MS: (EI) m/z (%): 230 (M
+
, 44), 185 (100). 
MP: 173.4 – 179.2 °C 
  
Experimental Part – Synthesis 
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4,7-Dimethoxy-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258l) 
 
According to the general procedure catalyst 192 (5.0 mg, 24.5 μmol, 5.00 mol %), phthalazine 
244h (93.3 mg, 490 µmol, 1.00 equiv) and silyloxyfuran 275a (153 mg, 981 µmol, 2.00 
equiv) in diglyme (1.50 ml) were stirred for 11 d at 160 °C. The reaction mixture was 
evaporated and purified over SiO2 (1:1 cyclohexane/ethylacetate + 1% AcOH) to yield 116 
mg of crystalline product (96 %). 
1
H-NMR: (400 MHz, CDCl3) δ 11.36 (s, 1H, OH), 6.86 (d, J = 9.8 Hz, 1H, 3-H), 6.81 – 
6.61 (m, 2H, 5-H, 6-H), 6.32 (dd, J = 9.9, 5.1 Hz, 1H, 2-H), 3.84 (s, 3H, O-
CH3), 3.80 (s, 3H, O-CH3), 3.47 (dd, J = 8.7, 4.1 Hz, 1H, 7b-H), 2.70 (dt, J = 
8.8, 4.3 Hz, 1H, 1a-H), 0.79 (t, J = 3.8 Hz, 1H, 1-H). 
13
C-NMR: (101 MHz, CDCl3) δ 182.8, 151.9, 149.9, 125.3, 122.4, 121.2, 119.6, 109.8, 
108.9, 56.1, 56.1, 28.2, 26.3, 21.8. 
MS: (EI) m/z (%): 246 (M
+
,100), 
EA: (%) for C14H14O4: calcd C, 68.28; H, 5.73; found C, 68.36; H, 5.79. 
MP: 183.8 – 184.9 °C 
  
Experimental Part – Synthesis 
167 
5-(Methylthio)-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258ma), 6-
(Methylthio)-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258mb) 
 
According to the general procedure catalyst 192 (4 mg, 19.6 μmol, 5.00 mol %), phthalazine 
244i (69.2 mg, 392 µmol, 1.00 equiv) and silyloxyfuran 275a (76.6 mg, 490 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 3.5 d at 145 °C. The reaction mixture was 
evaporated and purified over SiO2 (6:4 cyclohexane/ethylacetate + 1% AcOH) to yield 87.0 
mg of crystalline product (95 %, 1.2:1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 12.35 (brs, 1H, OH), 7.35 (d, J = 7.9 Hz, 1H, 7-H), 
7.16 (dd, J = 8.0, 2.1 Hz, 1H, 6-H), 7.05 (d, J = 1.5 Hz, 1H, 4-H), 6.45 – 6.37 
(m, 1H, 3-H), 6.34 (dd, J = 9.6, 4.9 Hz, 1H, 2-H), 3.18 – 3.07 (m, 1H, 7b-H), 
2.78 – 2.68 (m, 1H, 1a-H), 2.49 (s, 3H, S-CH3), 0.86 (t, J = 3.8 Hz, 1H, 1-H). 
 
1
H-NMR: b: (500 MHz, CDCl3) δ 12.35 (brs, 1H, OH), 7.32 (d, J = 1.1 Hz, 1H, 7-H), 
7.12 (dd, J = 8.1, 2.0 Hz, 1H, 5-H), 7.07 (d, J = 7.9 Hz, 1H, 4-H), 6.45 – 6.37 
(m, 1H, 3-H), 6.26 (dd, J = 9.6, 5.1 Hz, 1H, 2-H), 3.18 – 3.07 (m, 1H, 7b-H), 
2.78 – 2.68 (m, 1H, 1a-H), 2.52 (s, 3H, S-CH3), 0.89 (t, J = 3.8 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 182.4, 182.3, 138.2, 137.0, 133.0, 131.3, 129.4, 129.2, 
128.4, 127.8, 126.6, 126.3, 126.2, 126.1, 126.0, 125.8, 125.0, 124.8, 31.3, 31.1, 
28.6, 28.4, 23.1, 23.0, 16.1, 15.8. 
MS: (EI) m/z (%): 232 (M
+
, 54), 187 (100). 
EA: (%) for C13H12O2S: calcd C, 67.21; H, 5.21; found C, 67.06; H, 5.20. 
MP: 115.5 – 123.4 °C 
  
Experimental Part – Synthesis 
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5-Methyl-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258na), 6-Methyl-
1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylic acid (258nb) 
 
According to the general procedure catalyst 192 (2.9 mg, 14.2 μmol, 2.50 mol %), phthalazine 
244j (56.6 mg, 392 µmol, 1.00 equiv) and silyloxyfuran 275a (76.6 mg, 490 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 3.5 d at 150 °C. The reaction mixture was 
evaporated and purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 72.6 
mg of crystalline product (92 %, 1:1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 12.13 (brs, 1H, OH), 7.33 (d, J = 7.6 Hz, 1H, 7-H), 
7.11 – 7.06 (m, 1H, 6-H), 6.98 (s, 1H, 4-H), 6.40 (d, J = 7.8 Hz, 1H, 3-H), 6.30 
(dd, J = 9.6, 5.0 Hz, 1H, 2-H), 3.15 (dd, J = 8.7, 4.0 Hz, 1H, 7b-H), 2.76 – 2.68 
(m, 1H, 1a-H), 2.34 (s, 3H, CH3), 0.85 (t, J = 3.8 Hz, 1H, 1-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 12.13 (brs, 1H, OH), 7.27 (s, 1H, 7-H), 7.06 – 7.04 (m, 
2H, 4-H, 5-H), 6.42 (d, J = 7.7 Hz, 1H, 3-H), 6.25 (dd, J = 9.6, 5.0 Hz, 1H, 2-
H), 3.13 (dd, J = 8.7, 4.0 Hz, 1H, 7b-H), 2.76 – 2.68 (m, 1H, 1a-H), 2.37 (s, 
3H, CH3), 0.87 (t, J = 3.8 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 182.39, 182.38, 137.8, 136.7, 132.2, 130.6, 129.4, 129.4, 
128.7, 128.63, 128.62, 128.1, 128.0, 127.8, 126.4, 126.2, 125.6, 124.5, 31.5, 
31.3, 28.6, 28.5, 23.0, 22.9, 21.3, 21.1. 
EA: (%) for C13H12O2: calcd C, 77.98; H, 6.04; found C, 78.00; H, 5.93. 
MS: (EI) m/z (%): 200 (M
+
, 32), 155 (100). 
MP: 147.4 – 150.5 °C 
  
Experimental Part – Synthesis 
169 
7,7a-Dihydro-6aH-cyclopropa[h]quinoline-7-carboxylic acid (258oa), 1a,7b-Dihydro-1H-
cyclopropa[f]quinoline-1-carboxylic acid (258ob) 
 
According to the general procedure catalyst 192 (6 mg, 29.4 μmol, 5.00 mol %), phthalazine 
248f (77.2 mg, 589 µmol, 1.00 equiv) and silyloxyfuran 275a (115 mg, 736 µmol, 1.25 equiv) 
in diglyme (1.50 ml) were stirred for 1 d at 105 °C. The reaction mixture was evaporated and 
purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 101 mg of crystalline 
product (92 %, 1:1.4). 
1
H-NMR: a: (500 MHz, DMSO-d6) δ 12.47 (brs, 1H, OH), 8.39 (dd, J = 4.8, 1.7 Hz, 1H, 
2-H), 7.62 (dd, J = 7.7, 1.7 Hz, 1H, 4-H), 7.28 (dd, J = 7.7, 4.9 Hz, 1H, 3-H), 
6.49 (dd, J = 9.6, 1.1 Hz, 1H, 5-H), 6.46 (dd, J = 9.6, 4.6 Hz, 1H, 6-H), 3.05 
(dd, J = 8.2, 4.1 Hz, 1H, 7a-H), 2.67 (dddd, J = 8.3, 4.8, 3.8, 1.1 Hz, 1H, 6a-
H),0.72 (t, J = 3.9 Hz, 1H, 7-H). 
1
H-NMR: b: (500 MHz, DMSO-d6) δ 12.47 (brs, 1H, OH), 8.41 (dd, J = 4.8, 1.7 Hz, 1H, 
5-H), 7.96 – 7.90 (m, 1H, 7-H), 7.24 (dd, J = 7.7, 4.8 Hz, 1H, 6-H), 6.69 (ddd, 
J = 9.7, 5.2, 0.9 Hz, 1H, 2-H), 6.52 (d, J = 9.8 Hz, 1H, 3-H), 3.09 (dd, J = 7.7, 
4.0 Hz, 1H, 7b-H), 2.61 (dddd, J = 8.1, 5.2, 3.7, 0.6 Hz, 1H, 1a-H), 0.67 (t, J = 
3.9 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, DMSO-d6) δ 175.8 (2C), 152.4, 149.6, 148.5, 148.1, 136.7, 135.1, 
132.2, 128.8, 128.2, 127.6, 126.0, 124.6, 122.84, 122.75, 32.1, 29.2, 28.1, 27.0, 
22.8, 21.8. 
MS: (EI) m/z (%): 187 (M
+
, 36), 142 (100). 
HRMS: (ESI) m/z calcd for [C11H8NO2]
-
: [M-H]
-
 186.0561; found 186.0557. 
MP: 204.7 – 212.8 °C (dec. 220 °C). 
Experimental Part – Synthesis 
170 
1a,9a-Dihydro-1H-cyclopropa[a]phenanthrene-1-carboxylic acid (258pa), 1a,9c-Dihydro-
1H-cyclopropa[c]phenanthrene-1-carboxylic acid (258pb) 
 
According to the general procedure catalyst 192 (3.0 mg, 14.7 μmol, 2.50 mol %), phthalazine 
244l (106 mg, 589 µmol, 1.00 equiv) and silyloxyfuran 275a (138 mg, 883 µmol, 1.5 equiv) 
in diglyme (1.50 ml) were stirred for 3 d at 160 °C. The reaction mixture was evaporated and 
purified over SiO2 (7:3 cyclohexane/ethylacetate + 1% AcOH) to yield 115 mg of crystalline 
product (83 % 2:1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 11.96 (s, 1H, OH), 8.20 (d, J = 8.3 Hz, 1H, 7-H), 7.89 
– 7.82 (m, 1H, 4-H), 7.78 (d, J = 8.3 Hz, 1H, 3-H), 7.59 (d, J = 8.4 Hz, 1H, 2-
H), 7.57 – 7.51 (m, 1H, 6-H), 7.48 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H, 5-H), 7.34 (d, 
J = 9.9 Hz, 1H, 8-H), 6.57 (dd, J = 9.8, 5.1 Hz, 1H, 9-H), 3.38 (dd, J = 8.3, 3.8 
Hz, 1H, 1a-H), 2.97 – 2.89 (m, 1H, 9a-H), 0.83 (t, J = 3.7 Hz, 1H, 1-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 11.96 (s, 1H, OH), 8.27 (d, J = 8.3 Hz, 1H, 9-H), 7.89 
– 7.82 (m, 1H, 6-H), 7.74 (d, J = 8.2 Hz, 1H, 5-H), 7.62 (ddd, J = 8.4, 6.8, 1.4 
Hz, 1H, 8-H), 7.57 – 7.51 (m, 1H, 7-H), 7.31 (d, J = 8.3 Hz, 1H, 4-H), 6.61 (d, 
J = 9.4 Hz, 1H, 3-H), 6.47 (dd, J = 9.5, 5.0 Hz, 1H, 2-H), 3.81 (dd, J = 8.8, 4.1 
Hz, 9c-H), 2.97 – 2.89 (m, 1a-H), 0.88 (t, J = 4.0 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 183.2, 182.6, 133.2, 132.9, 131.9, 130.3, 130.1, 128.7, 
128.6 (2 C), 128.02, 127.96, 127.3, 127.1, 127.09, 126.8, 126.6, 126.5, 126.4, 
126.0, 125.9, 125.8, 125.5, 123.3, 122.5, 120.9, 33.2, 29.74, 29.65, 27.5, 22.2, 
20.2. 
HRMS: (ESI) m/z calcd for [C16H11O2]
-
: [M-H]
-
 235.0765; found 235.0760. 
MS: (EI) m/z (%): 236 (M
+
, 50), 191 (27). 
MP: 145.3 – 148.8 °C. 
Experimental Part – Synthesis 
171 
Triisopropylsilyl-4-fluoro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylate 
(258qa), Triisopropylsilyl-7-fluoro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-
carboxylate (258qb) 
 
According to the general procedure catalyst 192 (1.5 mg, 7.4 μmol, 2.50 mol %), phthalazine 
244c (43.6 mg, 294 µmol, 1.00 equiv) and silyloxyfuran 257c (88.4 mg, 368 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 1 d at 130 °C. The reaction mixture was 
evaporated and purified over SiO2 (cyclohexane -> cyclohexane + 1% ethylacetate) to yield 
102 mg of liquid product (96 %, 1.3:1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 7.23 – 7.11 (m, 2H, 6-H, 7-H), 7.01 – 6.89 (m, 1H, 5-
H), 6.70 (d, J = 9.8 Hz, 1H, 3-H), 6.44 – 6.31 (m, 1H, 2-H), 3.07 (dd, J = 8.3, 
4.0 Hz, 1H, 7b-H), 2.70 – 2.59 (m, 1H, 1a-H), 1.37 – 1.27 (m, 3H, SiCH), 1.15 
– 1.06 (m, 18H, CH3), 0.91 – 0.86 (m, 1H, 1-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 7.23 – 7.11 (m, 1H, 5-H), 7.01 – 6.89 (m, 2H, 4-H, 6-
H), 6.44 – 6.31 (m, 2H, 2-H, 3-H), 3.28 (dd, J = 8.5, 4.0 Hz, 1H, 7b-H), 2.70 – 
2.59 (m, 1H, 1a-H), 1.37 – 1.27 (m, 3H, SiCH), 1.15 – 1.06 (m, 18H, CH3), 
0.91 – 0.86 (m, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 174.93, 174.85, 161.3 (d, J = 246.4 Hz), 159.1 (d, J = 
249.4 Hz), 134.7 (d, J = 4.3 Hz), 132.9 (d, J = 4.0 Hz), 128.3 (d, J = 8.9 Hz), 
127.4 (d, J = 8.3 Hz), 127.1, 126.8 (d, J = 2.4 Hz), 125.2 (d, J = 3.9 Hz), 124.3 
(d, J = 3.3 Hz), 123.3 (d, J = 3.1 Hz), 120.0 (d, J = 16.3 Hz), 118.9 (d, J = 14.9 
Hz), 117.2 (d, J = 6.0 Hz), 114.2 (d, J = 21.5 Hz), 113.3 (d, J = 21.4 Hz), 30.4 
(d, J = 2.8 Hz), 27.8, 26.6, 24.1, 24.0 (d, J = 5.8 Hz), 23.1, 17.8 (d, J = 2.6 Hz, 
12 C), 12.0 (6 C). 
EA: (%) for C21H29FO2Si: calcd C, 69.96; H, 8.11; found C, 69.99; H, 8.06. 
MS: (EI) m/z (%): 360 (M
+
, 1), 317 (100). 
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Triisopropylsilyl-4-chloro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylate 
(258ra), Triisopropylsilyl-7-chloro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-
carboxylate (258rb) 
 
According to the general procedure catalyst 192 (1.5 mg, 7.4 μmol, 2.50 mol %), phthalazine 
244e (48.4 mg, 294 µmol, 1.00 equiv) and silyloxyfuran 257c (88.4 mg, 368 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 1 d at 135 °C. The reaction mixture was 
evaporated and purified over SiO2 (cyclohexane -> cyclohexane + 1% ethylacetate) to yield 
110 mg of liquid product (99 %, 1.1:1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 7.33 (d, J = 7.6 Hz, 1H, 7-H), 7.32 – 7.26 (m, 1H, 5-
H), 7.17 (t, J = 7.8 Hz, 1H, 6-H), 6.93 (d, J = 9.8 Hz, 1H, 3-H), 6.47 (dd, J = 
9.8, 5.1 Hz, 1H, 2-H), 3.10 (dd, J = 8.3, 4.0 Hz, 1H, 7b-H), 2.75 – 2.64 (m, 1H, 
1a-H), 1.41 – 1.29 (m, 3H, SiCH), 1.23 – 1.04 (m, 18H, CH3), 0.88 (t, J = 3.8 
Hz,1H, 1-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 1H, 6-H), 7.14 (t, J = 7.8 Hz, 1H, 5-H), 
7.04 (d, J = 7.5 Hz, 1H, 4-H), 6.39 (d, J = 9.6 Hz, 1H, 3-H), 6.39 (dd, J = 9.7, 
4.5 Hz, 1H, 2-H), 3.42 (dd, J = 8.5, 4.1 Hz, 1H, 7b-H), 2.75 – 2.64 (m, 1H, 1a-
H), 1.41 – 1.29 (m, 3H, SiCH), 1.23 – 1.04 (m, 18H, CH3), 0.91 (t, J = 3.9 Hz, 
1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 174.87, 174.84, 134.7, 134.5, 132.7, 132.5, 130.6, 128.3, 
128.2, 128.1, 128.0, 127.8, 127.36, 127.35, 126.9, 126.4, 125.5, 121.3, 31.1, 
28.1, 28.1, 27.4, 24.1, 22.8, 17.8 (6 C), 17.8 (6 C), 11.98 (3 C), 11.95 (3 C). 
EA: (%) for C21H29ClO2Si: calcd C, 66.90; H, 7.75; found C, 66.84; H, 7.57. 
MS: (EI) m/z (%): 376 (M
+
, 1), 333 (100). 
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Triisopropylsilyl-4,7-dichloro-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylate 
(258s) 
 
According to the general procedure catalyst 192 (1.5 mg, 7.4 μmol, 2.50 mol %), phthalazine 
244b (58.6 mg, 294 µmol, 1.00 equiv) and silyloxyfuran 257c (88.4 mg, 368 µmol, 1.25 
equiv) in diglyme (0.50 ml) were stirred for 1 d at 90 °C. The reaction mixture was 
evaporated and purified over SiO2 (cyclohexane -> cyclohexane + 1% ethylacetate) to yield 
110 mg of liquid product (91 %). 
1
H-NMR: (500 MHz, CDCl3) δ 7.23 – 7.16 (m, 2H, 5-H, 6-H), 6.83 (d, J = 9.9 Hz, 1H, 3-
H), 6.48 (dd, J = 9.9, 5.1 Hz, 1H, 2-H), 3.42 – 3.37 (m, 1H, 7b-H), 2.68 (ddd, J 
= 8.7, 5.2, 3.8 Hz, 1H, 1a-H), 1.39 – 1.27 (m, 3H, SiCH), 1.17 – 1.05 (m, 18H, 
CH3), 0.88 (t, J = 3.9 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 174.3, 133.0, 132.4, 130.8, 129.9, 129.1, 128.5, 128.2, 
121.2, 28.4, 27.5, 22.7, 17.8 (6 C), 12.0 (3 C). 
EA: (%) for C21H28Cl2O2Si: calcd C, 61.30; H, 6.86; found C, 61.56; H, 7.02. 
MS: (FAB) m/z (%): 411 ([M+H]
+
, 37), 367 (100). 
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Methyl-7,7a-dihydro-6aH-cyclopropa[h]quinoline-7-carboxylate (258ta), Methyl 1a,7b-
dihydro-1H-cyclopropa[f]quinoline-1-carboxylate (258tb) 
 
According to the general procedure catalyst 192 (9.9 mg, 48.4 μmol, 5.00 mol %), phthalazine 
244k (127 mg, 968 µmol, 1.00 equiv) and methoxyfuran 257b (118 mg, 1.21 mmol, 1.25 
equiv) in diglyme (1.50 ml) were stirred for 12 h at 120 °C. The reaction mixture was 
evaporated and purified over SiO2 (6:4 cyclohexane/ethylacetate) to yield 177 mg of liquid 
product (91 %, 1:1.1). 
1
H-NMR: a: (500 MHz, CDCl3) δ 8.42 (dd, J = 4.9, 1.7 Hz, 1H, 2-H), 7.41 (dd, J = 7.7, 
1.7 Hz, 1H, 4-H), 7.16 (dd, J = 7.7, 4.9 Hz, 1H, 3-H), 6.41 – 6.31 (m, 2H, 5-H, 
6-H), 3.72 (s, 3H, CH3), 3.31 (dd, J = 8.3, 4.1 Hz, 1H, 7a-H), 2.76 (dtd, J = 8.2, 
4.0, 1.4 Hz, 2H, 1a-H), 0.94 (t, J = 4.0 Hz, 1H, 1-H). 
1
H-NMR: b: (500 MHz, CDCl3) δ 8.46 (dd, J = 4.8, 1.7 Hz, 1H, 5-H), 7.70 (dd, J = 7.7, 
1.7 Hz, 1H, 7-H), 7.14 (dd, J = 7.7, 4.8 Hz, 1H, 6-H), 6.63 (d, J = 9.5 Hz, 1H, 
3-H), 6.60 (dd, J = 9.9, 4.5 Hz, 1H, 2-H), 3.75 (s, 3H, CH3), 3.07 (dd, J = 8.2, 
4.1 Hz, 1H, 7b-H), 2.69 (dddd, J = 8.3, 4.7, 3.7, 1.1 Hz, 1H, 1a-H), 0.90 (t, J = 
3.9 Hz, 1H, 1-H). 
13
C-NMR: (126 MHz, CDCl3) δ 175.3, 174.9, 152.6, 149.8, 148.2, 148.0, 136.1, 134.6, 
131.1, 128.4, 128.0, 127.7, 125.9, 124.4, 122.2 (2 C), 52.4, 52.3, 32.6, 29.8, 
28.3, 27.4, 22.7, 22.0. 
HRMS: (ESI) m/z calcd for [C12H12NO2]
+
: [M+H]
+
 202.0863; found 202.0860. 
MS: (EI) m/z (%): 201 (M
+
, 28), 142 (100). 
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5.8.4 Enantioselective catalysis 
5,10-Dihydroboranthrene (287) 
 
A suspension of dichlorodihydroboranthrene 189 (228 mg, 932 µmol, 1.00 equiv) and 
triethylsilane (271 mg, 2.33 mmol, 2.50 equiv) in DCE was sonicated for 1 h at 50 °C and 
stirred for 15 h at room temperature. The obtained reaction mixture was evaporated at 10
-2
 
mbar to obtain white powder (160 mg, 98%). The product is insoluble in common deuterated 
solvents and not analyzable by standard techniques. A solid state structure was obtained by 
Wagner and co-workers.
32
 Reaction of dihydroboranthrene 287 (5.00 mg, 28.4 µmol, 1.00 
equiv) with 3,3-dimethylbut-1-yne (9.34 mg, 114 µmol, 4.00 equiv) in C6D6 (0.5 ml) cleanly 
yielded the hydroboration product (
1
H-NMR) as reported by Wagner and co-workers.
33
 
Methyl-1a,7b-dihydro-1H-cyclopropa[a]naphthalene-1-carboxylate (258b) 
 
Dihydroboranthrene 287 (3.9 mg, 22.2 µmol, 0.05 equiv) and (-)-β-pinene 291 (7.56 mg, 55.5 
µmol, 0.125 equiv) were stirred in C6D6 (0.50 ml) at rt to give a colloidal solution, which was 
evaporated and dissolved in diglyme (0.50 ml). Phthalazine (244a) (58.7 mg, 451 µmol, 1.00 
equiv) and methoxyfuran 257b (66.4 mg, 677 µmol, 1.5 equiv) were added and the reaction 
mixture was stirred for 2.5 d at 160 °C. The reaction mixture was evaporated and purified 
over SiO2 (19:1 cyclohexane/ethylacetate) to yield 18.9 mg of liquid product (21%). Recorded 
1
H-NMR spectrum is in accordance with the above obtained one. 
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Chiral HPLC Chromatogram: 
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5.9 Domino IEDDA/[1,9]-sigmatropic rearrangement 
4-Hexyl-2,3-dihydrofuran (292a) 
 
To a stirred solution of lactone 294 (2.00 g, 11.7 mmol, 1.00 equiv) was added 1M DIBAL-H 
in DCM (12.9 ml, 12.9 mmol, 1.10 equiv) at –78 °C over 20 min. After stirring for 15 min the 
reaction mixture was warmed to –30 °C, stirred for 50 min at –30 to –20 °C and quenched 
with MeOH (1.60 ml, 38.8 mmol, 3.30 equiv). After stirring for 15 min the mixture was 
allowed to warm to rt and stirred for 30 min, quenched with saturated aqueous NaHCO3 (15 
ml), separated and extracted with DCM (15 ml), pre-dried with brine (10 ml), dried over 
Na2SO4, and evaporated to afford colorless oil (2.049 g). A stirred solution of the oil in 
CH2Cl2 (50 ml) at –50 °C was treated with Et3N (6.50 ml, 47 mmol, 4.00 equiv) followed by 
methanesulfonyl chloride (1.18 g, 15.3 mmol, 1.30 equiv). The solution was stirred for 1 h at 
–50 °C, warmed to rt and heated at reflux for 14 h. The reaction mixture was then cooled to rt, 
filtered over 3 cm SiO2 (slurry 3% TEA in cyclohexane), eluted with solvent (1:4 
ethylacetate/cyclohexane + 1% TEA, 100 ml) and evaporated. The concentrate was bulb-tube 
distilled to obtain colorless oil (830 mg, 46%). 
1
H-NMR: (400 MHz, C6D6) δ 6.07 – 5.98 (m, 1H, 5-H), 4.28 (t, J = 9.5 Hz, 2H, 2-H), 
2.57 – 2.45 (m, 2H, 3-H), 2.07 – 1.97 (m, 2H, 1’-H), 1.47 – 1.15 (m, 8H, 2’-H, 
3’-H, 4’-H, 5’-H), 0.87 (t, J = 7.2 Hz, 3H, 6’-H). 
(3a,9b)-3a-Hexyl-2,3,3a,9b-tetrahydronaphtho[1,2-b]furan (296a) 
 
Catalyst 192 (4.0 mg, 19.6 μmol, 5.00 mol %) and phthalazine 244a (51.1 mg, 392 µmol, 1.00 
equiv) in diglyme (0.50 ml) were thoroughly stirred for 1 min. Hexyldihydrofuran 292a (84.1 
mg, 490 µmol, 1.25 equiv) was added, the reaction mixture was stirred for 1 d at 160 °C, 
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evaporated and purified over SiO2 (15 g, 1:19 ethylacetate/cyclohexane) to yield 19.4 mg of 
liquid product (19 %). 
1
H-NMR: (500 MHz, CDCl3) δ 7.36 – 7.32 (m, 1H, 9-H), 7.29 (td, J = 7.4, 1.4 Hz, 1H, 7-
H), 7.23 (td, J = 7.4, 1.4 Hz, 1H, 8-H), 7.16 – 7.12 (m, 1H, 6-H), 6.49 (d, J = 
9.7 Hz, 1H, 5-H), 5.72 (dd, J = 9.7, 1.1 Hz, 1H, 4-H), 4.47 (s, 1H, 9b-H), 3.91 
(dt, J = 8.1, 6.2 Hz, 1H, 2-H), 3.71 (q, J = 8.1 Hz, 1H, 2-H), 2.13 (dd, J = 7.9, 
6.1 Hz, 2H, 3-H), 1.53 – 1.44 (m, 2H, 1’-H), 1.31 – 1.10 (m, 8H, 2’-H, 3’-H, 
4’-H, 5’-H), 0.84 (t, J = 7.0 Hz, 3H, 6’-H). 
13
C-NMR: (126 MHz, CDCl3) δ 134.1, 132.6, 132.2, 129.8, 128.8, 127.5, 126.8, 126.1, 
82.6, 66.6, 47.1, 40.1, 38.7, 31.6, 30.0, 25.0, 22.6, 14.1. 
MS: (EI) m/z (%): 256 (M
+
, 12), 171 (100). 
4-Hexyl-5-(methylthio)-2,3-dihydrofuran (297a) 
 
A solution of 1.6M t-BuLi in pentane (1.94 ml, 3.11 mmol, 1.20 equiv) was added drop wise 
over 10 min to a solution of hexyldihydrofuran 292a (400 mg, 2.59 mmol, 1.00 equiv) in dry 
THF (1 ml) at –78 °C and stirred for 35 min. The resulting yellow suspension was slowly 
allowed to warm to 0 °C over 10 min and stirred for another 30 min. The mixture was cooled 
to –50 °C and (MeS)2 (281 μL, 3.11 mmol, 1.20 equiv) was added over 15 min. The mixture 
was slowly allowed to warm to rt and stirred for 14 h. Evaporation of solvents and bulb-tube 
distillation (0.2 mbar/100 °C) gave a colorless oil (398 mg, 77%). 
1
H-NMR: (400 MHz, CDCl3) δ 4.27 (t, J = 9.3 Hz, 2H, 2-H), 2.61 (tt, J = 9.3, 1.1 Hz, 2H, 
3-H), 2.23 (s, 3H, SMe), 2.16 (t, J = 7.6 Hz, 2H, 1’-H), 1.42 – 1.19 (m, 8H, 2’-
H, 3’-H, 4’-H, 5’-H), 0.88 (t, J = 6.8 Hz, 3H, 6’-H). 
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13
C-NMR: 
13
C NMR (101 MHz, CDCl3) δ 144.1, 116.1, 68.4, 33.3, 31.7, 28.8, 28.1, 27.0, 
22.7, 15.3, 14.1. 
MS: (EI) m/z (%): 200 (M
+
, 8), 129 (100). 
(3a,9b)-6,9-Difluoro-3a-hexyl-4-(methylthio)-2,3,3a,9b-tetrahydronaphtho[1,2-b]furan 
(298a) 
 
Catalyst 192 (2.5 mg, 12.3 μmol, 5.00 mol %) and difluorophthalazine 244s (40.7 mg, 245 
µmol, 1.00 equiv) in diglyme (0.50 ml) were thoroughly stirred for 1 min. 
methylthiodihydrofuran 297a (61.4 mg, 307 µmol, 1.25 equiv) was added, the reaction 
mixture was stirred for 1.5 d at 125 °C, evaporated and purified over SiO2 (15 g, 1:19 
ethylacetate/cyclohexane) to yield 67.8 mg of liquid product (95 %). 
1
H NMR: (500 MHz, CDCl3) δ 6.96 (td, J = 9.1, 4.3 Hz, 1H, 7-H), 6.83 (td, J = 8.7, 4.1 
Hz, 1H, 8-H), 6.34 (d, J = 1.8 Hz, 1H, 5-H), 4.82 (d, J = 0.7 Hz, 1H, 9b-H), 
3.94 (td, J = 8.2, 3.6 Hz, 1H, 2-H), 3.72 (ddd, J = 9.2, 8.2, 6.4 Hz, 1H, 2-H), 
2.63 (ddd, J = 12.7, 6.4, 3.6 Hz, 1H, 3-H), 2.42 (s, 3H), 2.16 (ddd, J = 12.7, 
9.2, 8.2 Hz, 1H, 3-H), 1.88 (ddd, J = 13.4, 12.5, 3.8 Hz, 1H, 1’-H) 1.45 (ddd, J 
= 13.6, 11.7, 4.5 Hz, 1H, 1’-H), 1.24 – 1.03 (m, 7H, 2’-H, 3’-H, 4’-H, 5’-H), 
1.01 – 0.90 (m, 1H, 5‘-H), 0.82 (t, J = 7.0 Hz, 3H, 6’-H). 
13
C NMR: (126 MHz, CDCl3) δ 157.1 (d, J = 249.5 Hz), 153.5 (d, J = 234.36 Hz), 146.3, 
122.2, 119.3, 116.2, 113.4, 108.7, 76.2, 66.4, 51.2, 39.8, 39.2, 31.5, 29.7, 24.5, 
22.6, 14.5, 14.0. 
EA: (%) for C19H24F2OS: calcd C, 67.42; H, 7.15; found C, 66.99; H, 7.09. 
MS: (EI) m/z (%): 338 (M
+
, 100). 
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5.10 Calculations 
5.10.1 General information 
The DFT calculations
33
 have been conducted with the exchange-correlation functional 
B3LYP and the Gaussian basis set 6-31(d,p). Consecutive frequency calculations were made 
to check for the absence of imaginary frequencies or in the case of a transition structure for 
the existence of only one imaginary frequency. 
The Transition state calculations used the Synchronous Transit-Guided Quasi-Newton 
(STQN) Method via QST2 keyword. And the intrinsic reaction coordinate calculations to 
connect starting material and product have been executed by using the IRC keyword with 
stepsize = 10 and scf=(tight, direct). 
5.10.2 Complexation of phthalazine 
Phthalazine (183) 
 
Cartesian coordinates of optimized structure: 
N                  2.43845600    0.68482300   -0.00007100 
C                  1.29410900    1.32887500   -0.00012800 
C                  0.01180700   -0.70881700    0.00006700 
C                  1.29410900   -1.32887500    0.00012100 
N                  2.43845600   -0.68482300    0.00005700 
C                  0.01180700    0.70881700   -0.00006700 
C                 -1.21609600    1.41135900   -0.00012900 
C                 -2.40262800    0.70804700   -0.00006000 
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C                 -1.21609600   -1.41135900    0.00013600 
C                 -2.40262800   -0.70804700    0.00007400 
H                  1.36827100    2.41590900   -0.00023000 
H                  1.36827100   -2.41590900    0.00022200 
H                 -1.21129800    2.49771300   -0.00023100 
H                 -3.34932100    1.23981700   -0.00010700 
H                 -1.21129800   -2.49771300    0.00023800 
H                 -3.34932100   -1.23981700    0.00012700 
Complex of Phthalazine (183) and 5,10-Dimethyl-5,10-dihydroboranthrene (192) 
 
Cartesian coordinates of optimized structure: 
C                 -2.72210300   -3.48755700   -0.69724500 
C                 -2.16477100   -2.41019100   -1.39440500 
C                 -1.62331300   -1.31889200   -0.70590800 
C                 -1.62329300   -1.31871900    0.70624200 
C                 -2.16473400   -2.40987800    1.39498800 
C                 -2.72207900   -3.48740000    0.69808000 
C                 -1.62328300    1.31891500    0.70590500 
C                 -1.62324500    1.31874300   -0.70624500 
C                 -2.16466300    2.40991000   -1.39499600 
C                 -2.72199800    3.48744000   -0.69809000 
C                 -2.72203800    3.48759600    0.69723300 
C                 -2.16472900    2.41022000    1.39439800 
N                  0.54504700   -0.00016600   -0.68364400 
C                  1.68276000   -0.00046000   -1.34486800 
C                  2.94881700    0.00030900    0.71043500 
C                  1.68275500    0.00041700    1.34487300 
N                  0.54504500    0.00013400    0.68364800 
C                  2.94881900   -0.00034900   -0.71042700 
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C                  4.17466000   -0.00071600   -1.41451800 
C                  5.35992600   -0.00038100   -0.70798500 
C                  4.17465700    0.00068200    1.41452800 
C                  5.35992500    0.00035300    0.70799600 
B                 -0.98055500    0.00016800    1.39809700 
B                 -0.98054000   -0.00016300   -1.39809600 
C                 -0.80381300    0.00032900    2.99932400 
C                 -0.80378200   -0.00033700   -2.99932000 
H                 -3.15350500   -4.32423000   -1.24186900 
H                 -2.16638100   -2.42317200   -2.48246200 
H                 -2.16631200   -2.42264600    2.48304800 
H                 -3.15344200   -4.32396000    1.24290800 
H                 -2.16622800    2.42268200   -2.48305600 
H                 -3.15334400    4.32400600   -1.24292400 
H                 -3.15342700    4.32427700    1.24185500 
H                 -2.16635300    2.42319800    2.48245500 
H                  1.58496700   -0.00070200   -2.42333000 
H                  1.58496100    0.00064300    2.42333500 
H                  4.17050200   -0.00125900   -2.50002400 
H                  6.30603200   -0.00067100   -1.23960600 
H                  4.17049900    0.00122900    2.50003400 
H                  6.30602900    0.00064800    1.23962000 
H                 -0.29366000    0.88819500    3.39906100 
H                 -1.80091400    0.00023100    3.45554600 
H                 -0.29348800   -0.88742600    3.39911300 
H                 -0.29344200    0.88740600   -3.39911600 
H                 -0.29363300   -0.88821400   -3.39903900 
H                 -1.80087900   -0.00023600   -3.45555200 
Complex of methylchloropyridazine 218 and 5,10-Dimethyl-5,10-dihydroboranthrene (182) 
Cartesian coordinates of optimized structure: 
C                 -2.29128100   -3.61039100   -0.76755200 
C                 -1.77728600   -2.51336100   -1.46241800 
C                 -1.64280300   -1.25262600   -0.85834900 
C                 -2.02233400   -1.10612400    0.50875300 
C                 -2.51605600   -2.22805100    1.19515300 
C                 -2.66309500   -3.46711300    0.56811900 
C                 -1.63575400    1.55602400    0.33088500 
C                 -1.25782100    1.40966600   -1.03679700 
C                 -1.04071000    2.56691500   -1.80240300 
C                 -1.20682400    3.84547600   -1.26555700 
C                 -1.57667800    3.98864200    0.07067300 
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C                 -1.77594500    2.85138400    0.85623000 
N                  1.90358200   -0.27117600   -0.02687400 
C                  3.18713700   -0.36636600   -0.44710500 
C                  3.78738800   -0.18799900    1.75411100 
C                  2.49520100   -0.08697900    2.23640000 
N                  1.58989100   -0.14269300    1.21066700 
C                  4.14468800   -0.31578400    0.54675500 
B                 -1.90201600    0.28864800    1.21692200 
B                 -1.10459700   -0.02007400   -1.67005200 
C                 -2.13673700    0.42645600    2.77875500 
C                 -0.51694300   -0.20273200   -3.12786200 
H                 -2.39652200   -4.57119600   -1.26460600 
H                 -1.48487500   -2.64518300   -2.50036200 
H                 -2.80385800   -2.13565100    2.23887500 
H                 -3.06089100   -4.31510700    1.11943200 
H                 -0.74357900    2.47385200   -2.84321200 
H                 -1.04435200    4.72344900   -1.88527000 
H                 -1.70552200    4.97889300    0.49976800 
H                 -2.05766000    2.98167300    1.89762100 
H                 -1.61914800    1.28013300    3.22775900 
H                 -3.20991800    0.58862800    2.96561200 
H                 -1.86362500   -0.47032900    3.34418800 
H                  0.20531500    0.56982000   -3.40765500 
H                 -0.04046400   -1.17447900   -3.28789800 
H                 -1.34002700   -0.13713300   -3.85706900 
C                  1.99819200    0.06445800    3.63554100 
H                  0.90861300    0.10855600    3.64062600 
H                  2.32819300   -0.77730900    4.25268100 
H                  2.39777800    0.97812100    4.08719800 
Cl                 3.45854600   -0.53714600   -2.14874000 
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5.10.3 [3,9]-Sigmatropic rearrangement  
5.10.3.1 Optimization and frequency calculations 
Starting Material 274 (MeO in trans-conformation): 
 
Cartesian coordinates of optimized structure: 
C -3.77874300 -1.06423000 -0.65049300 
C -2.62315300 -1.58492000 -0.17706400 
C -1.52657000 -0.73214800 0.25654100 
C -1.68913000 0.73900500 0.11128200 
C -2.96800800 1.22517700 -0.38503100 
C -3.95496100 0.37312500 -0.74859200 
H -0.28495300 -2.31938700 0.90388100 
H -4.59077100 -1.71568700 -0.95917700 
H -2.48953700 -2.66036500 -0.09335100 
C -0.39618700 -1.24163100 0.80074500 
C -0.67656900 1.58575000 0.42118100 
H -3.10159500 2.30015300 -0.47082400 
H -4.89659300 0.75979500 -1.12777200 
C 0.73970100 -0.39015100 1.30313200 
H -0.80433500 2.65699400 0.29097000 
C 0.66014500 1.10634100 0.88042100 
O 1.64363600 1.26956700 -0.21128700 
C 2.46356200 0.19400300 -0.13099500 
C 2.08729100 -0.77994300 0.71649100 
H 2.58607100 -1.72081400 0.88882700 
H 0.74349200 -0.45308500 2.40289200 
H 1.03832100 1.73568200 1.69449600 
O 3.52438800 0.32436000 -0.93980800 
C 4.41400400 -0.78790000 -0.96224700 
H 3.89674800 -1.69569800 -1.29398400 
H 5.20331500 -0.53233400 -1.66932400 
H 4.84735100 -0.96153800 0.02990100 
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Starting Material 274 (MeO in cis-conformation): 
 
Cartesian coordinates of optimized structure: 
C                  3.84694900    0.40277900   -0.93607700 
C                  2.79161200    1.21702300   -0.70323600 
C                  1.60405600    0.74220200   -0.00943500 
C                  1.55430100   -0.68986200    0.38759300 
C                  2.73642900   -1.49716400    0.12646500 
C                  3.81875400   -0.98191300   -0.50284600 
H                  0.62125400    2.61744300    0.00985200 
H                  4.73000200    0.77670900   -1.44532800 
H                  2.81061000    2.25767600   -1.01633400 
C                  0.57727300    1.56950100    0.29989100 
C                  0.44306600   -1.21595800    0.96061800 
H                  2.71760600   -2.53803900    0.43806000 
H                  4.68443000   -1.60840600   -0.69825800 
C                 -0.64738100    1.12539800    1.05567100 
H                  0.41680200   -2.26833600    1.23044700 
C                 -0.79712600   -0.41741400    1.18022100 
O                 -1.81677500   -0.79971500    0.17210600 
C                 -2.47692900    0.35212200   -0.13467600 
C                 -1.94874400    1.48251200    0.35739300 
H                 -2.32488200    2.48032600    0.19226800 
H                 -0.59302500    1.56308200    2.06531700 
H                 -1.25571000   -0.66335500    2.14475500 
O                 -3.56282700    0.23154700   -0.91328800 
C                 -4.14403900   -1.07180600   -1.03905300 
H                 -4.48943300   -1.44773200   -0.07025600 
H                 -4.99560500   -0.94495600   -1.70829100 
H                 -3.43455900   -1.78358900   -1.46794700 
Transition State 274 (MeO in cis-conformation) to 258b’ 
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Cartesian coordinates of optimized structure: 
C -3.46452200 -1.43598300 -0.49014500 
C -2.28361700 -1.67080400 0.15403000 
C -1.37612000 -0.59848000 0.45265700 
C -1.70261500 0.75589500 0.01925900 
C -2.96155000 0.94936400 -0.63447400 
C -3.80218400 -0.10281100 -0.88281500 
H -0.07907800 -1.76126600 1.69894500 
H -4.15129700 -2.24870700 -0.70328400 
H -2.01294800 -2.67477200 0.47060600 
C -0.25851600 -0.79170800 1.24278800 
C -0.81478200 1.81013900 0.24908700 
H -3.22875900 1.95310300 -0.95233100 
H -4.74450900 0.07281200 -1.39455600 
C 0.75306700 0.26877400 1.49243000 
H -1.07672500 2.80708200 -0.09044700 
C 0.47758800 1.55962600 0.73673000 
O 1.60451100 1.19397300 -0.79098500 
C 2.28866400 0.20422400 -0.35142200 
C 1.93914900 -0.41364100 0.83618800 
H 2.45101300 -1.24148900 1.30171500 
H 0.90264900 0.48242800 2.56128600 
H 1.08329900 2.40765400 1.03804100 
O 3.36852100 -0.11697700 -1.10586100 
C 4.18250400 -1.19910400 -0.66594000 
H 3.60783600 -2.13081200 -0.60588000 
H 4.97097000 -1.30676800 -1.41188500 
H 4.63089200 -0.98817800 0.31232100 
Transition State 274 (MeO in cis-conformation) to 258b’ 
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Cartesian coordinates of optimized structure: 
C                  3.56156000    0.53054100   -1.21029800 
C                  2.48623900    1.27516300   -0.82157900 
C                  1.47293400    0.72501600    0.03721400 
C                  1.57264100   -0.67176000    0.45593900 
C                  2.73384500   -1.40058100    0.03580900 
C                  3.68169200   -0.82541100   -0.76579100 
H                  0.46096800    2.57900700    0.38147500 
H                  4.32967600    0.95578200   -1.84813500 
H                  2.38221300    2.30971300   -1.13820800 
C                  0.47205600    1.50950000    0.57252600 
C                  0.57713000   -1.25120100    1.23995300 
H                  2.83491800   -2.43499200    0.35186800 
H                  4.54354600   -1.40775700   -1.08030700 
C                 -0.64365800    0.96153600    1.39134500 
H                  0.67026000   -2.29153500    1.53498000 
C                 -0.62579100   -0.55963800    1.49670000 
O                 -1.81924800   -0.94021800    0.08759600 
C                 -2.33816600    0.22547100   -0.11650800 
C                 -1.80955600    1.33563200    0.49716600 
H                 -2.17916000    2.34301900    0.37960300 
H                 -0.69417200    1.40378800    2.39801700 
H                 -1.28942300   -0.96889300    2.25177600 
O                 -3.44138200    0.33688700   -0.89217300 
C                 -3.93427600   -0.87723700   -1.46774000 
H                 -4.28095900   -1.56993200   -0.69544100 
H                 -4.76933300   -0.58008300   -2.10359200 
H                 -3.16339700   -1.37366900   -2.06383600 
Product 258b’ (cis-ester) 
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Cartesian coordinates of optimized structure: 
C -2.95019700 -1.56299100 0.67810800 
C -1.89017900 -0.94146100 1.33850200 
C -1.15230600 0.07037900 0.71907500 
C -1.51446500 0.49722600 -0.58003000 
C -2.58336700 -0.13581000 -1.23164800 
C -3.29359600 -1.16189500 -0.61476600 
H -0.17161800 0.78786300 2.52279100 
H -3.50324300 -2.35806000 1.16947000 
H -1.62212200 -1.25414700 2.34479800 
C -0.03764500 0.73879400 1.44479100 
C -0.81565400 1.61931100 -1.19646500 
H -2.85541000 0.18858100 -2.23282600 
H -4.11552200 -1.64365800 -1.13610500 
C 0.64940300 1.90656600 0.77211200 
H -1.14372700 1.93007400 -2.18509200 
C 0.17147500 2.28680100 -0.57458500 
O 1.31683900 -0.63053700 -1.03523000 
C 1.91228500 -0.29376400 -0.03403300 
C 1.43565100 0.60945800 1.04156400 
H 2.13145900 0.68286600 1.86981500 
H 0.97833200 2.73242800 1.39858900 
H 0.63248800 3.15140100 -1.04405900 
O 3.17118000 -0.72303200 0.25916500 
C 3.74637700 -1.61308400 -0.70806400 
H 3.82234600 -1.12819600 -1.68476700 
H 4.73714100 -1.86202900 -0.32762300 
H 3.13903600 -2.51574400 -0.81383100 
Product 258b’ (trans-ester) 
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Cartesian coordinates of optimized structure: 
C                 -3.09818200   -1.57907200    0.26731900 
C                 -1.89004100   -1.37541400    0.93498200 
C                 -1.11064100   -0.24564900    0.67827200 
C                 -1.57491000    0.72381600   -0.24035800 
C                 -2.79151000    0.50769000   -0.90309800 
C                 -3.54724800   -0.63598300   -0.65917000 
H                  0.15897600   -0.43634500    2.42980300 
H                 -3.68379500   -2.47144300    0.46748500 
H                 -1.54022000   -2.11059500    1.65568400 
C                  0.15961600   -0.02391500    1.42342300 
C                 -0.81323900    1.95014900   -0.44520000 
H                 -3.14229600    1.24999800   -1.61546400 
H                 -4.48474700   -0.78994200   -1.18520200 
C                  0.89216100    1.27964300    1.21016400 
H                 -1.21113800    2.67308100   -1.15277200 
C                  0.31621000    2.22477300    0.23094700 
O                  0.94976300   -0.35022900   -1.51054200 
C                  1.78685900   -0.40716400   -0.64122600 
C                  1.55376300   -0.05547800    0.78592600 
H                  2.31928000   -0.37234200    1.48320900 
H                  1.38313800    1.73740000    2.06601800 
H                  0.82572600    3.17392000    0.08973300 
O                  3.04438200   -0.82053700   -0.99586400 
C                  4.13506100   -0.82644700   -0.07689100 
H                  4.00975800   -1.58497900    0.70475900 
H                  5.01644400   -1.07856600   -0.66886400 
H                  4.28831800    0.15426100    0.38632900 
  
Experimental Part – Calculations 
190 
5.10.3.2 Thermochemistry 
(trans-ester)
34 
[Hartree] 
starting 
material 
transition state product 
ε0+Gcorr  -652.80711 -652.78815 -652.86944 
 
[Hartree] [kcal/mol] 
 
Δ‡G0(T=298) 0.01896 11.9 
 
ΔrG°(T=298) -0.06234 -39.1 
 
(cis-ester) 
[Hartree] 
starting 
material 
transition state product 
ε0+Gcorr  -652.807321 -652.792526 -652.85544 
 
[Hartree] [kcal/mol] 
 
Δ‡G0(T=298) 0.01480 9.3 
 
ΔrG°(T=298) -0.04811 -30.2 
 
5.10.3.3 IRC-calculations 
IRC Calculation Output (trans-ester) 
Energies reported relative to the TS energy of        -652.965701 
 -------------------------------------------------------------------------- 
    Summary of reaction path following 
 -------------------------------------------------------------------------- 
                        Energy   Rx Coord 
   1                   -0.06843 -15.89939 
   2                   -0.06829 -15.57316 
   3                   -0.06812 -15.24500 
   4                   -0.06794 -14.91269 
   5                   -0.06773 -14.58052 
   6                   -0.06751 -14.25219 
   7                   -0.06727 -13.92436 
   8                   -0.06702 -13.59500 
   9                   -0.06674 -13.26485 
  10                   -0.06645 -12.93419 
  11                   -0.06613 -12.60482 
  12                   -0.06580 -12.27327 
  13                   -0.06546 -11.94026 
  14                   -0.06509 -11.60891 
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  15                   -0.06471 -11.27781 
  16                   -0.06431 -10.94634 
  17                   -0.06388 -10.61405 
  18                   -0.06344 -10.28317 
  19                   -0.06297  -9.95599 
  20                   -0.06246  -9.62421 
  21                   -0.06190  -9.29264 
  22                   -0.06130  -8.96078 
  23                   -0.06063  -8.63044 
  24                   -0.05988  -8.29894 
  25                   -0.05905  -7.96853 
  26                   -0.05812  -7.63656 
  27                   -0.05709  -7.30599 
  28                   -0.05595  -6.97574 
  29                   -0.05468  -6.64614 
  30                   -0.05325  -6.31487 
  31                   -0.05164  -5.98387 
  32                   -0.04980  -5.65278 
  33                   -0.04765  -5.32203 
  34                   -0.04511  -4.99194 
  35                   -0.04213  -4.65994 
  36                   -0.03875  -4.32735 
  37                   -0.03511  -3.99470 
  38                   -0.03132  -3.66162 
  39                   -0.02752  -3.32850 
  40                   -0.02377  -2.99550 
  41                   -0.02012  -2.66259 
  42                   -0.01658  -2.32975 
  43                   -0.01318  -1.99700 
  44                   -0.00992  -1.66430 
  45                   -0.00688  -1.33161 
  46                   -0.00417  -0.99887 
  47                   -0.00197  -0.66603 
  48                   -0.00050  -0.33312 
  49                    0.00000   0.00000 
  50                   -0.00051   0.33296 
  51                   -0.00198   0.66593 
  52                   -0.00419   0.99885 
  53                   -0.00686   1.33172 
  54                   -0.00967   1.66442 
  55                   -0.01228   1.99642 
  56                   -0.01441   2.32556 
  57                   -0.01596   2.64648 
  58                   -0.01713   2.97095 
  59                   -0.01802   3.29791 
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  60                   -0.01869   3.62428 
  61                   -0.01919   3.94955 
  62                   -0.01954   4.26260 
  63                   -0.01980   4.56351 
  64                   -0.02003   4.88149 
  65                   -0.02022   5.20482 
 -------------------------------------------------------------------------- 
IRC calculation output (cis-ester) 
Energies reported relative to the TS energy of        -652.969501 
 -------------------------------------------------------------------------- 
    Summary of reaction path following 
 -------------------------------------------------------------------------- 
                        Energy   Rx Coord 
   1                   -0.07807 -14.44562 
   2                   -0.07783 -14.10792 
   3                   -0.07756 -13.77178 
   4                   -0.07728 -13.43927 
   5                   -0.07698 -13.10729 
   6                   -0.07667 -12.78140 
   7                   -0.07634 -12.44654 
   8                   -0.07598 -12.11346 
   9                   -0.07561 -11.78139 
  10                   -0.07520 -11.44516 
  11                   -0.07478 -11.11074 
  12                   -0.07432 -10.77588 
  13                   -0.07382 -10.44221 
  14                   -0.07327 -10.10889 
  15                   -0.07265  -9.77493 
  16                   -0.07195  -9.43810 
  17                   -0.07116  -9.10133 
  18                   -0.07026  -8.76682 
  19                   -0.06923  -8.43120 
  20                   -0.06807  -8.09660 
  21                   -0.06676  -7.75997 
  22                   -0.06529  -7.42316 
  23                   -0.06365  -7.08597 
  24                   -0.06183  -6.74898 
  25                   -0.05982  -6.41229 
  26                   -0.05758  -6.07553 
  27                   -0.05508  -5.74016 
  28                   -0.05223  -5.40380 
  29                   -0.04900  -5.06678 
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  30                   -0.04540  -4.72921 
  31                   -0.04153  -4.39147 
  32                   -0.03752  -4.05343 
  33                   -0.03347  -3.71536 
  34                   -0.02948  -3.37740 
  35                   -0.02557  -3.03952 
  36                   -0.02176  -2.70174 
  37                   -0.01805  -2.36406 
  38                   -0.01443  -2.02647 
  39                   -0.01093  -1.68894 
  40                   -0.00761  -1.35138 
  41                   -0.00461  -1.01373 
  42                   -0.00217  -0.67594 
  43                   -0.00056  -0.33809 
  44                    0.00000   0.00000 
  45                   -0.00053   0.33805 
  46                   -0.00200   0.67588 
  47                   -0.00410   1.01363 
  48                   -0.00648   1.35121 
  49                   -0.00873   1.68785 
  50                   -0.01051   2.01816 
  51                   -0.01178   2.34090 
  52                   -0.01276   2.67071 
  53                   -0.01355   3.00687 
  54                   -0.01416   3.34318 
  55                   -0.01463   3.67834 
  56                   -0.01498   4.00393 
  57                   -0.01522   4.30088 
  58                   -0.01541   4.61689 
  59                   -0.01557   4.93856 
 -------------------------------------------------------------------------- 
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5.10.3.4 Mulliken charge distribution 
Starting material 274: 
 
Transition state 274 to 258b’: 
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Product 258b’: 
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5.10.4 [1,9]-Sigmatropic rearrangement 
5.10.4.1 Thermochemistry 
 [Hartree] 
starting 
material 
transition state product 
ε0+Gcorr  -578.803505 -578.74622 -578.84107 
 
[Hartree] [kcal/mol] 
 
Δ‡G0(T=298) 0.05728 35.9 
 
ΔrG°(T=298) -0.03756 -23.6 
 
 
[Hartree] 
starting 
material 
transition state product 
ε0+Gcorr  -1214.763699 -1214.710 -1214.8034 
 
[Hartree] [kcal/mol] 
 
Δ‡G0(T=298) 0.05411 34.0 
 
ΔrG°(T=298) -0.03969 -24.9 
 
 
5.10.4.2 Optimization and frequency calculations 
Transition State to product 296a 
Cartesian coordinates of optimized structure: 
C                 -3.23313200   -1.13861800    0.13835100 
C                 -1.92444800   -1.50907600    0.31407800 
C                 -0.87243400   -0.55021300    0.19715900 
C                 -1.18746900    0.81136300   -0.18025700 
C                 -2.55652700    1.15474000   -0.35113500 
C                 -3.54442000    0.21060200   -0.19044900 
H                  0.69150800   -1.92343600    0.66356100 
H                 -4.03259500   -1.86407500    0.24838600 
H                 -1.66749400   -2.53339000    0.57140700 
C                  0.46046800   -0.88797300    0.41174700 
C                 -0.11956900    1.68651800   -0.46413100 
H                 -2.81069800    2.17391800   -0.62835100 
H                 -4.58424900    0.49412200   -0.32856300 
C                  1.52413300    0.13794900    0.65892900 
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H                 -0.32371600    2.63491300   -0.95113700 
C                  1.18714200    1.25674700   -0.28719900 
O                  1.47759300   -0.34994600   -1.65222800 
C                  2.71078700   -0.82300600   -1.23638700 
C                  2.89644400   -0.43270300    0.26324200 
H                  3.16636000   -1.28705300    0.89535400 
H                  1.99637300    1.93356500   -0.55317800 
C                  1.52213100    0.59070800    2.14590600 
H                  1.73515500   -0.25469200    2.80785700 
H                  2.29339800    1.34939600    2.31179800 
H                  0.55438700    1.01626600    2.42310600 
H                  2.77804600   -1.92326300   -1.33797300 
H                  3.53503000   -0.39010700   -1.83426500 
H                  3.66911700    0.33117300    0.41070100 
Transition State to product 298a 
Cartesian coordinates of optimized structure: 
C                 -3.74485100   -0.13966600   -0.19167400 
C                 -2.70583800   -1.02106100   -0.13081500 
C                 -1.35221800   -0.60513300    0.05868600 
C                 -1.06499900    0.81025200    0.10771300 
C                 -2.17782200    1.69519700    0.04276300 
C                 -3.46356300    1.25599200   -0.10040100 
H                 -0.50478000   -2.55120800    0.06978300 
H                 -4.76032800   -0.49836100   -0.30594200 
C                 -0.29304200   -1.48786900    0.15307700 
C                  0.26232300    1.23513100    0.11658700 
H                 -4.26712700    1.98225600   -0.15408600 
C                  1.05306100   -1.10185100    0.70243200 
H                  0.46271800    2.29102300    0.00700700 
C                  1.30785600    0.29025900    0.14178500 
O                  1.06525600   -0.80737500   -1.63169400 
C                  1.95533000   -1.85552700   -1.42709600 
C                  2.08780800   -2.07995000    0.11333300 
H                  1.84548500   -3.10577800    0.41389000 
C                  1.04139600   -1.14379000    2.25141700 
H                  0.80726300   -2.15275900    2.60478800 
H                  2.02313400   -0.86399700    2.64435200 
H                  0.29678700   -0.45291400    2.65543100 
H                  1.58718500   -2.78282400   -1.90224400 
H                  2.94762100   -1.63745500   -1.85632700 
H                  3.09046400   -1.86710600    0.49727400 
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F                 -1.92120800    3.02290000    0.10441700 
F                 -2.93930700   -2.34781500   -0.20659100 
S                  2.98984400    0.82659000    0.18926600 
C                  2.92947900    2.52094700   -0.48197400 
H                  3.97158100    2.80842300   -0.63467600 
H                  2.41061600    2.52758600   -1.44190700 
H                  2.46493700    3.22332000    0.21250900 
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6 Appendix 
6.1 Abbreviations 
6-31g Gaussian basis set 
Ǻ Angstrom Ac acetyl 
Alox aluminium oxide 
b3lyp Becke, three-parameter, Lee-Yang-Parr (exchange-correlation functional) 
BD bidentate BMEA bis(2-methoxyethyl)amine  
BuLi butyllithium DA Diels-Alder 
DMG directed metalation group DCE 1,2-dichloroethane 
DCM dichloromethane DFT density functional theory 
DIBAL-H diisobutylaluminum hydride DIEA diisopropylethylamine  
DMF N,N-dimethylformamide EA elemental analysis 
EI electron impact ESI electron spray ionisation 
Et3N triethylamine EtOAc ethyl acetate 
EtOH ethanol eq. equivalents 
ERG electron releasing group eV electron volts 
EWG electron withdrawing group FAB fast electron bombardment  
FVP flash vacuum pyrolysis FMO frontier molecular orbital 
FT fourier transformation G Gibbs free energy 
GC gas chromatography h Planck constant 
Hex hexane hν Planck relation (energy of a photon) 
HOMO highest occupied molecular orbital 
HPLC high performance liquid chromatography 
HSQC Heteronuclear Single Quantum Correlation 
i.a. inter alia i.e. id est 
IEDDA inverse electron demand Diels-Alder 
IR infrared IRC intrinsic reaction coordinate 
KS Klopman-Salem LA Lewis acid 
LDA lithium diisopropylamine LG leaving group 
LUMO lowest unoccupied molecular orbital 
m meta mCPBA m-chloroperbenzoic acid 
MD monodentate MP melting point 
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MPV Meerwein-Ponndorf-Verley m/z mass to charge ratio 
NMR nuclear magnetic resonance o ortho 
p para PG protecting group 
Ph phenyl ppm parts per million  
PTAD 4-phenyl-1,2,4-triazoline-3,5-dione 
s secondary SOI secondary orbital interaction 
t tertiary TBAB tetrabutylammonium bromide 
TBME tertbutylmethylether TEA triethylamine 
TES triethyleneglycol THF tetrahydrofurane 
TOCSY Total Correlation Spectroscopy TS transition state 
TsOH toluenesulfonic acid RNA ribonucleic acid 
rt room temperature TBAF tetrabutylammonium fluoride 
TBME tert-butylmethyl ether TIPS triisopropylsilyl  
TMDA trimethylethylenediamine TMEDA tetramethylethylenediamine 
TMS trimethylsilyl TLC thin layer chromatography 
UV ultraviolet ν frequency  
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